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The cover illustration indentifies the multiple linkages that tie agriculture, food and 
nutrition together for—especially—prevention, but also treatment, of disease for the 
improvement of human health. Speakers at NABC’s twenty-second annual conference, 
and other attendees during breakout workshops, addressed all of these linkages, as 
 recorded in this report.  Research in agriculture, food and nutrition is the underpinning 
component for improvements in production systems, inputs, crops and in processing for 
more healthful diets. Research also underpins safer food sources, labeling and regulation, 
including identifying biomarkers for human disease. Finally, education, communication 
and distribution play key roles in assisting consumers in choosing more healthful foods. 
The multiple links dictate the necessity of an interdisciplinary and interinstitutional 
research structure for effective coupling of agriculture, food and nutrition to the goal of 
improved human health. 
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PREFACE
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In 2002, NABC’s fourteenth annual conference—hosted by the University of Minnesota—had the theme Foods for Health. The resulting proceedings volume, NABC Report 14, was titled Integrating Agriculture, Medicine and Food for Future Health. 
Since then, delivery of healthcare has become one of the most pressing social, economic, 
technical and political challenges of our time. In 2007, expenditure on healthcare in the 
United States was 16% of the GDP, growing at twice the rate of inflation. Diet-related 
chronic ailments—diabetes, heart disease, stroke, cancer, obesity, asthma, etc.—account 
for about 75% of the expenditure. Recognizing that emphasis has been on therapeutic 
and surgical interventions rather than on prevention through improved diet, in March 
2009 NABC published Food and Agricultural Research: Innovation to Transform Human 
Health1, a white paper proposing a 21st-century plan to make food and agriculture a full 
partner in the endeavor to improve human health.
 Building on the themes presented in Food and Agricultural Research, NABC’s twenty-
second conference, Promoting Health by Linking Agriculture, Food and Nutrition, brought 
attendees representing academia, industry and government agencies to the University 
of California’s Davis campus, June 16–18, 2010. Speakers at NABC 22 addressed the 
science linking agriculture, food, and nutrition to health, with the goal of informing both 
research priorities and government policies that seek to improve human livelihoods. 
 Agriculture and conventional food systems have provided the basis for long and healthy 
lives, which have improved dramatically over the last century, and much of that improve-
ment can be traced to healthier diets. At the same time, we are faced with a growing 
critique that conventional food systems are a significant contributor to the health crisis 
that developed countries are facing, particularly related to obesity and diabetes. With 
this dichotomy—agriculture and diet being both the problem and the solution to an 
increasing health crisis—NABC 22 was framed, focusing on research strategies to better 
promote health through food and diet as well as on how governmental regulatory systems 
are providing oversight of the relationship between food and health.  
 The conference was organized in five sessions:
I. Agriculture, Food, and Health: The Problem and the Solution
• Food and Nutrition: The Good, the Bad, and the Ugly–Carl Keen (UC Davis)
• Trends, Innovations and the Future of Food-Product Development–Clare Hasler-
Lewis (UC Davis)
 • The American Diet: Voluntary Action vs. Government Action–Michael Jacobson 
(Center for Science in the Public Interest)
1Appendix, pages 257–268.
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 II. Food for Health Successes and Prospects
 • The Pipeline of a New Generation of Foods–Marlin Edwards (Monsanto Co.)
 • Mammalian Milk Genomics: Knowledge to Guide Diet and Health in the 21st 
Century –Jennifer Smilowitz (UC Davis)
 • Opportunities for Biofortification of Cassava: The BioCassava Plus Program–
 Martin Fregene (Donald Danforth Plant Science Center)
 III. Choosing Foods for Health
 • Functional Foods For Health: Negotiation and Implications–Charlotte Biltekoff 
(UC Davis)
 • Farm2School: Giving Children a Healthy Choice for Lunch–Robert Knight 
(Old Orange Grove)
 • Putting People First: Designing for Healthy Product Choices–Lauren Shimek 
(IDEO)
 IV. Regulatory Framework for Food Health Claims
 • Food-Labeling: Where Science, Health and Policy Meet–Barbara 
Schneeman(US Food and Drug Administration)
 • The Science Behind the Claims and Why the Product that Bears a Claim Needs to 
be “Healthy”–Joanne Lupton (Texas A&M University)
 • The EU Regulation on Nutrition and Health Claims: Current and Future Trends–
Miguel da Silva (European Advisory Services)
 V. Food for Health Strategies and Programs
• Alimentary Pharmabiotics: Common Ground for Academia with the Food and 
Pharmaceutical Industries–Fergus Shanahan (University College Cork)
• A National Network for Advanced Food and Materials–Rickey Yada (University 
of Guelph)
 • Where Will Business Find the Next Best Food and Nutrition Innovations?–Will 
Rosenzweig (Physic Ventures)
Martina Newell-McGloughlin (UC Davis) provided the banquet presentation, Plant 
Biotechnology: The Answer to your Nutrition Needs!
 Thus, an excellent cross-section of interdisciplinary talks was presented to 159 attendees. 
Most of the linkages among agriculture, food, nutrition and human health were covered: 
research aspects, production and distribution systems, processing, safety, regulation, label-
ing, communication, education and choice.
As is traditional for NABC meetings, participants gathered in smaller “breakout” 
workshops for further discussions of issues raised in the plenary and Q&A sessions.
ix
2Information on the Student Voice at NABC 23 will be available at http://nabc.cals.cornell.edu/studentvoice.
3Further information may be accessed via http://nabc23.umn.edu.
4Public Intellectual Property Resource for Agriculture
The Student Voice at NABC program provides grants of up to $750 to graduate students 
at NABC-member institutions (one student per institution) to offset travel and lodging 
expenses. Also, registration fees are waived for grant winners. The Student Voice delegates 
attended the plenary sessions and breakout workshops, and then met as a group to identify 
current and emerging issues relevant to the conference subject matter.2
This volume contains an overview of the conference, a summary of the break-
out-workshop discussions, manuscripts provided by the speakers, including the 
banquet presentation, and the Student Voice report. Transcripts of the Q&A sessions are 
included.
In 2011, NABC’s annual conference will return to the University of Minnesota, St. 
Paul, MN, with food again as the underpinning theme—Food-Security: The Intersection 
of Sustainability, Safety and Defense, June 15–17.3
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Workshops Summary
two breakout sessions were held at naBC 22 on days 1 and 2—each  comprising three parallel workshops—and oral reports (see footnotes) were delivered on day 3. The objective of the workshops was to provide all conferees 
the opportunity to speak, to listen and to learn about promoting health by linking ag-
riculture, food and nutrition. The reports are summarized, using terminology from the 
cover page.
research topics
• Use all tools—plant breeding, biotechnology, radiation, preservation etc.—to 
produce more healthy foods.
• Provide funding for specialty crops, e.g. fruits, vegetables.
• encourage production of more healthy crops, e.g. canola, high oleic soybean, as 
food sources.
• Biofortification.
• Biomarkers.
• Genomics, metabolomics, nutrigenomics for personalized foods.
1recorder, workshop ; recorder, workshop ; 3recorder, workshop 3; discussion facilitator, workshop 3, and 
verbal reporter at the conference; 5recorder, workshop 3; recorder, workshop , and verbal reporter at the 
conference; recorder, workshop , and verbal reporter at the conference; discussion facilitator, workshop ; 
9discussion facilitator, workshop .
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• Post-harvest shelf life.
• food supply/security with challenges from emerging pests/diseases, climate 
change, water supply.
• Identify the bases of consumer choice with a view to modifying taste/flavor, 
cost, and culture-affected eating habits.
• attention is needed to framing problems. for example, improving human 
 nutrition may require data on median income and food costs.
research Structure
• Major programs should be interdisciplinary and interorganizational, i.e. involving 
academia, industry, government and farmers.
• Include anthropological, social, economic, behavioral and communication skills, 
and relevant sciences in interdisciplinary programs.
• nurture interdisciplinary conversations to help generate collaborative programs.
• national r&D support should be allocated specifically for interdisciplinary 
and interorganizational programs [similar to Canada’s agricultural Bioproducts 
Innovation Program (aBIP), for example].
• Provide incentives to academics to collaborate, including joint appointments and 
participation in joint graduate programs.
research training
• redress the shortage of food scientists.
• expose students to multidisciplinary collaborative efforts.
• Provide a full repertoire of practical skills to students as part of science-capacity 
building.
• Develop skills in communicating with consumers (see also Communication below).
• follow the recommendations laid out in the national research Council’s 009 
report, A New Biology for the 21st Century.
regulation
• Credible, science-based.
• reduce the high cost of regulatory hurdles for low-acreage biotech-modified 
specialty crops, e.g. fruits and vegetables important for human health.
• elucidate biomarkers to appraise human-health claims for foods.
Labeling
• Develop easy-to-understand profiling of food healthfulness, e.g. a smiley face for 
“healthy.”
• assess the effectiveness of current food labeling.
3Burns, Da Silva, Martin, McLellan, Montero, ritchie, Steed, Swartzel, and tomich
education
• Promote education in food, nutrition and health for consumers (adults and 
K–), food preparers (e.g. chefs), and health-service providers (nurses, physicians).
• Graduate students in the applied sciences should be exposed to political science 
and learn skills for communicating with lay people.
Choice
• Provide incentives to growers and processors to provide, stepwise, more healthy 
food, e.g. reduced in calorie, salt and sugar contents and containing improved 
oils.
• replicate applicable aspects of the anti-smoking campaign to encourage healthy 
food choices.
• Use all available media—print, radio, television, Internet—to encourage people 
to consume fewer calories, less salt and less sugar.
• Structure food-stamp programs to encourage purchase of healthy foods.
• Identify forces shaping health and food choices by consumers.
Communication
• encourage dialog between consumers and academics involved with agriculture, 
food and nutrition. 
• fund behavioral/communication-based research to develop effective tools to 
motivate consumers to make more-healthy food selections.
• Communicate the advantages of improved quality of life and savings in medical 
costs that result from choosing healthy foods.
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food and nutrition: The Good, The Bad, and The Ugly 
Carl L. Keen and Roberta R. Holt
trends, Innovations and the future of food-Product Development 3
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The american Diet: voluntary action vs. Government action 
Michael F. Jacobson
Q&a 5
Part III–PLenarY SeSSIonS
agriculture, food and Health: the Problem and the Solution
 Promoting Health by Linking agriculture, food, and nutrition

the 19th century in the United States was a period of great expansion of population and of cities and territory. with the establishment of the railroad and enhanced food-preservation technologies, a variety of food products soon became 
available across the country. By the end of the century, markets began to replace the 
personal or local farm as the primary source of food attainment (williams, 00). new 
techniques in agriculture and food preservation were developed to meet new demands 
for greater food choices at modest prices. In the 90s, wilbur o. atwater at the USDa 
established the first compositional and requirement tables for food (welsh et al., 00). 
During the same time period, the US government expanded research into nutrition and 
food safety for the military (friedl and Hoyt, 99). In part, as a consequence of the 
above, by the early 900s a set of demands that met the needs of the average consumer, 
public health officials, government entities, and the food industry was established. These 
demands were, and continue to be, for foods and diets that are safe, nutritious, well bal-
anced, and modestly priced, while affording those in industry a profit. although initially 
the primary demands on the food industry were that the products they provided be safe 
and reasonably priced, the expectation today is that foods we consume will also protect 
against a wide variety of age-related diseases. Thus, changing concepts in the expectations 
of food in the past century have moved beyond the reduction of well-recognized nutri-
tional deficiencies (e.g. scurvy, rickets, and pellagra) to that of food providing “optimal 
health” (figure ).
Food and Nutrition: 
The Good, The Bad, and The Ugly
Carl L. Keen and roberta r. Holt
University of California
Davis, California
clkeen@ucdavis.edu
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It is important to note that consistent with these new expectations of diet by the pub-
lic, a major part of the rationale driving the development of current US and Canadian 
Dietary reference Intakes (DrIs) is that nutrient intakes should ideally be set at levels 
that reduce the risk for select chronic diseases, such as diabetes, heart disease and cancer 
(IoM, 99; Chung et al., 00). This expanded the mission of public-health policy 
from setting nutrient levels to prevent deficiencies that cause well-defined diseases to the 
establishment of dietary recommendations for the prevention of chronic disease states 
that are multifactorial in etiology, and for which established biomarkers are not yet well 
defined (Chung et al., 00; IoM, 00). as part of the DrI process, in addition to the 
identification of the adequate intakes (aI) and recommended dietary allowances (rDa) 
for essential nutrients, when possible the committees also identify tolerable upper intake 
levels (UL) for these nutrients, which are defined as the amount of the nutrient that can 
be consumed on a daily basis with no evidence of harm. Inherent to the UL concept is 
that there is a U-shaped curve for any essential nutrient. while the concept of U-shaped 
curves and the importance of ULs are well accepted by nutritionists, how the general 
public will interpret them is unknown. while common in the drug industry, in general 
the agricultural industry at large, and the food industry specifically, has minimized dis-
cussions concerning risks and benefits. a reasonable question is whether this is an issue 
that food companies should address in the near future. for the food industry, this new 
figure . The changing expectations from a healthy diet: from prevention of essential 
nutrient deficiencies to achieving optimal health.
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goal of the DrIs can be viewed as a huge opportunity or a daunting challenge. we would 
submit that the DrIs represent a major step forward in nutrition sciences; how the food 
industry will use them and communicate the potential value of the DrIs to the general 
public is yet to be determined. Below, we present examples where foods have been modi-
fied to reduce the risk of select diseases, and we discuss some of the potential benefits and 
hazards that can occur when this approach is taken. 
the Good: early nutrition Successes
In the past 00 years, a number of public-health agencies, and later the government, had 
numerous significant successes with respect to nutrition and health and the prevention of 
well-recognized primary nutritional deficiency disorders, by working in concert with the 
food industry. an example of this in the United States is the addition of iodine to table 
salt in 9 to prevent goiter. Iodized salt was initially limited to the state of Michigan, 
as the Michigan State Medical Society was first to work with their state’s salt producers to 
reduce industry concerns and advance the technology to bring this product to the public. 
Subsequent data showing a successful decline of goiter influenced the rest of the industry 
to iodize salt throughout the country, lest they lose a market opportunity. By no more 
then a decade later, iodine deficiency in the United States had been largely eliminated 
as a public health problem (Backstrand, 00; Bishai and naluba, 00). although this 
is a clear success story for the food industry, with respect to the general public there is 
little appreciation of the critical role that iodized salt has played in the prevention of 
iodine-deficiency disorders. Unfortunately, in part as a consequence of the current trend 
for salt avoidance, there are increasing reports that marginal iodine deficiency may be 
reemerging as a public health issue (Perrine et al., 00; tayie and Jourdan, 00). How 
health agencies and food companies might deal with the seemingly conflicting messages 
of the need to increase one’s iodine intake, as well as the need to reduce salt intake, is at 
present unclear. It is worth noting that the potential problem of iodine deficiency could 
be further amplified if individuals, in a desire to use more “natural products,” elect to use 
sea salt in place of iodinated table salt, as the former typically contains only trace amounts 
of iodine (Dasgupta et al., 00).
The medical community “encouraged” salt iodization whereas industry initiated the 
establishment of vitamin-D fortification. rickets was a common childhood disorder in the 
northeast, with 339 associated deaths reported in the United States in 933 (Backstrand, 
00). Prior to isolation of vitamin D to combat the disease, a variety of products was 
available on the market including irradiated milk, cod-liver oil preparations, and milk 
from yeast-fed cattle. with the isolation of vitamin D, the dairy industry was able to begin 
to fortify milk by 93. a combination of industry advertising and promotion by the 
american Medical association raised awareness of the preventative benefits of consuming 
vitamin-D-fortified milk (Bishai and naluba, 00). 
while rickets and goiter were considered substantial health issues by the general public, 
beri beri and pellagra were of less concern. These micronutrient deficiencies were not 
addressed until 9, when President roosevelt convened the Committee on food and 
nutrition of the national research Council for a national nutrition Conference for 
Keen and Holt
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Defense. at this conference the first rDas were presented.  The committee also expressed 
concerns with the lack of regulatory oversight with regard to fortification of foods, and 
established guidance for fortification under the authority of the fDa. The fDa established 
standards for flour enrichment with iron, thiamin and niacin in 9, and riboflavin in 
93 (Backstrand, 00). In 9, the US army began purchasing enriched flour only, 
and by the end of the 90s several states enacted laws mandating flour enrichment 
(Bishai and nalubola, 00). for the most part, the above food-fortification strategies 
were widely successful, significantly reducing the frequency and severity of what were 
once common nutritional deficiency diseases throughout the United States. 
regrettably, the above public-health successes have largely been forgotten, as has 
the critical role that the food industry has played in the prevention of these nutritional 
deficiency diseases. one often hears that diets 00 years ago were typically better than 
they are today, and that “natural foods” are typically superior to the modified foods one 
finds in today’s grocery stores. while these views are clearly flawed, less evident are the 
actions that are needed to correct these misperceptions. education campaigns in this area 
could have multiple benefits, ranging from a greater awareness of the historical role food 
companies have had in improving the general public health, to potentially creating an 
environment where the public is more responsive to the concept that, through relatively 
simple food modifications (fortification, raw-ingredient sourcing, food processing, etc.), 
further marked improvements in the health of the general population are likely to be 
achieved. It is reasonable to suggest that a greater acceptance of this concept would help 
agriculture and the food industry meet, in a timely fashion, many of the objectives that 
are shown in figure . However, it must be stressed that the last objective in figure  (a 
condition of “optimal health”) cannot realistically be achieved through diet alone. although 
most individuals accept this point, the extent to which they think that diet is the key to 
optimal health varies considerably. This variation is due in part to how one defines the 
phrase “optimal health.” Is it a sense of good health and well being, a reduction in the 
initiation and progression of certain chronic diseases, the achievement of one’s genetic 
potential, or the ability to play tennis and win at the age of 0? Depending on how the 
phrase is defined, the extent to which the food industry can help the general population 
meet this goal varies tremendously. equally important, industry needs to help manage 
expectations regarding how quickly we think significant specific changes in health through 
diet modifications should occur. for example, given what is already known concerning 
the influence of several nutrients on vascular function, most would agree that reduc-
tions in blood pressure across the general population could be achieved through some 
relatively simple diet modifications. However, there is a dearth of information on how 
select nutrients might influence one’s risk for many age-related chronic diseases, such as 
dementia. Thus, measurable progress in this area is bound to be slower. 
the Good: “Let food Be thy Medicine, Let thy Medicine Be  
thy food”
Hippocrates told his students ,500 years ago that food can heal through a proper diet 
(Halsted, 99). to this day, nutrition research is still focused on how diet can reduce 
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risk of onset and progression of a number of chronic diseases. However, a major problem 
facing the food industry with respect to the design of “healthy foods and diets” is that 
multiple factors can influence an individual’s nutrient needs. These factors include 
• age,
• sex,
• genetic background,
• reproductive status,
• lifestyle habits,
• presence of disease(s), and
• general environment.
Clearly, on a practical basis, foods, much less diets, cannot be specifically tailored to each 
individual’s needs. while this is not a major issue, if one is simply producing foods that 
are good for one’s general health, it is an issue if the food, and specific components in it, 
is being touted as a means of reducing the risk for select diseases or health conditions. 
although this concept is well accepted in medicine, the extent to which it can complicate 
dietary recommendations for the general public has received surprisingly little attention. 
This is, in part, understandable, given that many diet recommendations in the past were 
relatively generic (rich in plant foods and low in salt and saturated fat, etc.), but in the 
future this will become a greater issue as we increasingly view food and diet as tools for 
reducing the risk for a variety of diseases or health conditions. 
an example of the above is the relatively recent folic-acid fortification of cereal products 
in the United States and Canada. The target population for this diet modification was 
pregnant women—to reduce the risk of children being born with neural tube defects 
(ntDs)—yet the entire population is affected by it. furthermore, it is thought that the 
pregnant women who will benefit most are those who have genetic polymorphisms that 
affect folate absorption and metabolism (Blom, 009), therefore, the subset of women 
benefitting from folate supplementation might be quite small. on the other hand, folate-
fortification programs in the United States and Canada have been very successful with 
respect to the primary goal, a reduction (approximately 50%) in the incidence of infants 
born with ntDs (De wals et al., 00; obican et al., 00). The above outcome can 
certainly be heralded as an excellent example of the successful use of food as a means to 
reduce the risk for a severe health complication, yet others have argued that widespread 
folate fortification might increase the risk of other health complications, including the 
development of some cancers (Lucock and Yates, 009). at present, this is still an issue 
of debate, although current data suggest an increase in cancer attributable to the folate 
fortification program has not occurred. while the authors of the current paper support 
folate-fortification programs, the question that needs to be addressed is, to what extent 
should the potential risks and benefits of food-fortification programs, such as that for 
folate, be communicated to the general public? In a similar vein, to what extent, if any, 
does the food industry have a responsibility to provide the public with a variety of foods 
that contain various amounts of select nutrients?
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It would be wrong to dismiss the food folate-fortification issue as unique. Similar issues 
have been raised with respect to iron fortification of foods, and more recently vitamin D. 
Major concerns were once raised that iron fortification could present a significant health 
challenge to individuals with hereditary hemachromatosis. with respect to vitamin D, 
during the past five years increasing attention has been given to the idea that typical 
dietary vitamin-D intakes are suboptimal (Holick, 00). This change in thinking by 
some experts has come about due to recent data suggesting that vitamin D has positive 
physiological actions above and beyond bone health. Indeed, some experts are arguing 
that vitamin-D intakes should be higher than the UL that was set by the food and nutri-
tion Board in 99 (IoM, 99). The current paper is not the place for a debate on the 
relative pros and cons of increasing dietary vitamin-D recommendations, but rather we 
cite it as an example of where new expectations of a nutrient (e.g. high levels of vitamin 
D have been postulated to reduce the risk for colon cancer) may significantly influence 
current food-fortification programs. The key question that we ask here is, to what extent 
should the general public be involved, or aware, of this debate? Specifically, to what extent 
should the public be informed of potential risks, as well as potential benefits, of a marked 
increase in vitamin D in commonly consumed foods? assuming that we continue to 
develop new foods (changes in raw product sources, processing, formulation, etc.) that 
are aimed at substantially reducing the risk for select diseases in some population groups, 
the probability that some adverse effects will be associated with their use in other popula-
tions will undoubtedly increase. How do we communicate this risk, and who should be 
responsible for the communication?
the Good: evolution of Diet recommendations, and  
our expectations of food
During the past decade there has been a resurgence in the idea that shifts in our diet can 
translate into marked changes in our risk for certain diseases. Illustrative is the increasing 
research on phytochemicals that are thought to have vascular health properties. observa-
tional studies have suggested that large intakes of fruits and vegetables (5– servings per 
day) are associated with reduced risk of cardiovascular disease (Liu et al., 000; Joshipura 
et al., 00; Dauchet et al., 00); further analyses have shown even stronger associations 
with certain foods and specific phytochemicals (erdman Jr. et al., 00; Mink et al., 00). 
for example, interventional studies have suggested that the consumption of foods high 
in specific subclasses of the large flavonoid family, the flavanols and procyanidins, can 
improve a number of measures of vascular health, including vascular and platelet reactiv-
ity, and markers of inflammation (Holt et al., 00; Selmi et al., 00; Heiss et al., 00) 
(figure ). Intake of select purified phytochemicals, such as the flavanol (-)-epicatechin, 
provided in similar amounts to those found in food, has been shown to have positive 
vascular effects (Schroeter et al., 00). The type of work described above is critical as it is 
well established that the flavonoid and flavanol contents and profiles in foods can greatly 
vary depending on the agricultural and food processes from which the food product 
originated. Illustrative is that the effects of food processing might be especially important 
with respect to the availability of bioactive (-)-epicatechin, as it can epimerize with heating 
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and alkalization to (-)-catechin (Gotti et al., 009; ritter et al., 00). while the extent 
to which a shift in the flavanol profile of a food (e.g. from (-)-epicatechin to (-)-catechin) 
might alter its health effects is still an issue of debate, this is an example of the new way 
that phytochemicals in foods are being investigated. The recent work with flavanol- and 
procyanidin-rich foods is also important as the consumption of such foods has been re-
ported to improve the vascular health even of diabetics and patients with coronary artery 
disease (Heiss  et al., 00). taken together, this body of work is just one example of how 
a food product that is well characterized for its nutrient content can produce robust and 
consistent changes in specific biomarkers; and it is demonstrative of how current research 
on nutrition has moved towards the Institute of Medicine’s goal of defining nutrients that 
will slow or prevent the onset of chronic disease (Chung et al., 00). Clearly, evidence 
is accumulating that food can, indeed, be part of one’s medicine.
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figure . reported cardiovascular health effects after intake of indicated foods that are 
rich in flavanols and procyanidins (see Holt et al., 00; Heiss et al., 00).
the Bad: How Good is our food?
a common question from the lay public is: are our diets better today than they were 
50 or even 00 years ago? as is outlined above, a critical review of the facts shows that 
the answer to this question is an easy, “Yes.” However, despite the many examples that 
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show our diets are better today, many consumers feel otherwise. we would submit that 
an understanding of this divergence of views is critical as we seek to improve popular 
perception of the agricultural industry in general, and the food industry more specifically. 
as discussed above, we suggest that the public’s sometimes negative view of the food 
industry as it relates to their provision of “nutritious foods” is due in part to an evolution 
in our thinking as to what constitutes a healthy diet. a hundred years ago, the concept 
that our diet could be a key factor in the prevention, much less the treatment, of numer-
ous disease states received minimal attention. today, diet is viewed increasingly as a key 
player in the initiation, progression, and treatment of numerous diseases. as we change 
expectations of our diets, it should not be surprising that they are at times found wanting. 
as discussed above, an example of this is our limited ability at the present time to define 
the multiple factors that contribute to the positive vascular health effects of diets rich 
in plant foods. a predictable consequence of this is that intervention trials in which the 
effects of select plant foods are studied on biomarkers thought to reflect vascular health 
will, at times, be negative. when the information from negative trials is not carefully 
presented, it can lead to cynicism in the public, and fuel the belief that some foods are 
not as beneficial as we have preached. on the positive side, the above issue is one that 
can be managed with appropriate educational campaigns. However, on the negative 
side, for the most part, the agricultural industry has not taken a leadership role in the 
development of such campaigns.
food safety is another area where there can be striking differences of opinion between 
the lay public and health professionals. while the vast majority of experts in the broad 
field of food safety would endorse the statement that our food supply is safer today than it 
was 50 years ago, we increasingly hear concerns over food safety from the general public. 
These concerns span a wide range of issues from the potential risks of pesticide residues on 
fruits and vegetables, to genetically modified foods, to the increasing use of nanomaterials 
in food products (Borchers et al., 00). In the absence of strong educational campaigns, 
unease over food safety will only increase. It is imperative that we find ways to communi-
cate to the public food-safety messages that can, at times, be complex. an example of this 
problem can be drawn from current ongoing debates concerning pesticide residues, where 
distinctions are typically not made between variables such as exposure versus risk. as a 
consequence, one often hears the argument that organically grown fruits and vegetables are 
“healthier” than conventional counterparts. while there are a number of reasons why one 
might prefer organically grown foods, the fear that conventional grown crops are unsafe 
should not be one of them. again, proactive educational campaigns are needed.
another major issue facing agriculture and the food industry today is an increasingly 
prevalent opinion that the food industry is primarily driven by a quest for profit, even 
when it is to the detriment of the health of the general public. Illustrative of this, a com-
monly heard theme in the United States is that irresponsible food companies are largely 
to blame for the current obesity epidemic (Parloff, 003; Ludwig and nestle, 00). 
This claim is often based on the idea that many of the low-cost foods available in the 
marketplace today have little to offer in the way of “good nutrition,” but rather are simply 
inexpensive sources of energy (Drewnowski and Darmon, 005). It has been argued that 
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these nutrient-poor low-cost foods are being disproportionately consumed by individuals 
in lower socioeconomic groups, with the result that these individuals are at a heightened 
risk for nutritional deficiencies, as well as numerous diseases including obesity and diabetes 
(Drewnowski and Darmon, 005; Drewnowski, 009). at its worst, one increasingly sees 
and hears terms, such as “toxic food corridors,” being used to describe how components 
of the food industry are in effect a major cause of the obesity epidemic. Clearly, this 
is an area where the food industry again needs to be part of coordinated educational 
campaigns. The message that the “food industry” is putting out “toxic foods” is one that 
demands urgent attention. while some food industries might view this issue as one that 
only concerns fast-food restaurants, this is not the case. an example of how the concept 
of toxic foods can take hold, beyond the issue of obesity, can be drawn from the “trans 
fats” story. In the early 900s, it was discovered that liquid oils could be hydrogenated to 
form trans fatty acids, and trans fat became the first man-made fat to be widely used in 
the food supply. In the 950s, trans fats were viewed by many, including the american 
Heart association, as a positive factor in the diet. However, in the early 990s a series of 
papers suggested that diets high in trans fats might be a risk factor for vascular disease. 
although the extent to which trans fats are causal in the initiation and progression of 
vascular disease is still a subject of debate, in 003 the fDa required trans fat labeling 
on the Nutrition Facts label. In 00, new York City banned the use of trans fats in res-
taurants, and multiple other cities have since followed their lead (okie, 00) . whether 
or not the removal of trans fats from the food supply will have a measurable effect on the 
risk for vascular disease in the general population is not the issue here. rather it is that 
the food industry was widely portrayed as being a culprit in the story, adding trans fats 
to foods in order to increase their bottom line. That trans fats were initially viewed by 
many public health officials as being good is a part of the story that was largely ignored, 
and to this day many view trans-fat-containing foods as toxic. 
the Ugly? Changing expectations of food:  
evolution of Biomarkers. 
a major problem in the food industry is that health claims are often made for products 
on the basis of minimal or no data. recently, the public has been exposed to one story in 
the media after another in which food companies are pilloried for making unsubstanti-
ated health claims about their products. This is a problem that is bound to increase, as 
the demands for health-promoting products will certainly expand as individuals look 
to their diets as a means of reducing their risks for the development, and treatment, of 
select chronic diseases. while it is easy to make the argument that food companies should 
provide at least some data in support of their claims that their products do indeed have 
health-promoting effects, far more contentious is the question of how extensive this data 
base should be. In contrast to the pharmaceutical industry, intellectual property, as it relates 
to potentially newly discovered health benefits of common nutrients in the food supply, 
is hard to define. Historically, this has not been an issue, but if we increasingly turn to 
diet (and select foods) as a form of medicine, this is an issue that merits attention. In this 
regard, a national academy of Sciences Institute of Medicine committee recently pub-
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lished a monograph entitled Evaluation of Biomarkers and Surrogate Endpoints in Chronic 
Disease (IoM, 00) that deserves special attention. This comprehensive report provides 
a number of observations and recommendations concerning the use of biomarkers in 
nutrition and disease studies. In figure 3, we highlight three of these recommendations. 
on the surface all are reasonable, but if they were to be implemented it could potentially 
have a chilling effect on research in the area of functional foods. Given the low costs of 
food relative to pharmaceuticals, the expenditure involved in conducting studies according 
to these recommendations would in most cases be prohibitive. Therefore, there is a real 
risk that many food companies will scale back their research efforts on ways to improve 
the “nutritional value” of foods if they perceive no competitive advantage to this type of 
work. a conundrum facing the general agricultural industry, and more specifically the 
food industry, is how, from an economic perspective, private companies can justify the 
development of new foods that substantially improve human health. we would submit 
that it is imperative that this issue is addressed with alacrity, for if it is not, there is a real 
concern that many in the food industry will reduce their efforts with respect to the future 
development of impactful health-promoting foods. 
figure 3. Biomarker evaluation process recommendations (IoM, 00)
Conclusion
The concept that one’s health is in part dictated by diet is well recognized. regrettably, 
the focus of too many discussions in this area is often on the putative negative effects 
of “bad diets” and “bad foods,” rather than on the identification of diets and foods that 
may confer significant positive health effects. There is a clear need for the development 
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of new educational programs that not only inform the public about the potential health 
benefits of foods, but that communicate, in an easy-to-understand way, the principles of 
benefit-risk analysis. The agricultural industry in general and the food industry specifically 
are poised  to make significant new advancements in the generation of what might be 
viewed as revolutionary health-promoting foods; after ,500 years we are getting closer 
to meeting Hippocrates’s challenge. 
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without question, health is on the front burner of trends, innova-tions and future food-product development efforts (rahavi and Kapsak, 00). More than ever before, consumers are interested in how to get healthier 
through diet: the secrets of eating smarter and the science of staying healthy. what really 
makes us fat? Do low-carb diets really work? what should we eat to help us live longer 
(Park, 00)?
Diet trends are not new. and, unfortunately, many diet trends of the past 0 years 
have not been healthful—some even unsafe (Younger, 009). for example, in response 
to a 99 Lucky Strike cigarette advertising campaign (“reach for a Lucky instead of a 
Sweet”), smoking became the approach to weight loss for many in the 930s and ’0s 
(watlins, 959). In the 950s, people prayed for weight loss. Support groups and cab-
bage soup were strategies in the 90s. In the 90s diet pills (McBee, 9) were the 
rage, followed by the Scarsdale diet (tarnower, 99) in the 90s. and who can forget 
the low-carb craze of the 990s (atkins, 99)? During the last decade “lite” foods were 
hot (Heasman, 993) and more recently the “00 calorie” snack (Sloan, 00). foods 
provided in 00-calorie portion sizes have impacted food categories ranging from nuts to 
crackers to soups—even candy (figure )—in an effort to address escalating obesity.
escalating obesity
obesity has grown into a major public-health crisis over the last 5 years (flegal et al., 
00). In 95, only 0% of the US population was obese. In 00, obesity exceeded 
0% in all but one state (Colorado); it exceeded 30% in more than half a dozen others. 
The health consequences of obesity are numerous (CDC, 009a), contributing to heart 
disease, stroke, several types of cancer (including colon, prostate and breast cancers) and 
diabetes. obesity also increases surgery risk and causes gastrointestinal problems, and it 
shortens life by  to  years. 
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obesity has reached epidemic proportions on a global scale, and public-health organiza-
tions are taking action. In 009, the Centers for Disease Control and Prevention (CDC) 
hosted Weight of the Nation, an inaugural conference on obesity prevention and control 
(CDC, 009b). of particular concern is the incidence of childhood obesity (Daniels, 
009), which has tripled in the last 30 years (CDC, 00). a study in the New England 
Journal of Medicine found that about 0% of children who were overweight at age 0–5 
years were obese adults at age 5 (whitaker et al., 99). In february 009, first Lady 
Michelle obama launched Let’s Move, an anti-obesity campaign targeted at children 
(white House office of the first Lady, 00). If childhood obesity continues to increase 
unabated, some public-health experts speculate that this will be the first generation that 
has a shorter life expectancy than their parents’ (olshansky et al., 005). Therefore, it 
is not surprising that the one of the top-ten functional food trends is “foods for ailing 
adolescents” (Sloan, 00a). we can expect to see many more functional-food products 
targeted at children, particularly for weight control.
food-Consumption trends
according to the 2009 Food & Health Survey from the International food Information 
Council (IfIC), % of adults are changing the amounts of food they eat to lose or main-
tain weight (IfIC, 009a). They are also changing the types of foods or food components 
they eat. But fewer than 0% are counting calories and only % of consumers correctly 
estimated their daily caloric intake; % overestimated their energy needs (IfIC, 009a). 
figure . an answer to the obesity problem?
33Hasler-Lewis
according to the June 00 report of the Dietary Guidelines advisory Committee, “it 
is time for everyone in this country to know how many calories they need in a day” 
(DGaC, 00). 
another food-innovation strategy that companies have used to address the obesity 
epidemic is the development of products containing bioactive components that increase 
energy metabolism. one example is enviga—a line of sparkling green-tea beverages 
jointly marketed by the Coca-Cola company and nestlé (http://www.enviga.com). enviga 
contains a unique combination of bioactive ingredients (green-tea antioxidants and caf-
feine) that burn calories by increasing metabolism. Product claims state that consuming 
three cans burns 0 to 00 calories. not surprisingly, these claims are highly controversial 
(CSPI, 00). of course an equivalent number of calories can be expended by walking 
a mile, which is more healthful and also free.
eating to Lose weight
Certain foods or food categories are also being investigated for weight-loss benefits, 
including dairy products (Lanou and Barnard, 00). a recent meta-analysis of thirteen 
randomized, controlled trials found that increasing daily calcium intake from dairy by 
, mg/day was associated with an increase in excretion of fecal fat of 5. g/day com-
pared with low calcium (<00 mg/day), which could be relevant for weight management 
(Christensen et al., 009). However, the clinical evidence for the role of dairy products in 
weight loss is still relatively modest (Zemel, 009). almonds are also being investigated for 
their role in weight management. They are a good source of fiber, which increases satiety, 
and recent evidence from clinical studies showed no weight gain even when adding in 
excess of 300 almond calories a day to the diet (Hollis and Mattes, 00). 
Getting away from highly processed foods and back to whole foods, “whole health eat-
ing,” is a leading diet trend. Consumers are interested in foods that not only aid weight loss, 
but also help them live a healthier, longer life, referred to as “functional foods” (Hasler and 
Brown, 009). a 005 expert-panel report from the Institute of food technologists (Ift) 
defined these as “foods and food components that provide a health benefit beyond basic 
nutrition” (Ift, 005). Interest in naturally functional foods and whole-food nutrition 
is likely to be one of the strongest health trends for the next 0 years (Sloan, 009).
Several factors are driving the healthy-eating trend, including wellness-focused consum-
ers, an epidemic of chronic disease driven in part by aging demographics, rising healthcare 
costs, food innovation, public-health policy, a business opportunity, and an overwhelming 
body of literature linking diet to health and wellness (Hasler and Brown, 009).
according to a recent article in Prepared Foods Magazine, health and wellness will 
continue to be top priorities for consumers, and their interest will continue to drive the 
functional-foods sector (rahavi and Kapsak, 00). a recent “State of the Industry” report 
in Food Technology Magazine, “what, when and where america eats,” stated that % 
of consumers are eating to manage specific health issues (Sloan, 00b). according to the 
IfIC 2009 Foods for Health Consumer Trending Survey, cardiovascular disease—including 
heart disease, cholesterol level, blood pressure and stroke—was cited as the leading health 
concern by % of consumers (IfIC, 009b).
3 Promoting Health by Linking agriculture, food, and nutrition
Heart Disease
Salt
Consumers should be concerned about heart disease, as it continues to be the leading 
killer of men and women in the United States (aHa, 00). one of the next product-
development challenges to address growing concerns about heart disease will be sodium 
reduction (Katz and williams, 00; Kuhn, 00). a study recently published in the 
New England Journal of Medicine showed that cutting salt intake by just 3 g a day—the 
equivalent of half a teaspoon—could reduce the number of new cases of coronary heart 
disease each year by 0,000–0,000 and save an estimated $0–$ billion in healthcare 
costs yearly (Bibbins-Domingo et al. 00) (figure ).
figure . Potential effects of cutting salt intake by 3 g/day (Bibbins-Domingo et al., 00).
although the contribution of excess sodium to morbidity and mortality from cardio-
vascular disease is considered to be fairly well established (Strazzullo et al., 009), not all 
experts agree that there is a comprehensive need for sodium restriction in prepared foods 
(alderman, 00). The current dietary guidelines recommend an upper daily intake 
of ,300 mg of sodium, whereas the average american consumes nearly 3,500 mg/day 
(USDa, 00). for people with hypertension, all african-americans and those over 0 
years of age, the recommendation is ,500 mg. approximately 0% of the US popula-
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tion falls into this lower-sodium group. furthermore, nearly 0% of individuals don’t 
know the current recommended daily amount of sodium that an average adult should 
consume (IfIC, 00).
The number of food products with low sodium claims has soared in the last few years 
(Scott-Thomas, 00a). with sodium restriction a major focus of the 00 dietary guide-
lines (USDa-DHHS, 00), we can expect the development of many more restricted 
sodium products in the future. In March, Kraft announced that it will cut sodium in 
products by 0% over the next  years (Kraft, 00). other companies, including Gen-
eral Mills, are following suit (Scott-Thomas, 00b). In april 00, the new York City 
Department of Health launched the National Salt Reduction Initiative—a partnership 
of cities, states and national health organizations guiding a voluntary reduction of salt 
levels in packaged and restaurant foods (Katz, 00). The food-innovation challenge is: 
how will mandatory sodium reduction in foods affect taste? taste is still the leading fac-
tor influencing purchases of foods and beverages—more important than even price or 
healthfulness (IfIC, 009a).
Vitamin D
another future product-development focus will likely be vitamin-D fortification. In addi-
tion to its essential role in bone health, vitamin D may reduce the risk of various types of 
cancer (Krisnan et al., 00) and also boost immune function (Maruotti and Cantatore, 
00). Many individuals have suboptimal vitamin-D levels (Kennel et al., 00), and 
emerging research suggests that they are at greater risk of mortality from cardiovascular 
disease or other causes (Melamed et al., 00; Ginde et al., 009). recently, an Institute 
of Medicine committee was named to undertake a study to assess current relevant data 
and update as appropriate dietary reference intakes (DrIs) for vitamin D and calcium 
(http://www.iom.edu/activities/nutrition/DrIvitDCalcium.aspx). The current recom-
mendation for vitamin D intake established by the food and nutrition Board ranges from 
00 to 00 IU. Some experts believe we may need ,000 to ,000 IU/day for optimal 
health (Landers, 009). vitamin-D intake recommendations are very likely to increase 
in the near future, which will result in supplementation of many more food products 
on the market or promotion of their natural vitamin-D content. an innovative strategy 
enhances vitamin-D content in mushrooms (e.g. figure 3), the only known commodity 
crop that naturally contains vitamin D. a serving of conventionally cultivated mushrooms 
(i.e. grown in the dark) contains ~% of the daily value (Dv) of vitamin D (http://www.
ars.usda.gov/SPUserfiles/Place/35500/Data/Sr/nutrlist/sra3.pdf). However, 
brief exposure to Uv light can increase that to over 00% of the Dv (Koyyalamudi, 
009). In 009, Good Housekeeping awarded one of its first annual vIP (very Innovative 
Product) awards to vitamin-D enhanced mushrooms (http://www.goodhousekeeping. 
com/product-testing/reviews-tests/appliances-electronics/innovate-products-awards).
In Summary
Interest in whole-food nutrition will be a leading trend in the food industry for the fore-
seeable future. More and more consumers are proactively influencing their own health by 
3 Promoting Health by Linking agriculture, food, and nutrition
including functional foods in their diets. future food-product development efforts will 
include a focus on weight loss and sodium reduction. vitamin D will be the new “hot” 
food ingredient. taste still reigns, and foods must be fun! americans are still not willing 
to give up all indulgences in the name of a healthy lifestyle (anonymous, 009).
figure 3. Mushrooms enhanced in vitamin-D content.
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food. Its customary purpose for millennia was to sustain life. each species, from bacteria to humans, has evolved so that it instinctively consumes a diet that is most beneficial, from the specialized diets of pandas to the omnivorous diets of 
chimpanzees and humans.
But in the past few centuries, due to technological developments and other factors, 
Homo sapiens has gotten off track. while technologically advanced nations have largely 
solved the age-old problem of hunger, many, including the United States, have come to 
treat food as entertainment, rather than as something that should be keeping our bodies 
running optimally. our food, sad to say, is contributing in a major way to diet-related 
diseases.
There’s general agreement that too many calories are promoting weight gain, and two-
thirds of american adults are overweight or obese. obesity, in turn, increases the risks of 
heart disease, diabetes, strokes, and numerous forms of cancer, with concomitant medical 
costs estimated to be around $50 billion annually.
numerous factors have contributed to the obesity epidemic over the past 30 years, but 
key is that we’re simply eating too much. according to the United States Department 
of agriculture (USDa), the number of calories available in the food supply jumped by 
0 percent—from about 3,00 in the 90s to 3,900 calories in the 000s. and if those 
calories are there, you can bet that someone is going to eat them. where are those calories 
coming from? Unfortunately, largely from such nutritional weaklings as soda pop and 
pizza and from the huge portions served by countless restaurants. 
Probably the next most harmful substance in the food supply is salt, or, rather, so-
dium. too much sodium is contributing to high blood pressure, which afflicts almost 
90 percent of elderly americans. High blood pressure is a silent killer that causes heart 
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attacks, strokes, and kidney disease. The average american is consuming about twice as 
much sodium as he or she should, with the vast majority of it coming from packaged 
and restaurant foods. although most adults are advised to consume no more than ,500 
milligrams of sodium per day, major chain restaurants like Denny’s and IHoP sell meals 
with two, three, or even four times as much. a typical can of soup provides at least two-
thirds of a day’s sodium.  
with sodium, there’s no one major culprit—not even potato chips or canned soup. 
Practically everything on grocery store shelves is a source of sodium. The bottom line, 
according to the former head of the national Heart, Blood, and Lung Institute and two 
colleagues, is that reducing sodium levels in packaged and processed foods by half would 
save about 50,000 lives per year (Havas et al., 00).
next on the list of dietary problems are saturated fat and trans fat, which contribute 
to heart disease. Prior to 990, trans fat was thought to be pretty innocuous, whereas it 
is now generally recognized to be, on a gram-for-gram basis, the most harmful fat in the 
food supply. researchers at the Harvard School of Public Health estimated in 00 that 
trans fat was causing ,000 to ,000 fatal and non-fatal heart attack, and probably 
50,000 to 00,000 deaths, per year (Mozaffarian et al., 00).
Saturated fat is a separate problem. we get a good deal of that fat from red meat and 
cheese. add to that the cholesterol from eggs and most other animal products. If we 
replaced much of the saturated fat in our diet with polyunsaturated fats, and reduced 
consumption of cholesterol, that would save, according to one conservative estimate, as 
many as 0,000 lives each year (Danaei et al., 009).
too much refined sugars, from cane, beets, and corn, cause tooth decay and obesity. 
while it recommends that the average person consume no more than about eight tea-
spoons (3 grams) of sugar a day, USDa estimates that americans are consuming about 
 teaspoons ( grams) a day. The most harmful source of refined sugars is soft drinks, 
both because they bathe teeth in a cariogenic solution for long periods of time and because 
beverages appear to be more conducive to weight gain than solid foods.
also impairing our diet is that we consume mostly refined grains in place of whole grains. 
Several recent studies indicate that refined carbohydrates, both simple and complex, may 
contribute about as much to heart disease as does saturated fat (Jakobsen et al., 00).
together, excess salt, trans fat, saturated fat, and added sugars cause about 00,000 
premature deaths every year. Because the illnesses that cause those deaths take decades to 
develop, and because the deaths cannot be pinned on specific foods, the awesome toll of 
diet-related deaths rarely makes for headlines. The story would be entirely different if a 
failed heart had a little label that said “cheese & steaks.”
In any case, the challenge before health officials is to identify and implement means 
of changing both personal habits and tastes and the composition of foods marketed by 
manufacturers and restaurants.
one thing that has become abundantly clear is that voluntary action, by itself, simply 
doesn’t work. regrettably, good words are typically not followed by good deeds. Let 
me present several examples and suggest measures that would help protect the public’s 
health.
3
Trans and Saturated fat
to help educate consumers about trans fat in packaged foods, in 00 the US food and 
Drug administration (fDa), after a -year gestation period, required food manufacturers 
to disclose the amount of trans fat on Nutrition Facts labels. That spurred many of them 
to switch to healthier oils. I estimate that, overall, the amount of artificial trans fat has 
declined by almost two-thirds over the past decade. Still, though, hundreds of millions 
of pounds of partially hydrogenated oil, with its trans fat, are being consumed each year 
and causing perhaps 0,000 to 0,000 deaths due to heart disease and diabetes.
But progress was slower in the restaurant world, because menus and menu boards don’t 
list trans fat. to tackle the restaurant problem, new York City’s health department mounted 
a year-long campaign to encourage restaurants to use oils that contain little or no trans 
fat. The result after one year? Zero percent change! The health department didn’t waste 
its time again. Instead it, and subsequently the new York City Council, severely limited 
the trans-fat content of restaurant foods, and within  months the problem was solved. 
Trans fat was gone…and, yes, restaurants and bakeries survived perfectly well. Indeed, 
McDonald’s said that it did not receive a single complaint when it changed its frying oil. 
But restaurants didn’t necessarily use healthier oils elsewhere in the country. 
another factor promoting the exodus of trans fat from restaurants was that a San fran-
cisco lawyer and my organization sued, or threatened to sue, Kraft, McDonald’s, Burger 
King, and KfC. That encouraged those companies to get into high gear and get rid of 
most of their trans fat throughout the country. other restaurants took notice.
at the same time, about a dozen cities and states—including California, Boston, Phila-
delphia, and Seattle—followed new York City’s example and passed laws barring trans 
fat from restaurant foods. to this day, though, some large-chain restaurants and probably 
thousands of small ones in jurisdictions that have not passed trans-fat laws, continue to 
serve food loaded with trans fat.
Consider that the american Heart association recommends that people consume 
fewer than  grams of trans fat a day, and the Dietary Guidelines for americans advises 
people to “keep trans fatty acid consumption as low as possible.” now consider that at 
Bob evans restaurants, an order of Stacked & Stuffed Caramel Banana Pecan Hotcakes 
has  grams of trans fat; and a standard order of three Buttermilk Hotcakes has 9 grams. 
at white Castle, the french fries, onion chips, and onion rings have between  and 0 
grams of trans fat per order, depending on the product and the size. and at Long John 
Silver’s, battered fish and shrimp have up to .5 grams of trans fat, while a fish dish with 
fries has  grams.
The fDa should simply ban partially hydrogenated oil to get rid of the remaining 
artificial trans fat. Denmark did that six years ago. fortunately, oil processors, seed de-
velopers, and farmers have provided a sufficient supply of alternative oils that should 
work in every food in the marketplace. replacing frying oils is easy; it takes more effort 
to replace shortenings that serve a structural purpose in such foods as doughnuts and 
frostings. Legally, all the fDa needs to do is declare that it no longer considers partially 
1Information obtained from company web sites.
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hydrogenated to be “generally recognized as safe” and then give industry a year or so to 
switch to healthier oils.
Cutting saturated fat is much harder than cutting trans fat. after all, saturated fat is 
abundant in meat and dairy products. Ideally, animals would be raised in ways that result 
in meat and dairy products that are lower in saturated fat. That could be accomplished by 
using certain breeds of dairy cows and beef cattle, keeping beef cattle on grass for more 
of their lives, and feeding dairy cows conjugated linoleic acid (leads to lower-fat milk) 
and rapeseed (leads to more unsaturated and less saturated fatty acids). Giving subsidies 
to growers for producing milk and meat in those ways would be one avenue. Meanwhile, 
consumers need to read labels. 
Salt
In 99, the white House Conference on nutrition recommended that salt intake be 
reduced. a decade later, an fDa advisory committee reviewed the safety of salt and con-
cluded that it was not “generally recognized as safe” at the levels consumed. Since then, 
countless other health authorities have urged people to consume less salt: the national 
academy of Sciences, the american Medical association, the world Health organization, 
the national Heart, Lung, and Blood Institute…the list goes on and on. Unfortunately, 
for 0 years, the food industry has ignored requests by government officials and health 
agencies to cut the salt. How much progress have they made on their own? none. we’re 
actually consuming more salt now than we did 0 or 30 years ago, though that’s partly 
due to increased overall food consumption. Lately, spurred by the imminent release of 
targets set by dozens of city and state health departments and of a major report by the 
Institute of Medicine, some of the big food processors have announced that they are going 
to cut the salt. and a few companies have actually made progress. Campbell has reduced 
sodium by about 30 percent in many soups and v juice.
But overall, progress has been meager. In 005, the Center for Science in the Public 
Interest identified the sodium contents of about 500 foods. Three years later we checked 
the sodium contents once again. The change? negligible. Some foods did contain less—but 
a roughly equal number of products contained more sodium.  
two months ago, a committee of the Institute of Medicine published a landmark 
report that said that, in light of 0 years of wasted opportunity while the food industry 
did almost nothing but say “leave it to us,” the government should set limits on sodium 
levels in packaged and restaurant foods. and what is industry’s response?: let us lower salt 
voluntarily! as the Grocery Manufacturers association said, it’s okay for government to 
regulate sodium in school foods, “but it’s less clear that the government has a role with 
regard to products that are sold widely throughout the marketplace.” If you think they’re 
trying to play government officials for suckers, I suspect you’re right.
Though salt may be the single most harmful substance in the food supply, the solu-
tion, of course, is not banning it and other sodium-containing food additives, but rather 
limiting the amount of sodium in various categories of foods, from bacon to bread. The 
British government, which has been mounting a serious and sophisticated sodium-re-
duction campaign, has set specific sodium targets for about 5 categories of foods and is 
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pressing industry to comply. achieving those targets would lead to a one-third reduction 
of sodium intake. Improvements to date amount to about a 0 percent reduction…and 
the saving of roughly ,000 lives each year.
It’s important to realize that there is a lot of “low-hanging” salty “fruit.” although some 
companies might be using the least amount of salt and other sodium-containing additives 
feasible, many other companies are using far too much. for example, Banquet chicken 
pot pies contain 50 percent more sodium (per 00 grams) than Marie Callender’s chicken 
pot pies, and Ken’s Steakhouse Caesar salad dressing contains twice as much sodium as 
walmart’s Caesar salad dressing. It’s clear that many companies can dramatically lower 
their sodium levels and still have perfectly marketable products. 
whole Grains
The 005 Dietary Guidelines for americans emphasized the value of consuming whole 
grains. General Mills began using more whole grains in all of its cereals, but, otherwise, 
progress has been spotty at best. according to the nonprofit whole Grains Council, 
“americans eat only about  percent of their grains as whole grains, despite government 
guidelines recommending that all of us make at least half our grains whole.”
I’m not saying that white flour and white rice should be banned, or that consumers 
should be required to eat foods that they don’t like. But companies could voluntarily replace 
some of the white flour with whole grain flour in almost everything they make—from 
pancakes to pasta. Depending on the food, probably up to 5 percent or so whole grain 
flour would not even be detectable. Government agencies—ranging from the Department 
of Defense to state departments of corrections—could play a role by requiring that more 
whole grains be served in cafeterias. The fDa should require that the percentage of whole 
grains in grain foods be disclosed prominently on labels. foods that brag “made with 
whole grains” should be required to disclose just how much—or little—whole grains is in 
their products. and the Centers for Disease Control could be mounting national media 
campaigns explaining the health—and taste—benefits of whole grains.
Calories
Cutting calories is something that most americans need to do. while that is something 
that each of us can do on our own, the federal government has begun encouraging 
industry to cut unnecessary calories from its offerings. Companies participating in the 
Healthy weight Commitment foundation have agreed to cut .5 trillion calories per year 
from their products by 05. at first blush that sounds great, but once you get out your 
calculator, it doesn’t look so wonderful. for starters, about 0 trillion calories are put 
into the food supply each year. next, the industry took credit for supposedly removing 
about 500 billion calories from their products between 00 and spring 00—before 
the program even began! So you end up with supposed cuts that amount to only about 
five or ten2 calories per person per day. But you shouldn’t even believe that, because no 
company is going to handcuff its marketing whizzes and tell them that the company has 
2Depending on how it is calculated.
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hit its annual calorie limit and can’t ship any more foods. This Healthy weight Commit-
ment foundation may be more smoke and mirrors than substance. as for other voluntary 
action, few restaurants have cut their humongous portion sizes and few voluntarily list 
calories on their menus.
a few companies have been marketing 00-calorie packets of cookies and soft drinks, as 
if those are the answer to obesity. But something that the restaurant industry vehemently 
opposed could have a real impact: calorie disclosures on the menus and menu boards of 
chain restaurants. Because of local and state laws that industry fought for years, people in 
new York City, Philadelphia, Seattle, and California are already seeing such information. 
a federal law (that industry accepted only because it preempted the proliferating state 
and local laws) will kick into effect in the next year or so.
Beyond menu labeling, the fDa should require warning labels on soft drinks, otherwise 
known as “liquid candy.” Soft drinks, quintessential junk foods, are a major source of 
calories and contributor to obesity. They should bear label statements noting their con-
tribution to obesity and tooth decay and suggesting that people drink water or diet soft 
drinks instead. Congress also should consider disallowing the use of food stamps (from 
the Supplemental nutrition assistance Program, SnaP) for buying soft drinks. Currently, 
the several billion dollars a year that SnaP users spend on soft drinks can be seen as a 
subsidy to the industry, while it undermines low-income consumers’ health.
food Dyes
one other area that indicates the insufficiency of voluntary action is artificial food dyes. 
a good index of the junkiness of our food supply is the per-capita consumption of food 
dyes, like red no. 0 and Yellow no. 5. americans are consuming about five times as 
much of those dyes—primarily in breakfast cereals, frozen desserts, candies, and other 
foods marketed for children—as we did 50 years ago. research that is too-little-discussed 
has examined the effect of food dyes on children’s behavior. numerous studies and a meta-
analysis have shown that dyes like red 0 and Yellow 5 cause hyperactivity and degrade 
learning in some children. The British government commissioned two large studies and 
concluded that dyes simply do not belong in the food supply. It asked companies to stop 
using most dyes before January , 00. The european Union is requiring most foods 
that contain dyes after July 09 to bear a label warning of effects on children’s activity 
levels. That likely will be the death knell of artificially dyed packaged foods in europe.  
Beyond their behavioral effects, studies have demonstrated that some dyes, such as 
Yellow no. 5 and Yellow no. , cause allergic reactions. More troubling is the evidence 
that several dyes (such as those two yellow ones) contain carcinogenic contaminants 
(such as benzidine) or cause cancer in animals (the evidence is most accepted for red 
no. 3) (CSPI, 00).
Companies also should voluntarily eliminate dyes from their products in the United 
States. But what we have now is a situation in which Kellogg’s strawberry nutri-Grain bar 
is naturally colored in Britain but colored with dyes in the United States, and McDonald’s 
strawberry sundae is naturally colored in Britain, but colored with red no. 0 in the 
United States. fortunately, a wide range of natural colorings can be used instead of syn-
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thetic dyes. at least two companies, the maker of neCCo wafers and Starbucks, have 
eliminated dyes from all their products.
I am highly skeptical of depending primarily on voluntary industry action to solve 
america’s dietary woes. regrettably, perhaps sincerely felt good words typically have not 
been followed by good deeds. That’s not to oppose voluntary actions—they’re invaluable. 
and it’s certainly not to let each and every person off the hook—we all bear ultimate 
responsibility for what goes into our mouths. But experience has shown that if we’re go-
ing to lose some pounds and reduce rates of diet-related diseases, government action is 
an essential ingredient.
regulation versus voluntary action
although I’ve emphasized the need for legislative or regulatory action to improve the 
american diet, I don’t want to leave the impression that that is the only strategy that should 
be used. Companies absolutely should undertake voluntary actions on any number of 
fronts, ranging from providing more readable and informative labels to reducing sodium 
levels. Industry can move a lot faster than government regulators—but government is 
often needed to provide the level playing field that would not disadvantage the more 
conscientious companies. and each and every consumer must make an effort to choose 
a healthier diet. after all, it is our bodies that will benefit.
Past and Possible future Successes
while the scientists and regulators battle things out in washington, agriculture schools 
and others certainly can play a role in affecting the american diet. Just think of some 
past successes:
• trimmed carrots have created a new market for the carrot industry.
• Bagged, washed salad greens contributed to a tripling of consumption over the 
past 0 years, according to USDa food consumption statistics (USDa-erS, 
00). Modified-atmosphere packaging has been a key technology to make that 
happen.
what are future blockbuster marketing advances? Laboratory researchers should cer-
tainly be funded to develop new products, such as: 
• Salt substitutes, or salt enhancers, or new kinds of salt crystals to enable reduc-
tions in sodium levels in different kinds of foods.  
• How about a safe, high-potency sweetener that actually tastes good?
• and how about meat replacements made from safe plant products? That would 
help reduce meat consumption and the associated health problems.  
I must say, though, that even if such products were developed, we shouldn’t expect too 
much. for instance, even though consumption of non-caloric sweeteners has increased over 
the years, consumption of caloric sweeteners has not decreased (Lempert, 00; Bnet, 
00) Moreover, cancer questions swirl around aspartame, acesulfame-K, and saccharin. 
even with meat substitutes, there can be problems: one meat substitute, which is made 
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from a fungus and marketed as Quorn frozen foods, causes severe and fairly common 
allergic reactions, ranging from projectile vomiting to hives to anaphylactic reactions. 
Such products should not even be allowed on the market.
agricultural economists could be contributing to the debate, as well:
• what are the health and economic costs of eating meat, instead of getting protein 
from plant products? and what are the environmental costs of meat production, 
considering the costs of producing fertilizer and pesticides to grow feed, soil 
erosion, and air and water pollution from feedlots and hog and poultry factory 
farms?
• How could support programs for the dairy industry be re-jiggered to encourage 
dairy farmers to feed cows in ways (discussed above) that reduce the saturated-fat 
content of milk?  
• economists need to examine how taxes and subsidies could be used to promote 
healthier diets: excise taxes on soft drinks; taxes levied at slaughterhouses on fatty 
beef cattle; subsidizing fruit and vegetable consumption via SnaP, school meals, 
and other federal food and feeding programs. economists can estimate how much 
such economic measures would nudge the american diet in a healthier direction.
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Mark McLellan: If you were the secretary of the Department of Health and Human 
 Services, what is the one thing you would have happen, starting tomorrow? Michael?
Michael Jacobson: one specific thing is to set limits on salt. That would have the single 
greatest health benefit.
Clare Hasler-Lewis: I would make vegetables very cheap and junk food very expensive. 
when you can buy a triple burger for ninety-nine cents, there’s something wrong with 
the food paradigm in this country.
Carl Keen: augment the nIH budget and ask for some studies to be done, because, for 
the most part, we have thoughts, we don’t have information.
McLellan: Let’s go to the audience for questions.
Kathleen Nolan (UC Cooperative Extension, Monterey County): Dr. Keen, please comment 
on whether a virus or other microorganism may influence maintenance of an individual’s 
weight.
Keen: There are good data from experimental animals, mainly chickens, that some viruses 
can cause significant increases in fat mass. rick atkinson, who used to be at UC-Davis, 
was one who isolated viruses from obese humans and obese monkeys. Cross injection 
studies looked promising. workers at the Pennington continue to pursue this. Some believe 
that it’s silly. on the other hand, the idea that a virus or a specific bacterium can cause 
some sorts of disease states is now well established. Ulcers provide an excellent example. 
It’s provocative, but it’s receiving a lot of scientific interest.
Agriculture, Food and Health: The Problem and 
the Solution
Q&a
Moderator: Mark McLellan
University of Florida
Gainesville, Florida
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Tom Tomich (University of California, Davis): everyone rightly raised the issue of the health 
crisis here in the United States. Carl stated that the evidence is thin that consumption 
of fruits and vegetables is linked to heart disease. Scientific evidence is surprisingly thin 
regarding many of the important causal relationships between food and health outcomes. 
Carl just made the predictable call for more research, but my question is a little different. 
I wonder if we are framing the questions in the right way. as an economist, I worry a lot 
about the right unit of analysis. we use the phrase “health-promoting foods,” but I could 
say “health-promoting diets,” “health-promoting communities,” or I could say, “health-
promoting society.” My question is—and I hope that clear compelling messages about 
priorities for work will come out of this meeting—what’s the right balance? I suspect 
it’s probably “and” rather than “or,” across those, but how do we get that right? I hear us 
talking a lot about foods, but is that the right unit?
Keen: I agree with you. But the thing that’s very impressive is that the proof is in the 
vegetable-fruit literature, although it’s not as robust as many think it is. If multiple factors 
in fruits and vegetables are driving it, not all fruits and vegetables are the same. The real 
issue is not to show that something is not a good fruit or a good vegetable, but if we take 
our blinders off and say, “Can we identify the family of nutrients that, in orchestration, 
are actually giving beneficial effects, and start finding out how to increase them in the 
diet?” The tricky part here is that most people are uncomfortable with the concept that 
one fruit is better than another or one vegetable is better than another, and we must get 
that out of our minds if we are to make big changes.
Jacobson: You’re right when you say, “Let’s look at a higher level.” There is pretty clear evi-
dence that certain diets are much better than others, in terms of health standards. [audio 
lost.] a virus may contribute to obesity, as may BPa and trans fats, but my hunch is that 
these are pimples on an elephant in comparison with a twenty percent increase in calories 
available, which is a huge thing that dwarfs these laboratory curiosities. 
Hasler-Lewis: we mustn’t ignore energy expenditure, which is a large part of the problem. 
Michael said something that Steve Cooper stated a number of years ago: “we’ve engineered 
activity out of daily life.” we need to educate people, not to spend an hour and a half in 
the gym, but to walk more, which could burn up twenty percent more calories.
Jacobson: The secretary of Health and Human Services stated the need for taking ten 
thousand steps per day. That’s difficult; about five miles. It’s not just leaving your car a 
little further out in the parking lot. 
Audience Member: My questions are for Michael. The organic segment of the food industry 
markets its products as “safer,” “healthier,” “tastier” and “better for the environment.” 
Since CSPI has a record of going after false assertions, and it’s become clear over the last 
few years from meta-analysis that none of these claims holds up, will CSPI go after these 
claims?
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Jacobson: If you see clear-cut, dishonest, claims that violate the law—made by large com-
panies—send them to me. we don’t play favorites. My organization, for instance, has 
been supportive of agricultural biotechnology, unlike most consumer and environmental 
groups. we work with facts, and, if we see dishonesty, we may go after it.
Audience Member: Thank you for that. My second question: regarding your “suitable 
substitute” statement about trans fats, I am wondering if CSPI is planning to make a 
public statement in favor of transgenic oilseed crops that allow increased oleic acid re-
placement of trans fats.
Jacobson: we haven’t commented on that particular type of seed, but we have been sup-
portive of agricultural biotechnology. This is the second time I have spoken at an naBC 
conference. ralph Hardy knows full well that we have been supportive of agbiotech. 
when it comes to particular seed, I don’t know how necessary it may be.
Ken Swartzel (North Carolina State University): David Kessler has suggested that we need 
to control our own diets.1 on the other hand, Michael suggests that the government 
regulations are needed, that people can’t do it themselves. The trans-fat issue is an example. 
The late Peter Jennings presented a documentary titled, “How to Get fat without really 
trying,” the point of which was simply that, on one hand we have a food pyramid and 
on the other hand we have government subsidies, which don’t line up. we should eat 
more of certain foods and less of others, and most of the government subsidies go to 
foods we should be eating less of. fruits and vegetables get practically no government 
subsidies. Clare, regarding your one issue of cheap fruits and vegetables and expensive 
burgers—government subsidies are controlling this.
Hasler-Lewis: That’s a great point. and there should be categories for people who are 
given food stamps, and they should not be able to exchange food stamps for items that 
are not healthful. That would be an edgy move, begging the question of how much we 
want government involved in our lives. It’s a controversial issue.
McLellan: we are the government and we are here to tell you what to eat! Michael?
Jacobson: I think you got David Kessler’s book exactly wrong. His main point was how 
industry is engineering foods to make them virtually addictive, through smart, tested 
combinations of sugar, fat and salt. He didn’t give a good prescription of what to do about 
it, because it’s hard to imagine companies not trying to make their foods as tasty as pos-
sible. on the subsidy issue, there are misconceptions. The ag economists that I am familiar 
with have said that the subsidies to corn growers have negligible effects on the prices of 
1Kessler D (009) The end of overeating: taking Control of the Insatiable american appetite. emmaus, Pa: 
rodale Books.
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corn, corn syrup and soft drinks. The reason for inexpensive food in general in the United 
States—corn, soybean, and even fruits and vegetables—is successful agricultural research. 
to make food more expensive, we would have to stop funding ag research. regarding 
government mandates on one hand and functional foods on the other to prevent colon 
cancer through vitamin D, etc., in reality it’s not a case of either-or. Big forces are in play. 
There needs to be judicious involvement, not suicidal involvement. Industry needs to do 
what it can do. take salt as an example. a level playing field put out by government can 
be extremely helpful. Company a is unlikely to lower its sodium content since its foods 
would not taste as good as Company B’s, unless government dictates that everyone has 
to meet a certain limit, although sometimes companies do the right thing on their own. 
and I believe that government is subsidizing the fruit and vegetable industries with the 
food stamp, school-lunch and wIC programs. Direct subsidies have screwed up the corn 
and soybean industries. If subsidies of the fruit and vegetable industries are necessary, 
they should be applied smartly so that more fruits and vegetables are consumed. Clearly, 
individuals have a role. we need to control our impulses, in large and small ways. If you 
have good, healthy foods around your house, you will probably eat them. If you have junk 
foods around the house, you’ll eat those  first. So we all need to contribute at different 
levels. It’s not all government; it’s not all industry; it’s not all consumers.
Barbara Schneeman (Food and Drug Administration): a recently published article stated 
that claims on food packages are simply marketing, creating the notion that we can 
somehow eat our way out of a chronic disease problem or eat our way out of obesity. 
You were talking about the idea of funding more research and being able to make more 
of those kinds of claims. But are such claims useful?
Hasler-Lewis: The issue of claims has been interesting to me for a long time. The good 
side is if it does what it’s intended to do: educate consumers at the point of purchase, 
such as choosing cholesterol-lowering Cheerios. I am a firm believer in information being 
available to people who choose to use it, provided that it’s based on science.
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working in agriculture, we have been at the center of some of the most significant and hottest debates in society. In  out of the last 0 years, grain consumption has exceeded grain production. we have seen energy costs 
quadruple, and concern over global warming has escalated greatly, with the last 0 years 
representing the warmest on modern record. These issues are central to agriculture, and 
we all face the question of how to overcome these obstacles and continue to provide the 
food supply the world needs. at Monsanto, we believe that innovation will be key, and 
we believe that we have a role to play, as an input producer in agriculture, in helping to 
meet these challenges.
food Quantity
Global population is increasing dramatically, and is expected to be over 9 billion by the 
middle of this century. Many experts agree that the food supply will need to double to 
meet the demands of that increased population. we have made an evaluation of how this 
is likely to affect our business. we have observed that corn consumption has increased by 
3% in the last 0 years, while soybean consumption has increased by 5%. as incomes 
increased in developing nations consumption of grain-fed beef has increased by %. 
at the same time 55% of the habitable land is now used for agriculture and two thirds 
of annual fresh-water withdrawals are used in irrigation. These forces are creating critical 
challenges, and we need to focus on how to improve agricultural sustainability.  
a few years ago, we began conversations with stakeholders to try to determine how 
we could best contribute to solutions to these challenges, and  years ago we launched 
a commitment comprising three primary factors and that we called our Commitment to 
Sustainable Yield. It includes the component of how to meet the need for an increased 
food supply and we committed to working with farmers to double yields of major food 
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and fiber crops by the year 030, relative to year 000. It included an evaluation of how 
to reduce environmental and resource impacts while achieving this increased food pro-
duction. and we committed to reducing agricultural inputs to a third lower than they 
are today per unit of output. we believe that there are many ways to increase crop output 
per unit of input, and we want to improve the economic viability of farming, to improve 
the lives of farmers, their families and their communities.
food Quality
although much of our effort is focused on the capability of producing enough food 
with the minimum impact to the environment, many of our initiatives are focused on 
improving food quality.
Soybean comprises almost two thirds of the US diet of edible oils, more than half of 
which is used in processes in which they are partially hydrogenated for stability. This 
partial hydrogenation leads to formation of trans fats, which are now widely recognized 
as undesirable in the human diet. So, we have opportunities to modify the composition 
of soybean oil to help address some issues concordant with it being a major source of 
fats in the human diet.
figure . Consumer awareness of dietary fat.
Consumers are aware of the various oil compositions and have clear perceptions of their 
desirability; nearly 90% of consumers understand the significance of trans fats (fig. ). 
They are aware of saturated fat and they also have perceptions about the relative health 
merits of various vegetable sources of edible oils. we believe that we have an opportunity 
to promote the healthfulness of mono-unsaturated fats as an alternative to saturated fats, 
which are now abundantly present in the human diet. The american Heart association 
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has recommended that saturated fats comprise only % of dietary energy, and recently, 
the Dietary Guidelines advisory Committee proposed that saturated fats be reduced from 
the current guideline of 0% of dietary energy intake to %. In reality, the current satu-
rated fat composition in the diet is about % and a 5% reduction to the recommended 
% would significantly reduce the risk of cardiovascular and other diseases. a majority 
of consumers read the nutritional labels on products they consider for purchase. They 
are aware of the significance of the information on dietary fats, and, in a 009 survey by 
the International food Information Council, 3% claimed to be trying to reduce their 
intake of saturated fats.
we have worked with a number of food-company representatives to design specifica-
tions for what we thought would be an improved composition of soybean oil. we defined 
significant reductions in the saturated fatty acids palmitic and stearic, a significant increase 
in the mono-unsaturated oleic and a reduction in linoleic acid to improve stability, and less 
linolenic to reduce trans fat (fig. ). we are at the pre-launch phase, and, within  or 3 
years, we will release vistive® Gold seeds, which will produce oil with this composition.
figure . vistive® Gold soybean will provide low-saturate,
high-stability and zero-trans-fat oil.
to achieve this, we reduced the activity of three enzymes that are involved in the bio-
synthesis of oil in soybean. The first is fatB thioesterase; by reducing its activity, we allow 
more of the fatty acids to be shunted toward oleic acid. reduction in faD desaturase 
results in an elevation in oleic acid. Both of these changes are delivered by rna inactiva-
tion of genes that naturally exist in soybean. and the third change is a faD3-desaturase 
reduction through conventional breeding, using a mutant in soybean that reduces the 
level of linolenic acid, which again promotes stability.
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with these three changes, soybean produces an oil that is almost identical in prop-
erties to high-oleic canola oil, an expensive specialty oil that is available in much less 
abundance than is soybean oil. This will be a major contribution to the abundance of 
oil with improved properties for food applications. french fries cooked in vistive® Gold 
soybean oil versus conventional partially hydrogenated soybean oil show a reduction of 
3% in saturated-fat content and a 9% reduction of trans fats. Importantly, this allows 
food companies to provide labels that indicate zero trans fats, no partially hydrogenated 
oil and lower saturated-fat content. 
This oil, importantly, could go into a range of food products, including those designated 
with the vistive® Gold emblem in figure 3, and reduce the saturated-fat levels in those 
processed food products. we can still get our fix of saturated fats through steak, ice cream, 
cheese and cheesecake and various other sources that we like to eat. The bigger picture 
is that 0% of the saturated fats in our diet come from prepared foods such as potato 
chips, french fries, margarines, and salad dressings, in all of which vistive® soybean oil 
could be substituted for currently used oils. Therefore, without making any changes in 
consumer habits, dietary preferences, if current oil sources are replaced by vistive® Gold 
in these processed foods, it could result in a 9% decrease in dietary intake of saturated 
fat for the average individual. and, for those in the top 0% of the population for intake 
of saturated fats, it would result in a 3% decrease in saturated fat. This is a significant 
opportunity for us to help food companies help consumers improve their diets.
figure 3. vistive® Gold could be incorporated into many foods 
with varied levels of saturated fat (Safa=saturated fatty acid, g/serving)
(Commercialization is dependent on many factors,
including successful completion of the regulatory process.)
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In addition to reductions in consumption of saturated and trans fats, it is also rec-
ognized by health experts that cardiovascular health would be improved by increasing 
the level of omega-3-fatty acids in our diet (fig. ). Currently, these omega-3 fatty acids 
come predominantly from fish and a recent analysis showed that, of the risks leading to 
death in the american population, the sixth largest is an excessively low dietary intake of 
omega-3 fatty acids. In this analysis, that single risk was associated with 00,000 deaths 
per year in the US population. of course, consumers are addressing this risk in increas-
ing numbers by taking fish-oil supplements, and we are looking at what we may do by 
changing the composition again of soybean oil, the major oil that is used in processed 
food manufacturing in the United States. we have defined a way by which the composi-
tion of soybean oil may be modified to contain 0% stearidonic acid (SDa), an omega-3 
fatty acid that currently comes from consumption of fish fat. The fish obtain it by eating 
algae, which possess the biosynthetic pathway to produce the SDa.
figure . Dietary changes endorsed by experts in health and nutrition.
we want to reproduce in soybean the biosynthetic pathway that exists in algae, by 
adding two enzyme steps, achieved by borrowing a gene from a plant and one from a 
microbe, that allow the conversion of fats normally produced in soybean oil to the :
fatty acid, SDa (fig. 5). This, we believe, is the preferable point at which to stop in the 
biosynthesis of omega-3 in soybeans, due to improved stability. It doesn’t have the off 
flavor or undesirable aroma that are associated with fish oil and eicosapentaenoic acid 
(ePa); in fact, the human body is able to convert SDa to ePa. with a 0% composition 
of SDa in soybean oil, just one acre of soybeans would provide as much potential ePa 
as is present in 0,000 3-ounce servings of salmon.
obviously, fish-oil sources are not a sustainable solution for the entire world. They are 
not available in the appropriate abundance in many parts of the world, and we would 
have a sustainability issue trying to get this much from fish. on the other hand to obtain 
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sufficient omega-3 fatty acids from soybean—with approximately 0 million acres 
grown in the United States alone—is very achievable. we have formulated this soybean 
omega-3 oil into various food products—yogurt, salad dressing, snack bars, smoothies, 
etc.—and the flavor properties are indistinguishable from currently used oils. This is an 
exciting opportunity for us to contribute to what is a major dietary limitation affecting 
human health.
Studies have demonstrated that SDa oil formulated into human diets results over the 
course of just  weeks in increased blood ePa, comparable to ePa formulated into the 
diet, which does not occur with commodity soy (fig. ).
vegetable Innovation
Onion
about 5 years ago, Monsanto bought into the vegetable seed business by purchasing 
Seminis, with the primary objectives of increasing crop productivity, yield, reducing 
need for inputs, and breeding in natural disease resistance. at the same time we had the 
opportunity to provide vegetables improved in terms of the consumer sensory experience, 
realizing that helping consumers find it easy and desirable to eat more vegetables would 
be a positive contribution to their health.
we’ve launched a couple of products. The evermild onion is a long-day storage variety 
that has the same mild properties of short-day onions that are available only seasonally, 
such as the vidalia onion from the United States and the Peruvian sweet onion, which 
is available in the winter. The evermild provides the same consumer benefit, but it is a 
figure 5. SDa soybean oil would provide a sustainable source of omega-3.
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long-day storage onion available throughout the year. Bella verde is an innovative new 
broccoli with an elongated stalk.  recently launched in europe, it produces nutritious 
tender side-shoots with improved consumer appeal.
Tomato
By moving into this vegetable space, we acquired an array of elite diversity in crop species. 
figure  illustrates diversity in tomatoes that are consumed around the world, represent-
ing all kinds of opportunities to use native genes to enhance quality, sensory properties 
and nutrition. Similar opportunities exist for our other major crops, peppers and onions; 
it’s a tremendously useful toolbox for plant breeders developing improved products for 
growers and for consumers.
figure  provides examples of innovations in our vegetable pipeline that are designed 
for consumer appeal. a seedless tomato in the upper left-hand panel combines cytoplasmic 
sterility with parthenocarpy, the ability of fruit to develop without pollination. we’ve 
developed a tomato that is completely seedless and delicious. Importantly, lacking seeds, 
it helps people with diverticulitis to avoid digestive distress. a great-tasting orange mini-
tomato, a grape tomato, is shown in the upper right-hand panel; very high in natural 
sugars with a great acid balance, it is absolutely delightful to eat. People who generally 
don’t like tomatoes do like this one, like the grower’s son who is sneaking some from the 
greenhouse in Holland. In the lower left-hand panel is an all-flesh tomato. Slicing tomatoes 
that are used in sandwich shops, etc., are often processed in central distribution centers, 
for safety reasons and shipped to sandwich vendors. In the process of being shipped and 
handled, they can lose 5% to 0% of the juice and, with it, much of the nutrition. our 
figure . SDa omega-3 increases heart-healthy ePa in humans.
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all-flesh tomato— to 3 years from launch—doesn’t have juicy locules so that, after slicing, 
the moisture and nutrition are conserved during distribution.  Some of our customers are 
excited about this prospect, which will help tomatoes be delivered more often to sand-
figure . Sensory appeal critical for driving consumption:
flavor, texture, color (nutrition) and convenience.
figure . tapping into diversity in elite germplasm.
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figure 9. CrC lettuce provides nutrition and flavor.
wich and fast-food businesses. and we have improvements in color and other nutritional 
components of tomato. In the lower-right hand panel, increased lycopene deepens the 
red color, which consumers find desirable aesthetically and nutritionally.
Lettuce
we have an innovation in lettuce that has been launched in europe and which we are 
working on for the United States. It’s a cross between the iceberg and romaine lettuces 
that has the crispiness and texture and processing capability of an iceberg with nutri-
tional benefits more comparable to the romaine. It is more attractive when shredded 
and processed. our studies on nutritional composition show that our “CrC” lettuce, 
represented in figure 9 by the variety rugby in the top panel, is a good source of vitamins 
a and C, unlike iceberg; it’s more like romaine in vitamin content. when we take it to 
consumer taste panels, we find that those who like romaine like it equally to romaine 
and romaine dislikers—a significant portion of the population—like it equally to iceberg, 
and much better than romaine. we think we have hit the sweet spot of doing something 
that improves nutrition while improving consumer appeal.
Broccoli
for a number of years, we’ve been working in collaboration with scientists at the John 
Innes Institute and others in europe to improve the nutritional content of broccoli through 
marker-assisted breeding. a relative of broccoli that grows in the hills of Sicily and is used 
locally in their salads, etc., has a higher content of -methylsulfinybutyl glucosinolate 
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(MSB), which is obtained in the human diet only through intake of broccoli. In humans 
MSB is converted to sulforaphane, which enhances the body’s own enzyme systems that 
preserve the activity of vitamins a, C and e, which are natural antioxidants that help to 
remove free radicals and environmental pollutants. we have introduced three genes to 
broccoli through marker-assisted breeding (fig. 0). The panel on the left demonstrates 
that, over widely different environments, two- to three-fold increases in MSB have been 
achieved. The upper-right section shows that consumer panels indicated that this broccoli 
is just as desirable to eat, whether consumed raw or cooked. By increasing the levels, we 
have found that the MSB is rapidly converted into much higher levels of sulforaphane 
in human blood, which are conserved for many hours after consumption.
as these examples illustrate, we are focusing on traits that we can deliver through seed 
and agricultural inputs that add benefits throughout the chain. Besides being beneficial 
for consumers, they have to be beneficial for growers, and for retailers, for produce and 
food companies. we have to share the benefits across the chain in order to get support 
in launching these products. we are working with regulators to validate the credibility 
of the nutritional improvements and we are working with consumers to make sure that 
the benefits are perceivable.
Biotechnology of fruits and vegetables
The wide perception is that biotech traits are not available in vegetables. In fact, some 
have been available for 5 years, virus-resistant squash for example. Bt sweet corn has been 
in the marketplace for nearly as long, and, of course, over 0 years ago, Cornell and the 
figure 0. Broccoli with improved nutrition, developed through marker-assisted breeding.
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figure . Biotechnology projects in asia.
figure . Biotechnology in the fruit and vegetable industries.
USDa launched virus-resistant papaya, which saved the papaya industry of Hawaii. other 
products are currently being worked on—whether by public or private institutions—in 
potato, tomato and fruit trees (fig. ).
a lot of the activity in biotechnology of foods is occurring in asia. figure  provides 
examples of a number of attributes that are being worked on by local and regional private 
interests as well as by government agencies, covering insect resistance, improved quality, 
virus resistance in eggplant, tomato and the brassicas.
edwards
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we are preparing to launch improved Bt sweet corn by 0, initially targeted toward 
the fresh market, which is primarily where the competitive product from Syngenta has 
been used (fig. ). The market size in the United States is miniscule versus that of field 
corn—50,000 acres of sweet corn versus 90 million acres of field corn. It is designed 
to provide in-plant resistance to pests as well as herbicide tolerance, which is the same 
technology we launched in field corn some time ago. It’s equivalent to our Genuity® vt 
triple Pro™ which is widely established in field corn as providing great grower benefits. In 
sweet corn it will provide additional benefit because much sweet corn is produced in the 
southeast—in environments with intensive insect pressure—and shipped north to markets 
for much of the off season. figure 3 shows results of a study that we conducted last fall 
in florida, Georgia and Mississippi. The lower left-hand panel provides the numbers of 
marketable ears per plot from this Bt sweet corn, hybrid ‘Passion,’ as well as from the 
equivalent hybrid but without the biotech innovation; in the absence of any insecticide 
application, we completely failed to produce marketable ears. In the State of florida, 
insecticide applications are recommended to begin before silking and continue at -day 
intervals all the way through product harvest, amounting to ten to twelve applications. 
In our trials, even with that level of insecticide application, we were producing only four 
to five marketable ears per plot. Therefore, this allows us to greatly reduce insecticide 
application in sweet-corn production and provide a better-quality, better-looking product 
to the consumer. There are other pests that this Bt doesn’t control so, at this point, we are 
not advocating complete elimination of insecticide applications, but we are confident we 
can greatly reduce it, perhaps even more than the 50% that we now recommend.
figure 3. Sweet corn hybrid ‘Passion’ with the addition of Monsanto’s Genuity® 
triple Pro™ technology requires less pesticide to produce marketable ears.
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There are many things that a company like ours can do in terms of providing agricul-
tural inputs to help in human sustainability.  Many issues are associated with today’s diet. 
The majority of the US population has inadequate intake of a whole number of essential 
nutrients. our calorie-rich diet is leading to problems with obesity, blood cholesterol, 
and type- diabetes. In fact % of the US GDP is spent in intensive care units. we have 
an opportunity—through increasing the attractiveness to consumers of our products and 
the internal composition of our products—to help address some of these issues.
Marlin Edwards joined Seminis, a subsidiary of Monsanto, in 
005 as the vice president of global research. Most recently he 
has led breeding technology at Monsanto where he developed 
the world’s foremost high-throughput genotyping lab. This 
has allowed as much as 35% of Monsanto’s plant breeding 
programs to be based on genetic marker-enabled selections.
Dr. edwards has been involved in multiple aspects of plant breeding and 
 agricultural biotechnology since he completed his post-doctoral research at 
north Carolina State University, where he conducted pioneering research into 
the application of molecular markers in plant breeding in the mid-90s. He has 
experience in breeding field corn, sweet corn, peppers and cucumbers. He has a 
PhD in plant breeding and genetics, an MS in horticulture from the University 
of wisconsin at Madison, and a BS in the agriculture Honors Program from 
Kansas State University.
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the life sciences are struggling with the challenges of diet and health. agriculture wrestles to become both more productive and more sustainable in the face of the world’s population growing past  billion. at the same time, in 
the most affluent parts of the world, diet-related diseases are considered to be the major 
threat to public health. The problems are complex; how can agriculture become simulta-
neously more productive and sustainable while foods become simultaneously safer, more 
nourishing and more delightful to our quality of life? The foods for Health Institute was 
established at UC Davis to promote research and development across the campus. The 
goal of the institute is to develop multi-disciplinary and multi-collaborative approaches 
to address these challenges and deliver on the bold promise to improve health and pre-
vent disease with food-based solutions. Promising to prevent disease (defined as not to 
cure disease or reverse the damage accumulated by disease, but to pre-emptively prevent 
disease from occurring) is indeed provocative. How can science address such an attrac-
tive yet seemingly insurmountable goal? one critical question for science and for food is 
at the core of the problem: what do we target to improve health in ways that ultimately 
reduce the risks of all diseases?
Preventing disease is a far-reaching goal. If healthcare approaches are truly preventa-
tive, then they act on individuals before diseases develop—any disease. If a food or food 
ingredient is developed to reduce the risk of one disease, but in so doing also increases 
the risk of any other disease, consumers aren’t healthier. The current strategy for treat-
ing diseases is built on a mature scientific foundation. Laboratory bench breakthroughs 
identify the causes of disease which become targets for diagnostic development to identify 
those afflicted with the disease. The same targets become the objects of high-throughput 
screening programs to identify candidate chemicals that could act to reverse disease, which 
in turn leads to their evaluation, testing and validation as small-molecule drugs. These 
pharmaceuticals are subsequently rolled out into a regulated, world-wide pharmaceutical 
industry and prescribed by trained clinical professionals as curative solutions to disease. 
Yet, if the goal is to prevent disease, then we cannot rely on diseases to define the scientific 
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targets on which to act. what are the targets for prevention? what mechanism do we act 
upon? what ingredients, when regularly ingested, are capable of acting on these targets 
and achieving this beneficial goal of overall prevention?
evolutionary Basis for Discovering Metabolic targets for 
Improving Health
Determining the targets for improving health is the fundamental problem of prevention. 
what are the targets, mechanisms of action and ingredients that we can discover that 
would make healthy people healthier? The good news is, an arsenal of “omic” technologies 
is at our disposal to approach this problem. The global scientific enterprise of genomics 
has sequenced various life forms. Science has now built this knowledge as a magnificent 
public resource; the entire genomic sequences of hundreds of viruses and bacteria, dozens 
of plants and animals and, of course, of Homo sapiens have been elucidated (Karolchik 
et al., 003; Pruitt et al., 00; Liolios et al., 00). what can genomics tell us about 
diet and health? an animal’s genome is its blueprint of evolution and the basis of each 
organism’s multiple solutions to its Darwinian pressures (Gould, 00). Understanding 
Darwinian pressures can reveal the basis for genetic outcomes. Plants exposed to a dry 
environment develop molecular strategies for water conservation. animals exposed to 
predators develop strategies for camouflage, protection or escape. to understand how 
animals have developed mechanisms of diet and prevention, we need a genomic model in 
which the Darwinian pressure was for nourishment and prevention. This basic scientific 
logic has been used previously in fields from pharmaceuticals to building construction. for 
example, the genomics of plants are mined to identify candidate drugs (oksman-Caldentey 
and Inzé, 00). Pharmaceutical companies have purchased the genetic rights to specific 
rainforests, reasoning that the jungle is full of candidate drugs (Mendelsohn and Balick, 
995). analyzing from the context of Darwinian pressure, it is clear that plants evolved 
in part to the threat of predation. Since they cannot run away, their defence has been 
to become chemical factories of selective toxicity (Xie and Lou, 009). The secondary 
metabolism of plants is an ingenious result of this pressure. Yet, our goal is not treatments 
for disease, but food-based solutions to achieve health.
what could possibly have emerged from millennia of evolution under the constant 
Darwinian pressures to be nourishing, protective, and to act on targets that improve the 
overall health of healthy animals? Milk. Lactation is the remarkable biological invention 
of mammals as the sole source of nourishment for post-natal infants.
Discovering the Darwinian Pressure of Milk as a Model for 
foods for Health
Through evolutionary experimentation, mammals have spent the last 0 million years 
developing “the most efficient, effective and adaptable means of postnatal nutrient 
provision that has ever arisen among vertebrates—lactation” (Blackburn, 993). Milk 
and lactation are an appropriate model to guide scientific discovery for foods for health. 
Lactation is appropriate for a wider range of activities than simply the chemicals in milk. 
The mammary epithelial cell is, in turn, itself a marvel of engineering: a bioreactor that 
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synthesizes bioactive components and guides the self-assembly of supra-molecular struc-
tures (German et al., 00). The constant Darwinian pressure on lactation has been to 
deliver a complete, absorbable ensemble of chemicals and structures that, when ingested, 
acts upon metabolic and physiologic targets that promote the competitive success of 
healthy mammals (ward and German, 00). This Darwinian pressure has led to the 
elaboration of complex food in milk that not only delivers nutrients as complex supra-
molecular structures (i.e. milk-fat globules, casein), but includes immune-modulatory, 
toxin-binding and growth factors and antimicrobial peptides and proteins that act within 
the intestine and beyond to promote health, growth and protection of the neonate. 
furthermore, safety and efficacy of milk has been rigorously tested during these same 
millions of years of evolution. Thus, unlike pharmaceutical research that must in every 
case ask: is it healthy? with milk, the question researchers need to ask is, “How does milk 
mechanistically elicit its health effects?”
Shifting the Paradigm for r&D: Disease treatment to 
Prevention
traditional drug development requires up to 0 years from candidate drug discovery to 
market, with greater than 90% of drugs failing during human trials (eliopoulos et al., 
00). The entire process from target discovery to successful intervention typically takes 
30 to 50 years. as a direct response to the length of time and poor success rate in which 
basic bench science is transformed into a breakthrough with clinical utility, the field of 
translational science under the nIH was initiated as a new multi-disciplinary field in which 
the stated objective is to bring science to practice (Zerhouni, 00). Yet, the current model 
of bringing science to practice is for the scientific discovery of pharmaceutical solutions 
to disease. This serial process requires the identification of pathways that are affected and 
their causal mechanisms—whether pathogens, toxins or enzymes. These causal mecha-
nisms become the target for pharmaceutical solutions. with in-vitro screening, thousands 
of molecules are tested for their ability to act upon the target. Subsequently, successful 
hits move to drug-development pipelines where their safety in animals and humans is 
tested and their efficacy is tested against the target and then the disease. finally, the small 
molecule found to act on the target is tested for efficacy, safety, and commercialization 
(tonkens, 005). The process of bringing scientific discovery to practice requires a quarter 
of a century. to speed up this process, key steps in this system will have to be accelerated. 
Yet, what part of translation of drugs should we skip: the efficacy or the safety?
If the translation of drugs for targeting disease requires decades of testing, how long 
would it take to discover, test, validate and bring to practice the prevention of disease by 
foods? a major challenge to prevention is actually in the time to translation. Prevention 
means that disease is prevented in healthy people. Do we wait an additional 50 years to 
assess the effectiveness in preventing disease by a food? fortunately, evolution has used 
0 million years for testing the efficacy anD safety of milk. for preventing disease with 
foods, research on milk at the foods for Health Institute has led to the adoption of a 
different translational model (figure ). Unlike use of serial development for discovering 
disease targets, health can be translated using parallel research and development. Based 
 Promoting Health by Linking agriculture, food, and nutrition
on the basic evolutionary principle in which lactation evolved under the relentless pres-
sure to be nourishing, supportive and protective, once a molecule in milk is identified, 
it is understood that it is going to be valuable. It is only to be known how and in what 
population will it be effective. This confidence of efficacy suggests we can immediately 
start the process of developing industrial scale sources of the molecule, processing strate-
gies, analytics and diagnostics of its presence and actions. once populations that could 
benefit from consuming the molecule are identified and metabolic benefit is clinically 
assessed, ingredients and products are already scaled up for commercialization.
figure . Parallel research and development for translating health.
Discovering the Mechanistic targets of Milk through 
evolutionary Genomics
Identifying and annotating the milk genome is proving to be invaluable for the discovery 
of genes encoding molecules in human milk and their respective physiological targets. In 
efforts to provide a collaborative and interactive platform for researchers to accelerate the 
understanding of the biological processes underlying the mammalian milk genome, the 
International Milk Genomics Consortium (IMGC) was initiated in 00. The IMGC 
has constructed a web-based portal as a public resource consisting of the genes of lacta-
tion and their annotation for the unique roles they play as molecules and structures for 
nourishment (www.milkgenomics.org). research in this field extends across mammals 
and their varying lactation strategies, to provide insights into the diverse roles of milk 
(Bovine, 009; Lemay et al., 009). IMGC has acquired lactation genomes across the entire 
evolution of mammals which permit the pursuit of a wide variety of scientific questions 
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about the origins, functions and distributions of lactation genes and their specific quality 
traits. for example, two animal species with contrasting lactation strategies have evolved 
in response to unique natural selective pressures: the black bear and the hooded seal. 
The black bear of the northeastern United States and Canada gives birth during winter 
hibernation. The mother bear continues to hibernate for –3 months postpartum, during 
which time she does not exit the den to eat or drink despite nursing her cubs (oftedal 
et al., 00). This example in which maternal stores solely support the first few months 
of lactation is a model for nutritional efficiency. at the other end of the spectrum is the 
hooded seal. This mammalian pup is born on an ice floe in the north atlantic, in polar-
bear country. The strategy for the neonate is to get off the ice floe and into the open sea 
quickly. During the  days of lactation, the mother seal transfers  kg of fat from her 
adipose stores and the pup gains  kg, of which three quarters is visceral fat. This most 
remarkable example of energy transfer in mammals supports the young seal through a 
post-weaning fasting period of 5–0 weeks (oftedal et al., 00).
one over-arching question relates to the rate of evolution of lactation itself. Given 
the basic principle that mutations accumulate during evolution, the more identical the 
sequences are for a given protein, logic and prior experimentation have documented 
that the more important its sequence is to the survival of the organism. By taking such 
a quantitative perspective to evolution, lactation has been vital to the success of mam-
mals. In figure , the sequence identity of proteins expressed from genes in the entire 
genomes of seven mammals is distributed and compared with the proteins expressed by 
lactation genes of the same mammals. Most of the milk proteins are highly conserved 
across mammals, whereas a much smaller subset is highly divergent across mammals. 
There is less conservation among mammals for proteins of the liver, adipose, and brain 
than for lactation-related genes. This conservation throughout evolution emphasizes how 
important these genes have been to the survival of the species. even evolution agrees that 
we have chosen the right model. 
a Success Story for foods for Health
recall our model, the mother-infant pair. The mammalian mother actively dissolves her 
tissues to make milk. everything in the milk is costly to the mother. If components found 
in milk do not enhance the survival of the infant, the cost to the mother would lead to 
its loss through evolution. However, if any component in milk, when consumed by the 
infant, provides it any competitive advantage over its genetic peers, it will be retained in 
evolution. This mother-infant pair is a Darwinian engine of nutrition. Considering this 
model, imagine to our surprise when we examined the various components in human 
milk and found that the third most abundant component class, at key stages of lactation 
more abundant than protein, were indigestible by the infant (Zivkovic et al., 00). How 
could this be? 
Discovery
The presence of indigestible saccharides in milk led to a multi-disciplinary pursuit. robert 
ward, in Bruce German’s laboratory, recognizing their paradoxical abundance, isolated 
these molecules from human milk and began to characterize their structures and func-
Smilowitz and German
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tions (ward et al. 00), although methods to characterize the chemical structures of 
these components were largely lacking. Their structural determination is one of the most 
complex problems for analytical chemistry. Carlito Lebrilla, a world leader in glycan 
analytics, and his team developed the tools to characterize the structures of the oligosac-
charides in milk (ninonuevo et al., 00, 00, 00; tao et al., 009, 00). If the 
infant cannot digest oligosaccharides, what are their functions? David Mills, a leading 
microbiologist specializing in the bacteria of the intestine, and his team characterized 
one component of the intestinal microbiota—Bifidobacterium infantis—which digested 
and thrived on oligosaccharides purified from human milk as their only carbon source 
(Sela et al., 00). This bacterial species was first isolated from the intestine of breast-fed 
infants. This is when the genius of milk became clear. Mothers are recruiting another life 
form: bacteria that protect their infants’ health. These results have identified a unique 
target for foods; the intestinal microflora anD how to alter its population to derive a 
health benefit (Zivkovic et al., 00). 
Translation
one advantage of doing research at the University of California at Davis is the breadth 
and depth of scientific and clinical programs across campus. Mark Underwood, the head 
of the neonatology Unit at the UC Davis Medical Center has been pursuing intestinal 
health as a target of success and failure for premature infants. Mark and his colleagues are 
now investigating the use of human milk oligosaccharides and Bifidobacterium infantis 
to protect premature infants at increased risk of intestinal disease. 
figure . Distribution of proteins expressed by lactation-related and total 
genomes of seven mammals.
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Commercialization
The final test of translational science is bringing it to practice for appropriate consumers. 
from the beginning of the project we have been simultaneously developing sources and 
technologies to produce this unique class of oligosaccharides as a food ingredient. Sources 
such as dairy process streams to decorated oligosaccharides, are all candidates that could 
achieve structure-function benefits of human-milk oligosaccharides. The UC Davis Center 
for entrepreneurship is working in parallel to define business models for this ingredient 
class to enter the food marketplace. The goal is to translate health to those who would 
most immediately benefit from consuming such ingredients. 
Conclusions
The challenges facing the life sciences and the entire agriculture enterprise are to deliver on 
the promise of prevention. The models established for small molecules as drugs developed 
by the pharmaceutical industry and delivered through the clinical profession as curative 
therapeutics are not appropriate for foods for prevention. This failure does not mean that 
we compromise the quality of science, the rigors of regulation nor the expectations for 
efficacy. new models that are capable of enhancing safety, efficacy and personal benefits 
from foods constitute the st century’s most vivid opportunity to improve the human 
condition. The University of California, Davis, has assembled the multiple disciplines to 
respond to such an opportunity. 
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During her PhD program, Smilowitz discovered metabolic phenotypes associ-
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and executed several clinical studies probing specific lipid metabolic pathways in 
the inflammation cascade. Her current research focuses on the development of 
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Cassava is an important staple crop in sub-Saharan africa. Between 1970 and 2007, its production and acreage tripled across africa and quadrupled in nigeria, the continent’s and the world’s largest producer (fao, 00). Sub-
 Saharan africa produced over  million tons of fresh roots of cassava in 00, of which 
no less than 95% was consumed as food; the starch provides >5% of dietary energy for 
an estimated 00 million africans (Dorosh, 00). frequent consumers of cassava are at 
greater risk for malnutrition—especially deficiencies in vitamin-a, iron, and zinc—than 
consumers of other diets, particularly those that are cereal-based (Gegios et al., 00). a 
nutrition survey in cassava-consuming areas of nigeria and Kenya revealed inadequate 
intake of vitamin a in 3% and % and inadequate iron intake in 3% and % of 
pre-school-aged children, respectively (Gegios et al., 00). vitamin-a deficiency causes 
a loss of 9,000 disability-adjusted life years (DaLYs1) in nigeria and ,000 DaLYs 
in Kenya annually; iron deficiency causes loss of 59,000 DaLYs in nigeria and 03,000 
DaLYs in Kenya (fielder, 009). 
Opportunities for Biofortification of  
Cassava for Sub-Saharan Africa: 
The BioCassava Plus Program
M. fregene, r. Sayre, C. fauquet, P. anderson and n. taylor
Donald Danforth Plant Science Center
St. Louis, Missouri
e. Cahoon D. Siritunga M. Manary
University of Nebraska University of Puerto Rico Washington University
Lincoln, Nebraska Mayaguez, Puerto Rico Children’s Hospital
  St. Louis, Missouri
mfregene@danforthcenter.org
1a measure of overall disease burden, expressed as the number of years lost due to ill-health, disability or early 
death.
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Current efforts to combat micronutrient deficiencies in africa include supplementation, 
through distribution of micronutrients to high-risk populations, addition to processed 
food and biofortification, i.e. the genetic improvement of nutrient content of crops via 
field-based breeding or genetic engineering. Supplementation requires tremendous effort 
to exceed 90% coverage and must be sustained for many years (Berti and rowley 00); 
few countries in africa are able to run effective supplementation programs. Biofortification, 
on the other hand, can achieve 00% penetration and, although it requires a substantial 
initial investment in research and dissemination, it is self-sustaining. Cost per DaLY saved 
for biofortification is 0% less compared to supplementation (nestel et al., 00).
BioCassava Plus (BC+) is a cassava-biofortification project at the Donald Danforth 
Center in St. Louis, Mo, funded by the Bill and Melinda Gates foundation. BC+ 
scientists are engineering cassava for increased accumulation of β-carotene, iron, and 
protein to provide minimum daily allowances of these essential nutrients as a means of 
ameliorating the burden of malnutrition that accompanies consumption of cassava as a 
staple food. Proof of concept for the enrichment of these nutrients has been demonstrated 
in the model cassava cultivar 0, which, in greenhouse and confined field trials in 
Puerto rico, contains up to 0 µg/g dry weight (Dw) of β-carotene (provitamin a), 0 
µg/g dry weight of iron, 0% protein storage roots, and reduced levels of anti-nutritional 
cyanogens.
Biofortification of Cassava
β-carotene 
β-carotene enrichment of storage roots in cassava is conferred by two transgenes: the 
Erwinia crtB phytoene-synthase gene, and the Arabidopsis -deoxyxylulose-5-phosphate 
synthase (DXS) gene. The crtB transgene includes a 0.-kb sequence for the plastid 
transit peptide for the Δ-palmitoyl-acyl carrier protein desaturase from coriander. The 
phytoene synthase encoded by the crtB gene catalyzes the committed step in β-carotene 
synthesis using geranylgeranyl-diphosphate (GGDP) from the plastid isoprenoid pathway 
as its substrate. DXS catalyzes the first step in the plastid isoprenoid pathway. Increased 
expression of this enzyme is intended to enhance concentrations of GGDP for β-carotene 
synthesis and also to ensure sufficient amounts of GGDP to maintain vitamin-e produc-
tion at or above wild-type levels. The crtB and DXS genes are each under the control of 
the Solanum tuberosum (potato) patatin promoter and flanked on their 3’ ends by the 
3’ untranslated region (Utr) of the nopaline synthase (nos) gene from Agrobacterium 
tumefaciens. The selectable marker is the neomycin phosphotransferase II (nptII) from E. 
coli under control of the cauliflower mosaic virus 35S (CaMv 35S) promoter (with x 
enhancer). The nptII gene is flanked on its 3’ end by the CaMv 35S 3’ Utr.
Plants expressing the crtB and DXS genes were initially evaluated in four-inch pots 
under greenhouse conditions. amounts of total carotenoids ranged from 30 to 0 µg/g 
Dw in storage roots of the top lines. By comparison, amounts of total carotenoids in 
storage roots of control 0 plants in these and subsequent greenhouse and field studies 
ranged from .5 to .5 µg/g Dw. Subsequent evaluations were conducted of storage roots 
of plants growing in soil beds in the greenhouse and in confined field trials in Puerto rico. 
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Concentrations of total carotenoids in roots from greenhouse beds typically ranged from 
30 to 5 µg/g Dw. Concentrations of carotenoids from the confined field studies ranged 
from 30 to 0 µg/g Dw. Concentrations of vitamin e were not significantly different 
between storage roots from the top β-carotene lines and non-transformed controls. In 
the transformed lines, the relative amounts of all-trans-β-carotene, the most nutrition-
ally efficacious form of carotenoid provitamin a, were 5 to 90% of the total carotenoid 
content. relative amounts of trans-β-carotene in non-transformed controls were only 50 
to 0% of the total carotenoid content. In collaboration with partners in africa, BC+ has 
confined field trials of the β-carotene-enriched GM events (i.e. transformed plant lines) 
ongoing in nigeria and another trial is planned for fall 00 in Kenya.
In addition to the consumer benefit of improved nutrient levels, BC+ β-carotene-
rich GM events also have producer benefits in terms of extended shelf-life. five of the 
events with the highest amounts of total carotenoids could be stored for up to  days 
after harvest, whereas the wild-type recorded up to 0% spoilage after  days. reduced 
shelf-life of cassava roots, a result of post-harvest physiological deterioration (PPD), is a 
major limitation to marketing of fresh roots. PPD begins  hours after harvest and can 
render the roots unpalatable and unmarketable within  hours. Short shelf-life affects 
cassava value-added chains because it increases losses during processing and limits access 
to markets distant from production sites. Longer shelf-life was correlated with total ca-
rotenoid content (r = 0.0) in the GM events, which is consistent with previous studies 
indicating that high levels of carotenoids in the roots (>  ppm fresh weight basis) delay 
PPD (Sanchez et al., 005).
nutrient retention during food preparation was also evaluated in three transgenic lines 
expressing higher levels of β-carotene. In three common nigerian food preparations—gari, 
fufu and boiled—retention of provitamin a ranged from % to 3%, equal to, or bet-
ter than, that seen in the wild-type 0 variety. values for in vitro bioavailability of 
provitamin a, as measured by uptake into micelles of Caco human intestinal cells, were 
similar for the transgenic and wild-type sources, i.e. % and 3%, respectively.
Iron 
Increased iron content was achieved by the expression of the FEA1 gene, from Chlam-
ydomonas reinhardtii, in cassava storage roots. The fea protein is an iron-specific metal 
transporter. It transfers iron efficiently at very low concentrations or at high pHs at which 
iron is largely insoluble. It does not transport toxic heavy metals unlike all other known 
metal transporters in plants. as with the β-carotene trait, FEA1 expression was driven by 
the patatin promoter and nos terminator. Seven GM events were tested in the greenhouse 
and in confined field trials in Puerto rico; iron content in the GM events ranged from 
30 to 0 µg/g Dw in storage roots compared to 0 µg/g dry weight in the wild type. 
real-time PCr analyses strongly suggest that the additional iron is stored as a ferritin 
complex in the transgenic plants.
The morphology, including branching and flowering, of transgenic plants was identical 
to that of wild-type plants in Puerto rico.
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Protein
Increased protein content in cassava was achieved by the expression of sporazein, a stor-
age fusion protein consisting of a 0-bp fragment of β-zein from maize, the sporamin 
gene from sweet potato and a 50-bp fragment of β-zein. Sporazein is a nutritionally 
balanced protein of 9. kD in which the zein components drive accumulation of the 
product to form protein bodies within the endoplasmic reticulum. as with the other two 
traits, the patatin promoter and nos terminator drive sporazein accumulation in cassava 
storage roots. 
Seven GM events expressing sporazein were tested in the greenhouse, in soil beds, and 
in confined field trials in Puerto rico. total protein content of storage roots harvested 
ranged from 9 to % Dw across all seven transgenic lines studied. The morphology 
and growth habit of these transgenic plants have shown no significant differences to 
non-transgenic controls in all three locations tested to date. no changes in expression 
of trait accumulation have been observed over the  months during which these plants 
have been tested in the greenhouse and field. as protein bodies are water-insoluble, water 
soaking overnight at room temperature resulted in 9% retention of the total protein 
content of the cassava roots. Boiling for 30 min resulted in 95% retention of the total 
protein content.
It is well known from other plant systems that the direction of reduced nitrogen to 
the synthesis of new proteins may come at the expense of nitrogen allocation to essential 
proteins required for metabolism. Thus, elevating expression of storage proteins in cassava 
may impair the growth or biochemical properties of roots. to address this concern, we have 
over-expressed a vacuolar targeted linamarase, an enzyme that breaks down linamarine, 
a cyanogenic glucoside found in cassava leaves, stems, and roots. This has been shown to 
increase the pool sizes of free amino acids in cassava.
Product Development of nutrient-enriched Cassava for africa
BC+ has achieved nutrient enrichment of cassava such that if a 5-year-old child con-
sumes 00 g/day of roots from the β-carotene, iron, or protein-rich GM events, (s)he 
will obtain 00% of the minimum daily allowance (MDa) of these nutrients. BC+ has, 
therefore, embarked on the expression of genes for the aforementioned nutritional traits 
in farmer-preferred cassava varieties from nigeria and Kenya, its two target countries. 
Genetic transformations at the Donald Danforth Plant Science Center (DDPSC) have 
successfully generated transgenic lines of oko-Iyawo, the most popular nigerian variety 
of cassava currently grown on  to % of total acreage (about  million hectares) in 
that country, and the Kenyan cultivar Serere.
Based on ex-ante impact studies for nutrient deficiency in Kenya and nigeria, a 
β-carotene- and iron-enriched oko-Iyawo for nigeria, and a β-carotene-, iron- and 
protein-enriched, and virus-resistant, Serere for Kenya were selected as first products. 
oko-Iyawo is resistant to cassava mosaic disease (CMD), which is of viral origin and is 
the principal production constraint of cassava in africa, whereas Serere is susceptible to 
CMD and needs to be engineered for resistance. Product development is divided into 
several stages, namely:
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• generation of transgenic events,
• greenhouse characterization and testing,
• field testing,
• selection of a lead event,
• food and environmental safety assessments in a regulatory field trial,
• biosafety approval for commercial release,
• on-farm trials, and finally 
• variety release and dissemination. 
Lead Event Selection
a commercial quality construct that is codon-optimized without extraneous genetic 
elements, will be created for the crtB, DXS, FEAI genes (β-carotene and iron traits) 
and transformed into friable embryogenic callus derived from oko-Iyawo. Six hundred 
transgenic plants will be regenerated and screened for events that possess a single copy 
of the construct, no vector backbone sequences and good rna expression. events, an 
estimated 5, that meet these criteria will be planted in the greenhouse and roots evalu-
ated for β-carotene and iron contents. events that meet the set targets of 0 µg/g Dw 
for the two traits will be transferred to confined trials in Puerto rico and nigeria for 
trait assessment under field conditions. This will be followed by two cycles of replicated 
confined field trials at three locations to select a lead event and a back-up for regulatory 
trials. a similar procedure will be followed for the Kenyan product, with the exception 
that the gene construct will contain sporazein and rnai for CMD and cassava brown 
streak disease (CBSD), a viral disease of cassava that is specific to east africa. 
Biosafety Regulatory Activities
Cultivation and consumption of cassava expressing these genes will require the granting 
of approval from regulatory bodies in nigeria, based upon food and environmental safety 
assessments of each novel gene/protein that confers the targets traits. a safety assessment 
is required for each event intended for commercial release. DXS, crtB, FEA1, sporazein, 
and npt II proteins will be purified, characterized, and assessed for potential toxicity in 
acute (single dose) oral gavage studies with mice. allergenicity of the DXS, crtB, and FEA1 
proteins will be assessed in accordance with international guidelines. This is a ‘weight of 
evidence’ assessment that includes the source of the gene, documented dietary exposure to 
the protein, any amino-acid sequence homology to known allergens, and protein stability 
upon incubation in simulated gastric fluid. 
The purified proteins will also be used to develop western blot and enzyme-linked im-
munosorbent assays for detection of the proteins in plant material. as the DXS and crtB 
proteins are enzymes and will be present at higher levels than what are typical in cassava, 
regulatory authorities will likely require information on substrate specificity. evidence 
from the peer-reviewed literature on known substrate specificity for these enzymes will 
be sought.
 Promoting Health by Linking agriculture, food, and nutrition
a key consideration of regulators is assessment of any unintended effects that result 
from elevated biosynthesis of metabolites in the carotenoid biosynthetic pathway. Unin-
tended effects are traditionally addressed in the safety assessment by performing extensive 
nutrient-composition and agronomic performance analyses. Compositional analyses of 
starch quantity and quality, fatty acids, total and free amino acids, minerals, vitamins, 
cyanogenic glucosides and phytates will be conducted. Protocols for the compositional 
and agronomic regulatory field trials—a final field trial conducted on a lead event to 
generate agronomic performance, food and environmental safety information—will be 
in accordance with international guidelines.
Reaching End-Users
agricultural development in africa is replete with examples of well intended scientific 
advances that have had limited impact because they were not sustainably adopted by 
producers and consumers. fortunately, there are also excellent examples of widespread 
successful adoption of new varieties. The strategy to reach end-users should avoid the 
mistakes of the former and build on the successes of the latter, while taking into account 
the special issues associated with transgenic varieties. Many failures have resulted from 
a narrow focus on preferred production characteristics. a critical aspect important for 
reaching end-users is seed production and distribution. In africa, the vast majority of 
cassava stakes for planting is generated from current plants by the farmer or obtained from 
neighbors; the private sector has little interest in this crop. However, non-government 
organizations (nGos) involved in development activities and some national agricultural 
systems now have good experience with dissemination of new varieties. BC+ will partner 
with organizations that have the best linkages to large numbers of farmers. tissue culture 
and an inexpensive two-node multiplication system for rapid and massive propagation 
will be used to bulk up foundation seed for distribution to large nGos and government 
agencies.
Cost-effective strategies for farmer adoption and consumer acceptance of β-carotene 
and iron-rich cassava entail a marketing and promotion plan. for example, gari is the 
most important food staple of the rural and urban poor and the gari market chains have 
extensive coverage; over 0% of cassava grown in nigeria is used for gari production. a 
great advantage is that the deep yellow color of high-β-carotene and -iron cassava is similar 
to a yellow gari product, made by addition of palm oil, already accepted by consumers. 
although gari processing tends to lead to a depletion of β-carotene and iron, levels of 
nutrient enrichment achieved in BC+ ensure that sufficient amounts of these nutrients 
remain to meet minimum daily allowances based on the average quantity consumed and 
bioavailability.  
anti-GMo nGos may be expected to mount campaigns in opposition to dissemina-
tion and adoption of β-carotene- and iron-enriched cassava. opposition can be overcome 
through demonstration of the benefits to consumers (improved nutritional quality) and 
to producers/processors (extended shelf life of storage roots). other elements for coun-
tering such opposition include: adhering strictly to bio-safety protocols and regulatory 
requirements; being transparent by engaging key stakeholders in constant dialogue to 
communicate progress and building confidence that the process is being properly and 
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responsibly run. other efforts include publication of studies to address the issues of safety 
and product quality, and setting up local product-development committees to design and 
implement communication and issue-management strategies.
Socio-economic Impact
An ex-ante socio-economic impact of BC+ was commissioned by the Bill and Me-
linda Gates foundation and conducted by Harvest Plus, a biofortification initiative of 
the Consultative Group on International agricultural research. The study established a 
baseline of DaLYs lost, estimated the cost of development and rate of adoption of BC+ 
products, and presented a comprehensive economic impact analysis of BC+ products 
(fiedler, 009). This resultant cost-effectiveness analysis was expressed in terms of cost 
per DaLY saved, a benefit-cost ratio, and an internal rate of return. a cost per DaLY 
saved of less than $ is considered “very cost-effective” (Berti and rowley 00); a 
benefit-cost ratio greater than .0 is considered an attractive investment, and the higher 
the internal rate of return the better. 
The cost of developing and disseminating a BC+ product is estimated at $.35 million 
over 30 years, broken down into four phases of $3. million (basic research, applied 
research, capacity building), $.9 million (applied research, product development, regula-
tory approval, capacity building), $.35 million (regulatory approval, release promotion, 
technology diffusion), and $3.0 million (promotion, technology diffusion, monitoring 
and supervision, maintenance) (fiedler, 009). although these costs are high, they are 
justified when considering the DaLYs lost due to micronutrient deficiencies: each year 
losses of DaLYs due to deficiencies in vitamin-a, zinc, and iron amass to .3 million 
in nigeria and 33,000 in Kenya. The study revealed that BC+ cassava varieties will be 
readily adopted by african farmers, achieving adoption rates of 0% in nigeria and more 
than that in Kenya. The higher rate in Kenya is based on the incentive for adoption based 
on viral resistance. This, in turn, will lead to consumption rates of % in nigeria and 
% in Kenya. well over half of these consumers live in rural areas.
accounting for these production and consumption rates and noting that the new cassava 
varieties have increased levels of iron (5%) and β-carotene (3,000%) when compared to 
wild types, the DaLYs saved were projected at ,000 in nigeria and ,000 in Kenya. 
These numbers were then used to calculate the cost-effectiveness of the project, incorporat-
ing pessimistic and optimistic parameters. for the pessimistic model, the cost per DaLY 
saved is $5, the benefit-cost ratio is , and the internal rate of return is %. In the 
optimistic model, the results are $33, 3, and 3%, respectively (fiedler, 009). In either 
model, the study suggests that biofortification is a cost-effective approach to reducing this 
region’s micronutrient deficiencies and the corresponding health problems.
In ConClusIon
Biofortification appears relatively more cost-effective than other interventions, particularly 
in regions where deficiency is widespread. fortification can achieve a near 00% coverage 
rate, penetrating rural areas and high-risk population groups and has a potentially high 
socio-economic impact. 
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Martin Fregene is a plant geneticist and molecular breeder 
with more than  years of experience in genetics and breed-
ing of cassava. In addition to developing the first molecular 
genetic map of cassava and initiating the first cassava molecu-
lar-breeding program, he is an authority on the utilization and 
molecular phylogeny of wild Manihot.
Dr. fregene began his career at the International Institute of tropical agricul-
ture (IIta), Ibadan, nigeria, in 99 as a cassava breeder, where he received a 
rockefeller foundation postdoctoral fellowship on genetic mapping that took him 
to the International Center for tropical agriculture (CIat), Cali, Colombia. at 
CIat, he developed a molecular genetic map of cassava. from 99 until 99 
he was an associate scientist at CIat working on tagging of genes controlling 
early yield, and resistance to diseases and pests in cassava. from 999, he served 
as senior scientist and cassava geneticist at CIat and for nine years led a program 
to develop CMD-resistant neo-tropical gene pools and to broaden the genetic 
base of cassava with genes from wild relatives.
In 00, he joined the Biocassava Plus (BC+) project at the Donald Danforth 
Plant Science Center, St. Louis, Mo, as product development manager. In March 
00, he was designated director of BC+.
fregene received his BS, MS and PhD degrees from the University of 
Ibadan.
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Alan Bennett: Martin, you addressed market challenges. Marlin and Jennifer talked 
about a pipeline—things that are coming through very promising. So, you told us a lot 
about meeting technical challenges, but what about market challenges—bifidobacteria 
were mentioned. Can both of you address what you think of the ability of the market to 
embrace health and nutrition traits.
Jennifer Smilowitz: The Bifidobacterium infantis and oligosaccharide combination is more 
of a medical food approach than something available to everyone at this point. one thing 
that will be an issue is making claims on prevention, like on food products, and that’s not 
where we are going. we are trying to discover molecular targets, using milk, for health, 
and the bifido and oligosaccharide combination is just one example. another business 
idea is to basically reconstitute HDLs that can bind pathogenic bacteria, but also are 
still functional HDLs. now, not all HDLs are the same. Some are actually dysfunctional 
and some are more functional, and so this could be more of a therapeutic or theranostic 
 approach. But the idea is to use milk, which is the food, in this endeavor.
Marlin Edwards: I should emphasize that all the projects I presented with respect to 
nutritional or sensory enhancement in vegetables are produced using conventional 
plant breeding. we use modern technology as a diagnostic tool—molecular markers to 
 understand the native genetics behind these traits, but they are delivered entirely through 
conventional breeding. So, we don’t expect complications in launching those. with re-
spect to the soybean-oil enhancements, of course there is a tradition in this country of 
acceptance of biotech projects in soybean oil and we are very hopefully that the public 
will embrace these products as they will have direct consumer benefits.
Food for Health Successes and Prospects
Q&a
Moderator: alan B. Bennett
University of California
Davis, California
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Bennett: a short follow-up for you, Martin. Your timelines are long and when you are 
talking about disability adjusted life years that’s got to be a frustration. two questions: Is 
there any way to accelerate these timelines? and does the Bill and Melinda Gates founda-
tion have a long-term commitment? will they see this through to the end?
Martin Fregene: on the timeline, I was asked the same question by my president: “This 
is too long. I want to see it happen in two years.” The truth is, if you are going to give 
farmers something reliable, you need to test for at least three years, so maybe you could 
reduce it to about five total, but that is about the minimum. not less than five. one year 
to create the event, one year to greenhouse test and then 3 years of field testing. and then 
on long-term commitment—yes, they are committed over the long haul.
Bennett: and while I have the microphone, I have a quick technical question for you. I’m 
intrigued by the sporazein trait and the ability to produce protein bodies. what implica-
tions does that trait have for nitrogen fertilizer, for example?
Fregene: It’s interesting that cassava has tons of nitrogen in the leaves. we aren’t taking 
more out of the soil; we are deploying what is already in the plant—in the leaves and also 
in the roots—and redeploying it into storage proteins. So far, we haven’t seen an effect in 
terms of lower yields. we haven’t seen a penalty. But, again, it’s early days so things may 
change. If we find a need for lots of nitrogen fertilizer, that would be a killer.
Audience member: a question for Jennifer, following up from what alan was asking. You 
said you are taking more of a functional-food approach toward regulatory or safety tests 
and so on, but you talked about genetically engineering bacteria, so doesn’t that raise a lot 
of flags? Martin, for example, had a 0-year program to try to get it through regulatory 
fences. Can you comment on that?
Smilowitz: we are not going to genetically engineer any plants or other commodities. we 
identify the molecular targets in milk and see where else we can find them. for example, 
human-milk oligosaccharides are also found in bovine milk, which we drink. and they 
are found in whey streams which are used as a by-product. we are enriching those. In 
terms of safety and efficacy we are using milk, which is pretty safe, right? we aren’t having 
any issues using this product with neonates.
Audience member: okay, but how are you enriching them?
Smilowitz: By engineering. with the Hilmar Cheese Company, we are using specially 
engineered pores to enrich them. 
Robert Wager (Vancouver Island University): My question is for Martin. first off, con-
gratulations on fabulous work. It must be very difficult to do biotechnology with all 
the constraints put on you in africa. It’s tremendous what I saw today. where are the 
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field trials of the stacked cassava being done and, secondly, what’s your opinion on the 
news that Kenya this week will finally push forward their biosafety regulations through 
parliament and how that relates to the difficulties of doing biotech work in most of the 
countries of africa?
Fregene: The field trials for stacked products right now are in Puerto rico, and they are 
yet to be tested in nigeria. In nigeria we still have single-trait events, β-carotene, with 
iron going to the field. on the question of the legislative and regulatory environment for 
doing this kind of work, you are right, the whole environment for biotech in africa is still 
very premature, very primordial. But Kenya, as a matter of fact, has passed a biosafety law. 
right now, they are going through the process of translating that law into a framework 
of laws that can be implemented. So the Kenyans actually do have a biosafety law. They, 
South africa, egypt and Burkina faso are about the only ones. The nigerians are in the 
process of passing the law, but the toughest part is translating that law into regulations 
and rules that can actually be used in practice. The Kenyans are now pushing ahead with 
that. It has taken them more than a year already, but, hopefully, things will improve. The 
selling point here that is good to mention is that we are looking at these not just as food 
but also as nutrition products. So when you talk about medicine, people are willing to go 
the extra mile and do something a little bit more risky than when you are talking about 
just food. This is also being sold as a nutritional product, and hopefully that will open 
the doors a little bit wider.
Tom Tomich (University of California-Davis): I’m interested in methods for risk assessment. 
In her banquet presentation, Dr. McGloughlin effectively put on the table that significant 
risks result from inaction, from doing nothing. That needs to be considered. But in terms 
of innovative technologies, there are production risks, which I think we have pretty good 
methods for, but then there are environmental risks and health risks, with which the 
methods are much more problematic. and then, getting back to alan’s question, there 
are also market risks about acceptance. So, my question for each on the panel is, “what 
do you view as the best practice in integrated risk assessment in your area and, how do 
you actually frame how those different elements fit together?”
Smilowitz: for integrated risk assessment, we are implementing clinical trials. and we are 
doing extensive tests with high through-put analyses to make sure we are actually captur-
ing all of the metabolites, to assess which are decreased and which are increased. we are 
using food as our model. I mentioned earlier that we are using engineering technology 
to enhance, let’s say, oligosaccharides in bovine milk, but it’s really through filtration. 
we’re not inserting genes and we’re not adding any chemicals; via filtration we are aug-
menting what is already found in nature. we are not interfering with Mother nature, 
and if we can show that with these clinical trials—feeding trials and many are already 
going on—we don’t feel like we are going to have too many constraints. now the issue is 
whether consumers will be interested in these products. we’re not there yet in terms of 
market research, but we are working on that.
Bennett
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Edwards: we are increasing natural dietary components of vegetables. of course we are 
concerned about and do studies to make sure that we are not increasing them beyond levels 
that consumers would otherwise get with other diets that are prevalent here or elsewhere 
in the world. So, there are those kinds of precautions. with respect to the modified oils I 
talked about, we already have GraS certification because the oil composition is similar 
to others in the marketplace. we are already free to use those other oils for the kinds of 
food-formulation processes that were described, but we work carefully with regulatory and 
government agents and experts in the field to do the feeding formulations and whatever 
is necessary to certify health effects.
Fregene: for BioCassava Plus, of the food-related, environmental and trade risks, trade 
is easiest to deal with. There is almost no trade in cassava between nigeria and other 
countries that might turn down GM crops. from the outset we make bioinformatic 
assessments for potential allergenicity related to the genes we are working with and we 
also do food toxicity tests—you purify the proteins and you feed them to rats and things 
like that. we also do environmental assessments. we are working hard to contain all the 
potential risk, but, as we go along, additional ones will show up. no doubt about that. 
The good thing is to have an issues-management plan in place to address all of the risks 
that shows that you have a rational, safe system. That way you build confidence and, 
hopefully, eliminate apprehension.
Concepcion Mendoza (University of California Cooperative Extension): Martin, yours is a 
novel approach to solving nutritional problems in developing countries. It’s a huge effort 
with a lot of investment. Have you done any sensory tests for consumer acceptability of 
these new products, especially using traditional food-preparation methods?
Fregene: That’s a very relevant question. as a matter of fact it will be done, but further 
down the road. we still don’t have a lead event selected. we don’t have a product that is 
going out. our model variety is different from the farmer-preferred variety. Before we 
jump through that hoop, we will have to have something acceptable to farmers. It’s in 
our product-development master document to do taste, food-processing and prepara-
tion tests to make sure that what we are producing will be acceptable, but right now we 
haven’t done it.
Betty Burri (Western Human Nutrition Research Center): Martin, are the high β-carotene 
varieties of cassava also low in cyanogens?
Fregene: The variety we picked is low in cyanide. But, ordinarily, people process it into 
gari, which gets rid of a lot of the cyanide.
Stanislaus Dundon (California State University): one of the socially desirable aspects of 
cassava is that the soil doesn’t have to be particularly fertile. The crop, as long as it stays 
in the ground, is like a storehouse. Its short shelf life means that it has to be eaten locally 
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and that’s good because that’s where the hungry people are. However, the financial world 
is interested in a competitive source of cheap starch to ship around the world. I suspect 
that, all of a sudden, that crappy land may become valuable and local farmers will lose 
control of it, meaning that the local people will lose control of that food source. Do you 
have any mechanism for preventing this side effect?
Fregene: I really haven’t thought about that, but I can give you my take on land, at least 
in Kenya and nigeria. The areas in which we are working in western Kenya and southern 
nigeria are heavily populated. The average land size per farmer household is approximately 
an acre. It’s really small. It would be hard for government or an investor from Dubai to 
buy that kind of land. It would create a social catastrophe; where are you going to move 
all those people to? So, where we are working, this is of lesser concern. where you have 
large tracts of land, less heavily populated, the danger of having that land taken away 
from them by large investors is there.
Jozef Kokini (University of Illinois): Marlin, I am very impressed with the work that is 
going on at Monsanto. This is the second time that I have seen this presentation and it is 
really spectacular. It’s wonderful to see that genomics is actually leading to new attributes 
beyond Bt corn. My first question is about the value of these advances to the farmer. I 
can see, for example, how, in the case of fruits and vegetables, improved quality might 
lead to value in the marketplace, but I’m just wondering if that would happen also in the 
case of a commodity like soybean. will the farmer be able to get a premium, if you will, 
for improved fatty acid characteristics? and similarly to a previous question, before you 
launch these in the marketplace are you doing the range of consumer tests and sensory 
evaluations to determine if their properties are similar to or better than those already 
available?
Edwards: In terms of the sensory properties of the products from the oil, obviously this is 
critical. we are starting some of the initial work in house, but a lot of it will be done by 
food-company partners who have already expressed interest in those ingredients. Clearly, 
those criteria will have to be satisfied in order for those products to go to market, but our 
experience so far has been extremely positive. with respect to agronomic properties and 
benefits to growers—flavr-Savr was mentioned earlier, and one of the challenges with 
flavr-Savr was that it was launched in a product that was completely inadequate for the 
production region. one of the mantras of our business is that products we launch have 
equal or superior agronomic and production properties, as well as the benefits from our 
traits. we don’t expect our traits to have enough value to carry them forward if they 
compromise agricultural productivity and farmer profitability. It’s clear that some of these 
traits will require some channeling in the marketplace in order to get them into product 
streams where the oils will deliver benefit. There likely will be additional cost for the 
growers and we recognize that we have to work through the whole value chain to set up 
an incentive system so that all the players in the process come out equal or advantaged. 
we’ve been able to do this in the past and it takes a lot of work, but that is clearly the 
model to ensure success.
Bennett
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Kokini: Do you see a two-tier pricing system emerging? today a soybean is a soybean and 
it sells on a cost per bushel basis. Do you see soybean with improved fatty acid charac-
teristics to be worth more per bushel than a standard soybean?
Edwards: we certainly hope so. from their usefulness in the human diet, clearly they 
will be worth more. we are working on traits that we hope will provide benefits that 
will create a pull from consumers through food companies, et cetera. That added value 
might exist at the consumer level, and it might exist at the food-company level in terms 
of formulation. There are several places where that added value might manifest. we have 
to work with all the partners to establish a distribution process where everyone shares, 
or these don’t go forward.
Audience Member: I also have a question about this new healthier soybean oil. How will 
the price compare to the soybean oil that we are producing today. How will that price 
compare to today’s olive oil? In my view, the new oil is probably comparable to some of 
the olive oils of lower quality.
Edwards: with respect to the lower saturated fats, indeed the composition is comparable 
to other oils. with respect to that enriched in omega-3 fatty acid, I don’t think it is com-
parable to any oil in the market. I’m sure that the value addition has been determined. 
Unfortunately I have to confess that I am not close to that, so I don’t know what the 
analyses today say; but, I will tell you that these products are very expensive to launch. 
we will spend tens of millions of dollars in regulatory costs to launch these products. we 
need to make sure they actually meet needs and create value in the marketplace. The value 
in the marketplace determines the price, but I don’t know the specifics, I’m sorry.
Ashley Burns (Clemson University): I’m a PhD student, here as part of the Student Voice 
program. My question is also related to the soybean issue. Have any of these products 
been tested on livestock? Has any work been done using these in feed? The high-oleic acid 
probably would not be beneficial to dairy producers due to associated milk-fat depression, 
but, has anything been done to alter fatty acid composition of our meat animals?
Edwards: again, I’m sorry that I don’t know the answer to that. In the process of launching 
these, we do feeding studies with a range of organisms, so I’m sure those kinds of studies 
can be done. However, given that there is considerable expense in launching these and we 
are actually formulating them for improvements in the human diet, I don’t suppose that 
benefits from feeding to livestock are a primary consideration in our evaluations.
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If functional foods are to provide one of the solutions to the problems of dietary health that we currently face, consumers will need to incorporate them into their lives, making sense of them in relation to existing beliefs and values. Therefore, we 
must understand not only the scientific means of producing foods with additional health 
benefits, but also the relationship between functional foods and existing understandings 
of food and health. More research is needed in this area, particularly in the United States 
where very little scholarly (as opposed to market) research has been conducted to examine 
the cultural dynamics of functional foods. Here I present some preliminary findings based 
on my analyses of the intersections between functional foods and beliefs about dietary 
health among american consumers.
The term “functional” is typically used to refer to foods that provide health benefits “that 
go beyond basic nutrition” (Clydesdale, 00; Hasler and Brown, 009) This definition 
is quite broad and very inclusive, generating questions and confusion: “aren’t all foods 
functional?” “what is the difference between a functional food and an ordinary food?” 
“Do blueberries and cholesterol-lowering spreads really belong in the same nutritional 
category?” Therefore, my remarks identify and focus on a specific subset of functional 
foods; those that have had their nutritional profile engineered or enhanced in order to 
promote health or aid in disease prevention. These products are novel enough to require 
a particularly deliberate process of negotiation as consumers integrate them into exist-
ing practices and try to understand them in light of established beliefs and values. I will 
also argue that it is important to distinguish “nutritionally engineered” or “functionally 
enhanced” products from those inherently endowed with nutritional properties now 
recognized as conferring important health benefits, which we may call “intrinsically 
functional” and which may or may not also be “functionally marketed.”
Functional Foods For Health: Negotiation and 
Implications
Charlotte Biltekoff
University of California
Davis, CA
cbiltekoff@ucdavis.edu
1The categories I distinguish here are influenced by those proposed by Scrinis (00) and Leighton (00).
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Drivers
Many social and demographic factors contribute simultaneously to growing consumer 
interest in functional foods and growing interest among manufacturers in innovating 
and marketing products with enhanced functional benefits. Hasler (000) has identified 
several of these: the aging of the population in concert with rising healthcare costs gen-
erating interest among baby boomers in using food as a means of preventing the chronic 
diseases of aging; technological advances such as those in biotechnology and nutritional 
genomics that have (and will) make new benefits possible; a changing regulatory context 
that, since the 990s, has allowed the kind of health claims that distinguish functional 
foods; and scientific research documenting the health benefits of specific foods or food 
components that back up these claims. These factors describe some of the environing 
conditions that create the possibility for functional foods to play a role in improving the 
dietary health of the population.
negotiation
The process of changing food habits takes place on two levels. Structural changes such as 
the technological, regulatory and economic alterations described above as “drivers” define 
the widest possible constraints within which change can occur on the more intimate level 
of daily life. It is on this intimate level of the lived conditions of consumption that people 
incorporate new items, made possible by structural changes, into their daily rituals and 
invest them with meaning (Mintz, 99). although the drivers allow functional foods to 
exist, the specific ways in which they are used and the meanings that become attached to 
them are worked out through a process of negotiation that is shaped in part by already 
established understandings about food and health. In her analysis of how middle-aged 
health-oriented finns view functional foods, Mari niva (00) describes the process that 
takes place on this intimate level as one of “contextualization.” She notes that consumers 
use “existing cultural categories to make sense of the new phenomenon and to find a 
place for the new products in everyday life.” The structural changes allowing for the pos-
sibility of functional foods to address dietary problems and improve population health 
are clearly in motion, but we know too little about the process of negotiation through 
which consumers may, or may not, make sense of these products, incorporate them into 
their daily rituals and invest them with meaning. 
food, Health and Pleasure
among existing understandings about food and health that play roles in how functional 
foods are negotiated and invested with meaning by consumers, the “health-pleasure para-
dox” is particularly significant (Biltekoff, 00). This is the long-standing idea that “good” 
foods taste bad and good-tasting foods are “bad for us.” Mark twain (9) expressed 
this paradox beautifully in Following the Equator: “The only way to keep your health is 
to eat what you don’t want, drink what you don’t like, and do what you’d rather not.” 
The sentiment endures because it expresses beliefs about the meaning of health that are 
prevalent in western, individualist cultures. we see health through the lens of our social 
and cultural values, imbuing the pursuit and accomplishment of health (and dietary health 
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in particular) with many of the same qualities that have historically been considered es-
sential to mature subjectivity and good citizenship: autonomy, willpower and self-restraint 
(Crawford, 9). to the extent that we see health as an accomplishment that is achieved 
through the exercise of the thinking self over bodily desires, we also understand health as 
anathema to carnal pleasure and associate healthy practices with self-denial.
one of the allures of functional enhancement is that it has the capacity to remake 
“bad food” as “good for us” and, perhaps, engineer a solution to the health-pleasure 
paradox. By combining the hedonics of a sinful treat with the nutrient profile of a “good 
food,” products like vitamuffins™ and Super Donuts® seem to make it finally possible 
for americans to indulge their way to health. while these products may indeed offer 
both pleasure and health, they are negotiated within the context of the health-pleasure 
paradox and understood by consumers in ways that clearly distinguish the pleasures that 
they offer from muffins and donuts that have not been enhanced with fiber, vitamins or 
essential fatty acids and packaged in calorie-controlled portions. The pleasure of the func-
tional treat is what Coveney and Bunton (003) call “disciplined pleasure”…“reasoned, 
reasonable and safe,” rather than risky or unplanned, and consistent with, rather than 
opposed to, the self-restraining dictates of health. This is not the reckless pleasure of a 
“sinfully” delicious dessert, but a studied attempt to achieve a balance between enjoy-
ment and responsibility that is simply inconsistent with the experience associated with 
unrestrained—and therefore often guilt-inducing—gustatory pleasures. a fan of Deep 
Chocolate vitalicious® vitatops is quoted in the “tastymonials™” section of the company 
website2 raving about the disciplined pleasures that the product affords: “when I eat the 
chocolate ones I feel like I am cheating on my diet when in fact I am eating something 
really healthy…I thank you for helping me start my day off with something that looks 
and tastes sinful but is great for me.” not surprisingly, in her study of finnish consumers, 
niva (00) found that “functional foods had no place in indulgence. They were excluded 
since, by definition, they encompass a planned controlled health orientation…” Because 
the experience of disciplined pleasure is defined against indulgence, it also brings with 
it the pleasure of moral superiority over those whose unregulated pleasures are taken as 
a sign of irresponsibility, indifference and immorality (niva, 00). Product innovation 
that aims to use functional enhancement to align eating habits with healthy outcomes 
should attempt to better understand, motivate and capitalize on the existing drive for 
disciplined pleasures while bearing in mind the ways in which it is distinct from the 
pleasure of indulgence.
the whole-Diet approach to nutrition
functional foods are also negotiated and contextualized in relation to existing consumer 
understandings about what constitutes a healthy diet. But the appeal of functional 
foods—with its emphasis on single nutrients and the value of specific foods—conflicts with 
fundamental tenets of dietary health that have been promoted in the United States for over 
2http://www.vitalicious.com/testimonials.html, retrieved May , 00.
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a century. Since the emergence of the science of nutrition in the late nineteenth century, 
dietary advice has focused on communicating the basic fact that foods are composed of 
nutrients and that certain foods are, therefore, nutritionally similar despite their apparent 
differences. early twentieth-century dietary reformers sought to teach the urban poor that 
the protein in a cheap cut of tough meat is the same as that in the most expensive steak, 
and that the real value of food comes not from its cost but from its nutritional content. 
These ideas were popularized in a campaign during world war I that promoted the idea 
that beloved but scarce foods could be replaced by abundant yet unfamiliar ones at no 
nutritional cost. During world war II, the food-group approach to dietary health was 
introduced and americans learned that eating right meant choosing at least one food 
from each of seven groups every day (Levenstein, 9, 993).
The idea that certain kinds of foods share nutritional qualities with others and that a 
good diet is varied and balanced remained central to dietary advice throughout the post-
war period. as the nutrition and health communities shifted their focus from preventing 
vitamin-deficiency diseases to managing the chronic diseases of middle age, dietary 
advice became increasingly focused on warning people to avoid or reduce consumption 
of potentially harmful foods (sodium, cholesterol, fat, etc.). The USDa food Pyramid’s 
hierarchical structure conveyed the notion that some foods are better eaten in abundance 
and others in moderation, but remained focused on the dietary totality. In the context 
of this new dietary paradigm, which warren Belasco has termed “negative nutrition,” 
the food industry—concerned about the potential for negative impact on sales—played 
a major role in shaping an ongoing “no good foods or bad foods” approach to dietary 
advice that emphasized the importance of the whole diet rather than the role of specific 
foods within it (Belasco, 99; nestle, 00)
Some observers have claimed that the emergence of functional foods represents a shift 
from a “food negatives” paradigm to a more positive approach to dietary health that entails 
seeking out functional benefits in food (Hasler, 000; Leighton, 00). while consumers 
are clearly interested in using foods to enhance health in new ways, the emphasis on the 
nutritional distinctiveness of particular foods and the particular value of specific micro-
nutrients conflicts with traditional nutritional ideals. although individual functional-food 
products may appeal to consumers seeking particular benefits, the general concept of 
functional foods may confuse consumers and be difficult to integrate into existing un-
derstandings of dietary health. In her analysis of lay perspectives on functional foods, 
Lotte Holm (003) pointed to two related dangers. She noted that the “detail oriented 
and fragmented” messages of functional foods are similar to food-safety messages that 
have historically generated “confusion, uncertainty and ambivalence.” She also noted 
that by introducing elements of one group into foods from another (vitamins in candy, 
for example), functional foods disturb the logic of food groupings and may, therefore, 
be “counter-productive to the nutritional health of populations.”
the nature of Healthy food
as the products of scientific innovation and industrial processing, functionally enhanced 
foods promise healthfulness but conflict with understanding held by many consumers 
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that healthy foods are those that are the most “natural.” In interviews with consumers in 
five european cities, Holm et al. found that healthy eating means avoiding additives, and 
that eating “pure” foods (homemade from raw ingredients and containing few additives) 
was understood to provide protection against the dangers of “modern foods” (Holm, 
003). niva’s subjects described healthy food as “pure,” “natural,” and “unprocessed” and 
felt that “foods enriched or fortified with healthy ingredients, even if they were extracted 
from nature, cannot attain the original balance and perfection of unprocessed foods” 
(niva, 00). researchers report that while american consumers are receptive to the idea 
that some foods are naturally functional, they are skeptical of functionally engineered 
foods that emerge from labs and factories. In their 00 telephone poll of  people, 
the Hartman Group found that when consumers are looking for health promotion and 
disease prevention they choose fresh and “real” foods (vegetables, fruits, vegetable juice, 
water, whole grains, fruit juice, fresh seafood, soy products, dairy products) over fortified 
or enhanced foods (Demeritt, 00).
The association of “naturalness” with healthfulness may seem irrational to those who 
are using technologies to improve the nutritional profile (and safety) of foods through 
processing, but it is consistent with long-standing beliefs associating health with a 
simpler, more rural past in which people lived closer to nature. The historian rachel 
Lauden argues that the idea that food was better and healthier in the pre-industrial past 
is based on a distorted view of history. She reminds us that, for our ancestors, “natural 
was something quite nasty” and describes a not-so-distant past in which natural not only 
tasted bad, but was also unreliable and often indigestible. Processed and preserved foods 
were healthier, tasted better and freed those who were not members of the aristocracy (in 
some cases up to 95% of the population) from unending agricultural and domestic toil 
(Lauden, 00). nonetheless, the idea that pre-modern foods were more pure, healthy 
and wholesome, and that contemporary eaters should avoid the dangers of processed foods 
by eating as much as possible like our great-great-grandmothers did, clearly has traction, 
as evidenced by the popularity of Michael Pollan’s work advising exactly this (Pollan, 
00, 00). In fact, longing for a past seen as simpler, more natural, and healthier is a 
historically consistent companion to our ongoing quest for progress through innovation 
and technology. There is evidence that even Plato longed for a more wholesome past, a 
lost Golden age that included whole meal ground at home (McCance and widdowson, 
95). foods offering nutritionally engineered functional benefits may appeal to our 
love of science, innovation and progress, but they also push up against these deeply held 
beliefs about the dangers of technology and the reassuring purity of those foods that are 
as close to nature as possible. 
Because the distinction between processed and “natural” foods is one that many con-
sumers find important when choosing a healthy diet, it may be counterproductive to 
continue to include intrinsically (or naturally) functional foods (such as blueberries and 
almonds) and functionally enhanced foods in the same broad category of “functional 
foods.” Gyorgy Scrinis (00) argues that the inclusion of whole or unmodified foods in 
the category of functional foods is a sleight of hand that extends the “aura of healthful-
ness attached to whole foods across to the ‘functional’ processed foods” and undermines 
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the “processed / unprocessed distinction as a basis for evaluating the healthfulness of 
foods.” The Hartman Group has found that consumers do not use or understand the term 
“functional foods” in the same way that those in the food industry do; for lay people, 
the notion of functionality is integrally related to the natural health-giving properties in 
food. They suggest that opportunity lies in offering products that mediate between the 
poles of naturally functional and artificially engineered foods (Demeritt, 00). Those 
who are developing and promoting functional foods can better address consumers in 
their contexts by adopting terminology and practices that recognize the meaningfulness 
of the distinction between intrinsically and enhanced functional foods while striving to 
find the optimal and acceptable intersection between them.  
the Politics of Health
Understanding existing beliefs about food and health can improve our ability to design 
and promote functionally enhanced foods that make sense to consumers, but if our 
aim is a healthier future then we should also consider broader historical contexts and 
implications. Hasler (000) describes the emergence of functional foods as a radically 
new approach to diet among consumers that began in the last decade of the twentieth 
century. But the changes she observes—consumers increasingly using food as a means 
to pursue optimal health and wellness—are part of a larger set of changes in the culture 
and politics of health in the United States that have been underway since the 90s. 
Though they involve increased effort among individuals to control and mitigate health 
risks through their eating habits, it is not clear that these changes have been, broadly 
speaking, “good for us.”
functional foods as a product category and a health practice emerge from and partici-
pate in the establishment of a particular set of understandings around health that began 
in the 90s.  around that time, the american public became increasingly concerned 
about health and safety in the context of growing awareness of environmental / occu-
pational health hazards (carcinogens in food, air pollution, environmental degradation) 
and lifestyle hazards (smoking, high cholesterol). Political and corporate resistance to 
health-related regulations combined with a growing professional and public emphasis 
on individual health promotion led to the emergence of what robert Crawford (00) 
calls “the new health consciousness.” He describes this as an “ideological formation that 
defined problems of health and their solutions principally, although not exclusively, as 
matters within the boundaries of personal control.”
for the middle class in particular, the pursuit of health has become a major focus of 
attention, activity and concern. Understood as an outcome of individual effort and calcu-
lation, health also is an increasingly significant marker of self-control and responsibility. 
Crawford (00) warns that, as the tasks related to maintaining personal health prolifer-
ate, awareness of the social aspects of health recede, leaving “little room for responsibility 
beyond the quest for personal well-being.”
functional foods are an artifact of this new health consciousness, one of many strategies 
that twenty-first-century americans can use to manage an ever-increasing sense of health 
hazards and to pursue health through individual effort and calculation. functional foods 
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play a role in increasing the required breadth of health knowledge (by introducing terms 
such as plant sterols and omega-3s into the public lexicon, for example) and add new 
tasks to an already extensive list of responsibilities. In doing so, they may participate in 
the foreclosure of our ability to see beyond individual responsibility and the marketplace 
of goods as a source of health and to recognize and act proactively in regard to the social 
factors that shape and impede health. while the aim of functional foods is to promote 
health, they also add to an ever-increasing sense of health risk; “am I getting enough 
antioxidants?” was not an issue that most people worried about before products bearing 
antioxidant health claims hit the shelves. what Crawford (00) calls the “anxiety / control 
spiral” (the more we seek to control risk, the more we know about risk, the more anxious 
we become about risk) may drive people to buy functional foods, but it may at the same 
time undermine a sense of security that is also an important aspect of well being.
an expansive view of the future of dietary health will include functional foods, but 
not to the detriment of social, political and legislative remedies that address the structural 
determinants of health. a better understanding of the ways that consumers negotiate 
functional foods on the intimate level of consumption in the context of existing values 
and beliefs about food and health is crucial to offering solutions in the marketplace. But 
we should not lose sight of the aspects of health that lie beyond consumption and beyond 
the reach of individual control, those environing social conditions that set the widest 
possible constraints for dietary health and its pursuit.  
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Dr. Biltekoff’s scholarship focuses on the values and beliefs 
that shape eating habits. Her research investigates the cultural 
aspects of dietary health; how our definitions of a good diet have changed over 
the course of the last century; what it means to “eat right”; and the historical 
relationship between dietary and social ideals.
In a book she is exploring the cultural politics of dietary advice from the late 
nineteenth century to the present.
The mandate of her cross-college appointment is to develop the intersection 
between UC-Davis’s established strengths in the science of food and drink and 
their emerging strengths in the social and cultural analyses of food and eating. She 
teaches courses on food and culture, including Eating America, Food and Health 
in the United States, Rethinking Obesity, and New Food Product Ideas. Biltekoff is 
co-director of the University of California’s Multi-Campus research Group on 
food and the Body and she serves on the board of directors of the association 
for the Study of food and Society.
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farm2school, a direct link between local farms and schools, has three objectives:• encouraging children to eat more fruits and vegetables—not functional 
foods, but fruits and  vegetables straight from the farm. 
• we want children to understand where their food comes from. 
• we want to make our local farms sustainable, especially economically, but also in 
terms of the environment.
Farm2School is part of the local-food and whole-food movements, in the same family as 
farmers’ markets—which are burgeoning—and as CSas (community-supported agricul-
ture, i.e. groups of people in a community who commit to buying and eating produce 
from a particular farm). CSa members pay up-front and, essentially, own a part of the 
farm, which provides financial sustainability to the farmer. CSas are also part of the local-
food movement and are burgeoning; in 990, there were just sixty in the United States, 
and now there are more than ,500. There were fewer than ten Farm2School programs 
in 99, and now there are more than ,000, gaining traction in various communities 
because of alignment of the interests of farmers, schools, government, students, and the 
public at large. They address a grass-roots consensus on health promotion by eating better 
and how to sustain elements of the community.
The Farm2School program that I’m involved with in southern California is called 
“old Grove orange.” we grow citrus, a crop that covered much of southern California a 
century ago. However, southern California has been almost completely developed since 
then, and just a few pockets of agriculture are left. Southern California’s economy and 
its urban infrastructure were developed on the basis of the citrus industry, which is now, 
all but gone. There’s much resident emotion about this change, much of which has oc-
curred within our generation.
Farm2School: Giving Children a Healthy 
Choice for Lunch
robert Knight
Old Grove Orange
Redlands, California
news4knight@hotmail.com
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old Grove orange
old Grove orange started three years ago, with one farm, mine—I grow oranges, 
mandarins, grapefruit, and kiwi fruit—and with one school district. now, it comprises 
twenty-three local growers—producing oranges, mandarins, kiwis and strawberries—and 
twenty-five school districts. we also have four apple growers, two peach growers, and two 
grape growers, who help feed a half a million children within those twenty-five school 
districts.
Local Means Fresh
a fundamental aspect of Farm2School is that “local” means fresh. Since we’re local, we can 
literally pick and deliver to schools in one day. when we pick strawberries, we have them 
at the school the same day. when we pick oranges, we have them at schools the next day. 
essentially, we are delivering new experiences to environments that are used to chicken 
nuggets. we are providing a backyard food experience, with a remarkably improved level 
of taste that children respond to. 
Fresh Means No Chemicals
another important aspect is that “fresh” means no preservative chemicals. Since we can 
deliver produce in a day or two, application of preservatives is unnecessary. I used to run 
a Sunkist packing house in which oranges were treated to ensure a shelf life of six to eight 
weeks. Sunkist put the fruit through a hydrochloric acid pressure wash, then a boric-acid 
bath, followed by fungicide treatment and a wax coating. The orange that was exported 
to China was treated the same as the orange eaten by a child in the same neighborhood 
of the orange grove. for local consumption, we can pick and deliver so quickly that 
preservative application is unnecessary.
The third thing is that we’re competitive with big global suppliers, primarily because 
we are local. we don’t need the $ million packing-house process. we don’t need all that 
chemistry. we don’t need the attendant management of effluent. In fact, we can pack 
citrus for half the price compared with highly mechanized packing houses; therefore, we 
can be price-competitive to the school district. Being price competitive along with the 
other advantages we bring, basically makes our clients’ decision for them.
Local Means Mission
Lunch Ladies with a Higher Calling
The other thing about local is, it means “mission.” as mentioned, our now-metropolitan 
area used to be covered with citrus groves, which are almost all gone. residual sentiment 
plays into the concepts expressed by Drs. Biltekoff1 and Shimek2 about “we want to go 
back,” and “we want something that’s whole and pure and not processed.” These emotions 
elicit buy-in from the community as a whole about moving from a commodity fruit-and-
vegetable or the “Chicken-Mcnugget” model for schools into getting local produce into 
1Pages 99–0.
2Pages 5–0.
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local schools. we have found that lunch ladies who tolerate grim “Chicken-Mcnugget” 
working conditions have a higher calling. at old Grove orange, we bus in the lunch 
ladies for a “you pick” day on the farm and they take away with them all the fruit they 
can carry. Consequently, they realize that some local farms are left, and there’s something 
that they can do about their “tater-tot” existence. These ladies influence choices that 
children make at school. They encourage the consumption of the locally grown fruits 
and vegetables.
Linking Food to Farm and Health
“Local” also means, in terms of mission, that we help children make connections between 
the fruit in their diet and the environment around them. one of the educational compo-
nents that we deliver to our schools is called “Citrus History in a Box.” every third-grade 
classroom gets a citrus carton full of oranges, picked from 00-year-old trees. Southern 
California is where the fresh-pack navel-orange business started in the late 00s and some 
of the original trees have survived. The older the navel-orange tree, the sweeter the fruit, 
and so we deliver an excellent taste experience. also in the box of oranges, we provide 
aerial imagery, showing what the land on which the school was built looked like sixty to 
a hundred years ago, i.e. carpeted with citrus groves. This makes a deep impression; not 
only do the children eat fruit from trees that were planted when their grandparents were 
young, they also see what their neighborhoods looked like back then. It brings home the 
relationship between the food that they’re eating, their supermarket and the surrounding 
neighborhood.
Parents Invested in Green Space, Heritage Preservation and Health
a key mission element is parents who understand that, “If our children eat this produce, 
the local growers will be able to maintain the open space, and preserve their heritage. of 
course there’s a health aspect also, born of feeling, “oh great, it’s not just tater tots it’s 
also whole food. It’s also natural products.” They relate to that.
figure  shows the seals of five cities in southern California. each includes citrus fruit 
and/or groves, revealing the essence of these communities at the time of their establishment. 
Dozens more could be included. Practically every single city seal in southern California 
has an orange on it, whereas not a single one of them has a grove left.
Happy Farmers
another fundamental element is that “local” means happy farmers. Growers who belong 
to old Grove orange receive substantially better returns than when selling on the com-
modity market. In fact, our growers are all “refugees” from the global distribution network. 
at the very least, we match the return a grower would get on the global market. In 00, 
we paid more than four times the global rate. Clearly, the pairing between schools and 
farmers is truly beneficial to both sides.
farmSchool provides price predictability and stability. when linked to a global com-
modity market, the price changes from day to day and from week to week. we tell our 
member growers what price we can meet or exceed for the coming season, and we’ve never 
varied from those projections. They appreciate that. also, our customers, the schools, like 
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that as well; otherwise, they have no idea what they will pay for their produce until after 
the fact. Because, as farmers, we’re not tied into a global market, we can decide what the 
local prices will be in conjunction with the school. There could be a freeze in florida or 
a drought in australia, but that price won’t change, which is something that’s appreciated 
on both sides. It’s another win-win.
Most of the farmSchool growers have tried farmers’ markets and CSas, which are 
labor-intensive and relatively small in scale. In a school district, one person may make 
decisions for 30,000 children. Having convinced one person, you have 30,000 new con-
sumers. That’s attractive. a school district as a customer is like six supermarkets selling 
your product.
another thing that farmers like is satisfaction gained from their community role. when 
selling into the global market, they never knew their customers. Their fruit would be 
hauled away and they don’t know what happened to it. There is community satisfaction, 
and satisfaction for growers with the fact that their fruit is going to children in their local 
area. It’s an experience that binds communities.
Icing on the Cake
Needy Children
The majority of the school districts in southern California provide free or reduced-price 
lunches to 0% to 0% of the children; the families are so poor that the government 
either pays for or subsidizes the meals. from a local foods and whole-foods point of 
figure . Southern Californian city seals.
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view, farmers’ markets and CSas are laudable, but they sell to elite, well-to-do custom-
ers. It is gratifying that farmSchool makes elite food available to the poorest people in 
the community, and on a massive scale. a half a million children are now eating fancy 
farmers’ market fruit—the same as is sold in elite communities like Santa Monica and 
Palm Springs. 
Needy Adults
There’s a lot of waste with agriculture. we throw away about a third of what we grow in 
the United States because it’s not big enough or it’s too big or it has undesirable marks on 
it. In commercial agriculture, these leftovers are ploughed into the ground. Such oranges 
usually go to a juice plant or to a cattle farm. we donate them to the needy; we donated 
93 tons of oranges in 009 and 9 tons the year before. If you see a needy person carry-
ing an orange in southern California, it’s almost 90% likely that it came from old Grove 
orange. and that is also something to which our community responds well. Having fruit 
and vegetable farms in an urban area can help solve the problem of hunger, especially.
Carbon Footprint
another source of pride stems from our belief that we provide negative carbon-footprint 
food.  Since our farms are collocated with our customers, we travel negligible mileage to 
deliver our unprocessed food to the school districts. furthermore, our groves are in the 
same air basin as our customers, and so we have forty or fifty thousand trees sequestering 
carbon. on one hand, much of the food eaten by our customers is shipped over long 
distances, some of it frozen and thus is energy intensive; on the other hand it’s reassuring to 
eat food in the knowledge that, the more you eat, the better it is for the environment.
a Parting Shot
Science and technology have produced a consensus that we need to promote consumption 
of fruits and vegetables by our children, and one of the ways to achieve that is to gauge 
community understanding. what are the factors—besides the food itself—that can rally 
a community to make this a priority for their children? I’m sure that a different set of 
factors prevails in each community, but we feel that, around redlands in the southern 
California area of Inland empire, we’ve found those factors, because we are doing well 
as demonstrated by our win-win relationship. 
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Robert Knight was born in redlands, Ca, and raised in an 
orange grove. as a restless teenager, the grove was the last place 
he wanted to be, and, upon graduation from high school, he 
headed to new York City. after spending the bulk of 0-odd 
years overseas, working as a telecom exec with at&t and 
Lucent, ironically he returned to the Inland empire to man-
age his family’s citrus business and raise his own pair of restless teenagers amidst 
an orange grove. Proud to be a fourth-generation orange grower—but shocked 
by how quickly Inland empire groves are disappearing—Knight founded the 
Inland orange Conservancy, a group dedicated to saving groves and building an 
orange-loving community.
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I will discuss putting people first and meeting their unmet needs and desires, when designing healthy choices in foods and beverages. Consumers have a broad range of options when it comes to food, which may even be overwhelming. also, it is pos-
sible to be overmessaged about health. People are being inundated about health from an 
array of sources. It’s coming from the food industry as part of the packaging, and through 
advertizing. It’s coming from the government and from food experts. It’s coming from 
bloggers and advocates expressing strong views about food. It’s even coming from retailers. 
Several retailers in the United States are working with experts developing systems to tag 
foods with stars or point values to express nutritional values and guide people on what to 
choose. Consumers are being inundated with messages about food and health.
food science, agriculture and nutrition have created healthy dietary options over the 
years. But these options are almost lost in the sea of choice. furthermore, science can 
take people only so far. as an analogy, science has given us the diving board and the pool, 
but many people prefer to sit at the water’s edge. Ultimately, consumers choose what 
to eat and inducing people to make healthy food choices is a complex problem. on the 
other hand, at IDeo we like exploring complex problems. Many drivers influence why 
people choose what to eat.
The question under consideration—as we design new healthy food products, services 
and experiences—is, “How do we help people to want to use the diving board?” It’s not 
just about product creation, but about understanding how a product fits into people’s 
lives so that they will embrace it.
Human-Centered Design Process
at IDeo we use a “human-centered” process, to uncover latent consumer needs and 
 desires and design meaningful solutions to meet them. we start with insights about people, 
gained by spending time with them in context, i.e. in their homes, in their workplaces, 
at school, and with their colleagues or their friends. we try to walk in their shoes, to 
understand what’s going on in their lives, and thus glean insights about their desires and 
Putting People First: Designing for  
Healthy Product Choices
Lauren Shimek
IDEO
Palo Alto, California
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their needs. we then look to the business world, for example, to discover opportunities, 
and use science and technology to design solutions.
when we visit people in their homes, we start by observing them and listening to what 
they say. Much of the process of observation entails listening. we try to build empathy, 
to understand what they are thinking and how they are feeling. establishing empathy is 
core to understanding the extent to which their actions are consistent with their beliefs. 
and sometimes they are totally inconsistent. In discussing food, we are commonly told 
that their eating habits are healthy, with details provided. on the other hand, when we 
tour the kitchen, we discover that the healthy choices that they had mentioned aren’t 
actually in the pantry or fridge. However, we defer judgment and try to discover why 
their thoughts and feelings fail to match what they are saying and doing. Clearly, these 
people have aspirations that they’re unable to meet. Such situations are great opportuni-
ties for design.
further to establishing empathy and deferring judgment, a project that we worked 
on at IDeo with the Centers for Disease Control was focused on helping “tweens” eat 
more fruits and vegetables. our objective was to understand the motivations, contexts 
and drivers involved and to develop solutions. accordingly, we spent time in various 
places around the country, including atlanta, Georgia, where we met Madison who was 
eight years old at the time. we used flash cards showing fruits and vegetables to initi-
ate conversation about diet, and it quickly became clear that she was unfamiliar with 
the items illustrated. we then asked what she’d had to eat that day. Breakfast at school 
comprised french toast sticks with syrup, and for lunch she’d had chicken nuggets and 
french fries. Her mother had three children in addition to Madison and by dinner time 
she was exhausted and, that evening, served pizza from the freezer. Madison hadn’t rec-
ognized some of the fruits and vegetables, because they weren’t foods that she was eating 
on a regular basis. furthermore, her mother didn’t know what Madison had eaten for 
breakfast or lunch. She hadn’t packed that lunch and wasn’t with her at school when she 
ate it. again, this could be an occasion for passing judgment, but we regarded it as an 
opportunity to design for the situation. were there time or financial constraints? or was 
convenience the chief issue? all of those factors played a role.
we have work on varied projects, talking to people about healthy food and lifestyle. 
I will share a few patterns and themes that we are seeing.
Healthy Choices
Choosing healthy food is more than selecting particular products, just as eating isn’t merely 
about being hungry. There’s certainly a physical aspect to being hungry and to eating, and 
sometimes it’s simply about calories; however, other factors impinge, such as the social 
element, particularly the community that develops through sharing food, e.g. around 
the dinner table and at parties. There’s a mental element also. Mindless munching may 
occur mid-afternoon at work, to provide mental stimulation rather than satisfaction of 
hunger. and there’s an emotional element, such as when a parent and child make a dish 
together—cookies or some other comfort food—providing opportunities for nurturing 
and bonding.
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we are seeing an evolution in what is defined as a healthy food. People are realizing 
that it’s more than what’s on the nutrition label (although they don’t always understand 
what they read there). Consumers look for familiar, recognizable ingredients, and are 
skeptical if the list of constituents is long. They like to have a sense of how a product is 
made. and packaging plays a role. Consumers like transparency, being able to see directly 
what they are purchasing. we are hearing that packaging that’s compostable or otherwise 
eco-friendly, has positive “healthy” implications.
Information Sources
new trusted guides are emerging as sources of information on healthy foods. with the 
Internet and its inherent accessibility, people are having their voices heard, with a much 
more widespread reach than before—from food bloggers to product reviewers to people 
who simply wish to express a point of view on food—and people are listening. and tra-
ditional channels continue, including books by Michael Pollan and Marion nestle, who 
also have blogs and post their opinions on the Internet, thus reaching wider audiences. 
whether or not you agree with their advice or points of view, it’s undeniable that they 
influence people’s thinking and decision-making.
with these convenient modes of communication, some positive messages are resonating. 
People actually do know what’s good for them in some senses, e.g. that baked is better than 
fried. However, even with that knowledge, they may not choose the healthiest options, and 
we see significant tension between what we call the “impulsive” and the “considered” sides. 
The impulsive side is about spontaneous, short-term gratification, whereas the considered 
side is about long-term implications, possibly involving planning. we know that many 
people with healthy lifestyles are planners, often deciding meals for the week in advance 
and shopping accordingly rather than shopping spontaneously. This is a thought-provok-
ing area for us: How do we design to accommodate the impulsive side? Can we induce 
people to keep long-term aspirations in mind or can we design healthy choices that cater 
to spontaneity, rather than trying to convert people to being planners?
at IDeo, we work across many industries—not just food and beverages—and we’ve 
been looking at difficult choices across those industries, such as stopping smoking and 
introducing new medicines and behavioral-change regimes. we have developed six prin-
ciples of change by design that provide useful guides as we consider products, experiences 
and technologies for healthier choices.
Six Principles
Use Judo
The first principle is “use judo,” the martial art that employs the momentum of your 
opponent. from the point of view that motivations don’t change but habits do, we try 
to manipulate motivation to alter habit. for example at IDeo, trash cans for collection 
of recycled material are integrated with trash cans for non-recycled material. The larger 
receptacle is for recycled items. This builds off the common behavior of people tossing 
trash under the desks, but encourages thought in the process to maximize recycling.
 Promoting Health by Linking agriculture, food, and nutrition
Joy Not Fear
The second principle is “joy not fear.” It’s common knowledge that fear can jumpstart 
change. for example, a heart attack or other serious medical event may instigate rapid 
alteration of behavior for the better, but often only on a temporary basis. How can we 
help people sustain an improved lifestyle?
Pie ranch is a wonderful organization in Pescadero, California. It’s a ranch and farm 
where they grow fruits and vegetables and raise livestock, and provide a youth-education 
program. we spent time talking to three teenage participants in the program who were 
struggling with obesity. Devon lived in an unsafe neighborhood in San francisco, so he 
spent a lot of his time inside playing videogames for entertainment. on a daily basis, he 
made the difficult choice not to engage in the violence and the crime that was around 
him, but to stay indoors. His participation in the Pie ranch program gave him the joy 
of healthy eating, helping him to ignore the negative aspects of his life: “The people there 
are nice to you. It’s like a welcoming environment, which is healthy, with actually organic 
food straight from the farm. I love it there. That place is like a Disneyland…” He had 
lost thirty pounds since joining the program. This is an example of promoting the joy of 
healthy eating instead of emphasizing negative long-term effects of obesity.
Removing Choice
Sometimes, removing choice can help people to make behavioral changes, including 
healthy decisions. an analogous program is one that Bank of america calls Keep the 
Change; each time a debit card is used, the amount is rounded up to the nearest dollar 
and deposited in a savings account. Some consumers who aspired to save money but 
didn’t, have been influenced by Keep the Change to balance their checkbooks to follow 
the accumulation of their savings. This is similar to consumers who aspire to eat healthy 
but fail to do so. Thus, an opportunity to elicit change is presented, where no change 
is actually necessary, and tension over choice is removed when people naturally achieve 
their aspirations in the long run.
Show, Don’t Tell
when asking people to change their behavior, to make healthy decisions, offering feed-
back is critical, otherwise how are they to know that they are doing the right thing? as an 
example of this principle, we worked with ford Motor Company during the development 
of one of their hybrid electric vehicles to help buyers get the best battery performance 
and optimal fuel efficiency. rather than telling drivers, “This is how you do it,” we built 
into the dashboard indicators that provide real-time feedback on whether they are doing 
the right things. a tutorial is also built in to encourage experimentation.
Finding Moments that Matter
How can we give people exactly what they need at the right time and place? Healthy Choice 
Fresh Mixers provide an example of a product that we at IDeo have worked on. It’s a dry 
pasta on the bottom with a sauce on top; the consumer adds water, boils it in a microwave 
oven, drains it and mixes in the sauce. It’s designed to be consumed away from home, e.g. 
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at work for lunch. Part of the objective is to provide a “cooking moment”—even within a 
busy schedule—about which people can feel good and see as healthy. It’s interesting how 
science, technology, policy, and design can give people just what they need at the right 
time and place, and in the right amount.
Build a Crowd
and the last principle comes from the television show “Jamie oliver’s food revolution.” 
oliver, a British chef, came to Huntington, west virginia, one of the most obese commu-
nities in the United States with the objective of starting a food revolution. on the reality 
show, he engaged a thousand people in the town, cooked a recipe with each and took a 
picture of each person with her/his dish. Considering that each of us is influenced by our 
environment and our culture, how do we build a crowd? How do we build momentum 
behind behavioral changes?
The following is an exchange that took place on one of oliver’s shows:
Oliver: Wow! I love working with kids. Elementary school is where it’s at. You know, this 
is where you mold kids. We’re going to do a little test. Right! Who knows what this is? 
[Holding up four tomatoes.]
Child: Potatoes?
Oliver: Potato? So you think that these are potatoes. They’re not potatoes, though. Do you 
know what it is? No? Who knows what tomato ketchup is? Yeah—that’s what it’s made 
out of.
Child: Tomato?
Oliver, voice over: The test I did with the kids today was shocking.
Oliver: Do you know what that is? [A beet.]
Child: Broccoli?
Oliver: Do you know what this is, Honey? [A beet.]
Child: Celery?
Oliver: No.
Child: Onion?
Oliver, voice over: Immediately you get a really clear sense of “Do the kids know about 
where food comes from?”
Oliver: Who knows what that is? [An eggplant.]
Child: A pear.
Oliver: No. I’ll give you the first word—egg.
Child: Eggshell!
Oliver: I’ve got another one here guys. What do you think this is? [A potato.]
Child: I don’t know.
Oliver, voice over: We’re talking about basic stuff. Even a potato—no idea. Most of 
them—no idea.
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Oliver: Okay, our last question. What is this?
Children in unison: Chicken McNuggets!
Oliver: You all knew that. You’re too good. Okay, what’s this?
Children in unison: Pizza!
This is reminiscent of our conversation with Madison in atlanta, Georgia. after oliver’s 
exchange with the schoolchildren, the teacher took it upon herself to bring fruits and 
vegetables to the class as object lessons. other teachers followed suit in other communities 
and then there were emails, and comments on the Internet. and so, a crowd was built in 
that community that sparked a national movement.
Jamie oliver won the teD Prize1, and, accordingly, he had an open call out to people 
to join his food revolution to offer their time, talent and services, everyone from web 
designers, marketing experts, to people that have a left-over winnebago that they will 
donate to someone who wants to drive around the country and teach kids. we are work-
ing with oliver to encourage this food revolution, to move it beyond him, to connect 
people with passion and dedication to maintain the food revolution and spread it across 
the nation.
In Closing
I’ll close with a few questions. at the end of an IDeo project, we usually have some 
interesting solutions, and often more questions.
• How might we support existing healthy behaviors through science and through 
policy?
• what if we foster the joy of eating healthy rather than the fear of eating poorly?
• How might science and technology provide meaningful feedback to consumers?
• How might consumers’ needs and desires, latent or not, play a role in creating 
new policy and in developing new technology?
1technology, entertainment, Design. It started in 9 as a conference bringing together people from those 
three worlds. Since then it has broadened in scope. The teD Conference, held annually in the spring, is the 
heart of teD. More than a thousand people attend. The event sells out a year in advance, and the content has 
expanded to include science, business, the arts and global issues. The teD Prize is designed to leverage the 
teD community’s exceptional array of talent and resources. It is awarded annually to an exceptional individual 
who receives $00,000 and, “one wish to Change the world.” after several months of preparation, (s)he 
unveils her/his wish at an award ceremony during the teD Conference. These wishes have led to collaborative 
initiatives with far-reaching impact.
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as food science innovator and technical build guide, Lauren 
Shimek brings a passion for food, technical expertise, and food-
science knowledge to food and beverage projects at IDeo.
Prior to joining IDeo, she developed breakthrough tech-
nologies and new food products at General Mills. She has 
worked in many food categories, e.g. snacks, bakeries and 
foodservice, and meals, including Progresso 50% Reduced Sodium soups in which 
she led product development from concept to market. at IDeo, since 00, 
Dr Shimek has worked on projects that span the aisles of the supermarket, from 
beverages to frozen foods to shelf-stable meals.
She holds a PhD in food science and a BS degree in biochemistry from the 
University of California at Davis. a self-professed foodie, she brings a personal 
enthusiasm for food and food culture to IDeo via her monthly Eater’s Digest 
newsletter and blog at www.foodspiration.com. She is also actively involved with 
the Institute of food technologists (Ift), serving as advisor for the national Ift 
Student association.
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Tom Tomich: Bob Knight mentioned community and the food movement, and just a week 
ago in the New York Review of Books—not Western Orchardist or California Agriculture, 
this was the New York Review of Books—there was an interesting piece titled “The food 
Movement rising” about agriculture, food, nutrition and health. no points for guessing 
the author’s name. He’s from the school of journalism just down the road, at our sister 
campus, UC Berkeley. It’s Michael Pollan. to set up the discussion, I want to share a 
quote from that piece and then turn to our panelists for their impressions and then also 
get your comments and impressions and questions for the panelists. I urge you to look at 
the whole article because there’s actually quite a bit of nuance to this quote that I won’t 
do justice to: “The healthcare crisis probably cannot be addressed without addressing the 
catastrophe of the american diet, and that diet is the direct, even if unintended, result of 
the way that our agriculture and food industry has been organized.” He’s talking about just 
the United States; this isn’t a global perspective. now, I want the panelists to step back, 
to use this observation. My questions to each of you are: “Do you see the emergence of 
a food movement?” and, if so, “what is the role of science and specifically food science 
vis-à-vis that movement?” and if you want to take it even further, “what would be the 
implications of the food movement for biotechnology?  How do you see those aligning? 
Misaligning? Partially aligning?” who would like to go first? Bob is stepping up. You 
already referred to the food movement, so how do you see the relationship between that 
movement on the demand side and science on the supply side?
Robert Knight: Certainly there’s the local food movement—having survived as a farmer 
on the basis of that local food movement for about the last 30 years. Yeah, there is a local 
food movement, but is there a role for science and technology in that food movement? 
There is so much of a role for science and technology just for agriculture. and the local 
food movement is a small segment of agriculture, but it is a valid segment. So, definitely 
there is a role for science and technology.
Choosing Foods For Health
Q&a
Moderator: tom tomich
University of California
Davis, California
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Tomich: Do you see potential alignment, or not so much, between the functional-foods 
biotechnology we are talking about and the kinds of preferences that that food move-
ment represents?
Knight: In my particular instance what people really connect to is being able to see the 
farm, have visibility into it, know they have transparent access to it, know that it is local. 
whether the product is historical like the orange or some other product that is new and 
wonderful through food technology, doesn’t matter so much, as long as they know who 
is growing it and where it is and that it’s part of the community.
Tomich: Thanks. Lauren do you want to have a go at all or part of that?
Lauren Shimek: I think that there’s a food movement beyond just the local food movement, 
for two reasons: one is because we go across the country and we talk to a lot of consum-
ers in various regions across income levels and we hear a lot of the same things. People 
have similar concerns. They have new definitions of healthy. They are looking at food 
in new ways, more critical ways. at the consumer level there is a heightened awareness. 
But also, there’s an interesting movement going on right now at the system level relevant 
to the quote—looking at the healthcare system, looking at the agriculture system, the 
industry and looking at the government—Michelle obama’s comments on obesity and 
food for example, and the symbolic garden at the white House. There’s Jamie oliver, and 
The Child and nutrition Bill may funnel more money to school lunches. There’s a lot of 
dialog. Discussion is coming up from the bottom and coming down from the top, which 
is key. as a food scientist, I think there is absolutely a role for science in this movement. I 
see food scientists as problem solvers. we’ve had amazing challenges in our history, when 
food wasn’t abundant and choice was limited. food science met those challenges, maybe 
in some cases too well. now we have abundance of food, and we have an obesity crisis. 
we have a lot of choice in the marketplace. I’d love to see the food-science community 
rise to this new challenge and put that same energy and excitement and knowledge to 
solving those new problems. But, it’s about acknowledging what’s going on now and how 
it’s different from what was going on 0, 0, 30, 50 years ago.
Charlotte Biltekoff: I’ll echo what the other panelists said, and yes there is a food move-
ment. I think we can all see it from the food network, to whole foods, to my field, to 
food study. There is a growing interest in food and there’s politics around looking for 
change around food and alternative food systems. But, I think it is increasingly difficult 
to talk about american culture and the population in unified terms. If we think about 
the changes just in, say, television from the three networks to the hundreds of channels 
available on cable—we are an increasingly niche-fragmented society and it is important to 
keep in mind that various interests are pulling us in many different directions. Living in 
Berkeley leads me to see the world through a certain lens and think that a food revolution 
is everywhere, when in fact it’s really not. we have a very diverse and fragmented food 
culture that is likely to become increasingly so. But, to address the question of science 
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on a slightly different level, some of my colleagues—my colleague, warren Belasco in 
particular—has recognized two alternative futures for food. He has studied the history 
of the future of food and shown that, historically, we have talked about the future of 
food in dichotomist terms. we have talked about a technological fix that involves solving 
the problems through science and technology and an alternative anthropological fix, 
where we change our values, we change our culture and how we live in order to solve the 
problem by, say, using fewer resources, eating more simply, that kind of thing. But the 
likely scenario is that we meet somewhere in the middle. and, as Belasco says, it may 
be that the solutions to our problems in food and health will come from technology, 
but they will have to look very much like somebody’s grandmother made them. a real 
or imagined grandmother, right? I think there will have to be some kind of meeting in 
the middle where these values—the technological fix and the anthropological fix—find 
a complementary solution.
Tomich: Thank you all. I want to open it now for audience questions and comments on 
choosing foods for health. 
Robert Wager (Vancouver Island University): Bob, I am very impressed with what you are 
doing. I had never heard of this before and it’s fabulous. However my questions are more 
to the other people on the panel. when I grew up in the 90s and ’0s, marketing was 
really about sexy, or new, or new and improved, and today it has moved toward fear sales 
marketing. about 0 years ago there was a Nature editorial that said scientists no longer 
have the luxury of staying in their labs and communicating only with their peers. Society 
needs scientists to speak up. I believe that’s very true, and, keeping in mind the saying 
that the public must know that you care before they will ever care what you know, what 
is your advice to the scientists here?
Shimek: It’s an interesting question in terms of the dialog between the scientific com-
munity and consumers and the role of the media. also interesting is the comment that 
scientists should show that they care. In the human-centered design process, empathy 
and mutual respect are important. My message to the scientific community would be to 
think broadly about the implications of what you are working on. as a scientist myself, 
there were times in my life when I made scientific decisions and didn’t necessarily think 
about their impact on products going into the marketplace, how they might shape that 
landscape. as a scientist, what seem like small decisions may add up across the community, 
and the things that I put into products that went onto supermarket shelves may actually 
have changed the landscape. I encourage you to think about that bigger picture, to step 
back from the moment of the technology or the ingredient and think about potential 
impact on consumers and the landscape as a whole.
Biltekoff: Understanding the context within which consumers choose foods is important 
to gaining a sense of empathy for the number of choices that people are making, the 
amount of variety they face and the uncertainty that results from conflicting informa-
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tion about what is good to eat. The ethos of caring and connecting through empathy 
with consumers is a way to reassure people in a very uncertain marketplace and to take 
seriously their anxiety over food choices even if those concerns seem irrational from a 
scientific perspective. 
Knight: It’s hard to imagine a lunch lady in a cafeteria getting excited about delivering 
a chicken nugget with some extra functional-food additive. This isn’t just a scientific 
issue, although scientists have a role in delivering new developments and how they are 
couched.
Tomich: our land-grant history—many of us are from public universities—goes back to a 
nineteenth-century notion that it’s not just about science, but it’s about responsive science 
that actually listens to the needs of our population. what’s different now is that most of 
the population, the vast majority, are not directly involved in agricultural production so 
that listening and engagement is now an infinitely more complicated process. But I think 
we can get really good at it.
Amanda Martin (University of Minnesota): I’m with the Student Voice program. when I 
go to the store I try to get the most calories for my dollar. with vitaMuffins and other 
00-calorie packs, we are spending more money to get fewer calories. are functional 
foods suitable only for a certain demographic or are they applicable to all socioeconomic 
strata?
Shimek: You bring up an interesting point about cost, and that your need may be different 
from that of someone who is struggling to obtain an abundance of food and calories. Cost 
is a huge driver for why people make their food decisions. In terms of the application of 
functional foods, I think that people here would agree that they span many demograph-
ics. However, it is more interesting to think about the specific needs of the groups you 
are discussing and how we tailor healthy food choices to meet those people’s needs and 
address those drivers. Cost is a hugely debated issue when it comes to healthy foods.
Biltekoff: Some critics raise the question of whether or not it is ethical to commodify 
healthfulness, and, if healthy food and health in general are a public good, is it ethical 
to invest so much in commodities—as a way of providing health—resulting in added 
value and added cost.
Barbara Schneeman (US Food and Drug Administration): I was intrigued by the comments, 
particularly from the first two speakers, that “fresh” is linked with healthfulness of a food 
choice. even with shipping and handling, food, including processed foods, is often more 
nutritious because nutrient content has been stabilized. The dietary guidelines point 
out that fresh as well as processed kinds of foods can help consumers meet the recom-
mendations. from the research that you do in terms of consumer perception, I wonder 
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if that’s a bridgeable gap? Is that connection with fresh so inherent that trying to create 
the understanding of the role that certain types of processed foods can play is something 
that consumers would reject? So, that’s one thing I would be interested in comments on. 
and I felt it would be worthwhile commenting on a project that was done many years 
ago. It was actually initiated by the California Dairy Council and the american Institute 
of wine and food. Julia Child was a major driver in the program, and it was an attempt 
to bring together culinary experts with nutrition experts for dialog on how we make sure 
we are moving together. The group eventually developed a motto that “in matters of taste 
consider health and in matters of health consider taste.” I don’t know if any activity is 
still related to that, but it speaks to the fact that tension between culinary and nutritional 
aspects has been there for a long time. How do we bridge that gap?
Tomich: It’s for the foodies on the panel.
Biltekoff: There’s a really important role for history in helping people to understand the 
value of food processing. I said in my talk that I think that the sense of a more whole-
some, rural past will always be with us and that nostalgia will always be a competing 
push against innovation and technology. But, that said, I do think that much of our food 
culture today is operating around a romantic view of the past. our job as historians is, 
of course, to trace historical change to help people understand the kind of contribution 
that something as simple as, say, industrially produced tortillas, may have had in freeing 
people up to do things with their lives other than pat tortillas all morning. food studies 
is a growing academic field in which we teach things like food history. Having a more 
realistic view of the history of food and food processing would go a long way.
Shimek: Processed foods are often criticized and under fire and yet there is a renaissance 
around canning and you can find wonderful boutique jam and jelly places in Berkeley 
and elsewhere, celebrating the craft of canning, which most of us are probably fairly 
removed from. So, there really is a role for processing and partly for seasonal reasons. If 
you are going to completely fresh then certain things are going to be out of season and 
the purpose of some of those original technologies was to have food throughout the year 
that would retain nutrients and flavor. So, there is a role there. The other piece, Barbara, 
you bring up is that with fresh comes the need to cook and prepare the food, yet there 
is loss of cooking skills and increasing ignorance of basic food preparation. That’s part of 
Jamie oliver’s campaign—teaching people basic cooking skills. I love the idea of everyone 
eating fresh, but there’s the seasonal issue and there’s the issue of our food culture and the 
knowledge that comes with that. an interesting food culture exists in the Bay area. You 
have a slow-food movement and a fast-food movement on the other side and I believe 
that a third option exists somewhere in the middle, where it’s not about eating all fresh 
all the time and it’s not about eating all processed all the time. It’s actually learning from 
both of those groups that have a point of view and figuring out what’s realistic and what’s 
a new possibility in the middle.
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Tomich: I was struck in this session by how dichotomist the attributes are: fresh, processed, 
natural, artificial, tastes great, less filling. It’s not the decision process that Carl Keen1 
was talking about when we think about comprehensive assessment of benefits and risks. 
I don’t know how we juggle those.
Audience member: a question for Bob Knight: to what extent do you think that it is pos-
sible to bring back the orange groves to California? when you started your talk, I thought, 
“okay, this is a great story.” But I was looking at it as an agricultural history of the Golden 
State, but when you finished your talk you said maybe this is not only a sustainable busi-
ness but also a profitable business. Do you think you are getting close to that on a wider 
scale? Is this a good example of how to integrate local agriculture in large metropolitan 
areas with huge numbers of possible consumers like La and the Bay area?
Knight: Indeed it is a sustainable business. It is a profitable business. But it isn’t going to 
take over California and that’s because of real estate values. The growers left in southern 
California are mostly family growers. It’s a lifestyle choice. They have inherited that land. 
It would be extremely difficult for someone new to move in and buy land and make it a 
profitable business. The good news is that what’s left we have a really good chance of being 
able to sustain as a jewel in our communities for years to come, but to increase that farm 
acreage—actually take out parking lots—that’s something I don’t expect to happen.
Bhimanagouda Patil (Texas A&M University): a significant challenge for plant breeders in 
this country, particularly western fruit breeders, is the development of fruits or vegetables 
that taste good. Scientific data indicate that fruits and vegetables that are bitter or tasteless 
contain higher levels of potentially bioactive compounds. when they are manipulated to 
make them tasty there is the possibility of losing compounds that are good for health. In 
a hundred years we might want the old varieties for their health benefits. we developed 
a very mild onion and we have a mild pepper for american consumers. on the other 
hand, foreign visitors ask, “why did you change this very good pepper to a mild one? 
we need the hot pepper.”
Shimek: That again brings up preparation, especially when it comes to vegetables, many 
of which require cooking. It’s pretty easy to wreck a vegetable. we’ve spent a lot of time 
with moms and kids and the struggle over vegetables—trying to find ways to make them 
attractive for children, and preparation is an interesting area to explore. It’s not just about 
the vegetable on its own, but how might we pair it with things that people can relate to 
that can still be healthy. How might we use those culinary tools, spices and herbs that 
aren’t going to take away from the health quality. Preparation is key, and we are actu-
ally experiencing what you are talking about right now with vegetables currently in the 
marketplace. If people don’t know how to prepare it, they shy away from the vegetable 
in question or may dislike it from having experienced a poorly prepared dish.
1Pages –.
9tomich
Biltekoff: what if it’s really true that in order to be healthy we have to eat what we don’t 
like? Part of what is at issue here is diversity of taste—what we consider tasty, right? we 
see some positive trends towards more complex and bolder flavor profiles in the market. 
That bodes well for increasing acceptance of a variety of intensity levels and profiles as 
tasty. Bob Knight’s program speaks to the question of taste education in a sense—exposing 
children to a wide array of different tastes. There is some natural aversion to bitterness at 
certain ages, but I do think there is a role for early education to play in making sure that 
a diversity of taste is experienced.
Michael Kahn (Washington State University): Yesterday we talked a lot about research and 
innovation, and the thing that struck me about the example that Lauren gave about the 
vegetables in the schools was that the teachers responded by bringing in vegetables and 
educating the kids. obviously, that was something that might have occurred to them 
before you did the experiment you did, but they clearly were making the assumption that 
these children knew about vegetables. ronald reagan was right, ketchup is a vegetable. 
They recognized ketchup, but they don’t recognize vegetables. Is this a problem where we 
know the information we need to deliver? functionally or non-functionally, a lot of the 
information goes back to pyramids. It goes back to proteins and vitamins and things like 
that. we know that, but we are not delivering it very well. This gets back to the comment 
about niches. a lot of the niches for those children clearly don’t include tomatoes.
Biltekoff: we may be delivering these foods into inhospitable contexts, basically. Delivery 
may not be the right metaphor. as a cultural historian and a cultural critic sometimes 
it becomes overwhelming because it is impossible to separate the question of why we 
can’t get people to eat right from larger social and political issues. and frankly, one of 
those is poverty and the massive increase in income disparity that has occurred over the 
last several decades. Much of what we are talking about here are low-income and highly 
stressed communities where people are working insane hours trying to keep up with ris-
ing real estate costs, costs of medical care and child care, et cetera—living in a landscape 
that is basically inhospitable to healthy food preparation and consumption. we in this 
room are not going to solve those larger problems, but I do think we have to keep in 
mind the relationship between the question why can’t we get people to eat right and the 
larger stressors on people’s lives that make making the right choices nearly impossible 
most of the time.
Shimek: There are some other interesting cultural pieces, of which I’m sure Charlotte knows 
a lot more. when I was in high school, all of the home-economics labs were turned into 
computer labs. So the home-ec nutrition program disappeared in favor of technology. 
as we outsource more and more of our food preparation and our cooking, those tradi-
tions are being lost. It’s interesting to examine the younger generation and important to 
understand the technology they are exposed to and the value that society now places on 
time and convenience, very different from even just 0 years ago.
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Knight: Looking specifically at schools in the districts that we serve in southern California, 
as I mentioned, 0 per cent to 0 per cent of the school meals are free or reduced, which 
means that, in these districts, children are being fed by their schools. They are getting 
their breakfast at school. They are getting their lunch at school. and schools will even 
give them backpacks to take home to feed them on weekends, in some cases. and so, 
schools are incredibly important in urban areas like metropolitan Los angeles because 
they are the ones that are determining taste. Many are unaware that they don’t cook in 
schools anymore. They open boxes, they microwave things, but they don’t wash dishes. 
everything is disposable. and so, when I saw that video2, I wasn’t surprised at all that 
those children didn’t know what a tomato was because if they are getting all their food 
from the school, they never see a tomato there. That’s why it’s important to find a solution 
to get those fruits and vegetables visible in schools. we are creating those kids’ tastes for 
a lifetime, and Farm2School is a good mechanism for that.  
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I used this title for my presentation recognizing that most members of the audience have an academic focus. I hope to encourage thought, by pointing out where universities really do play a role. The food and Drug administration (fDa) 
is a science-based agency and so the scientific expertise that universities can bring to bear 
on many of these issues is very important to decision making. Diversity of expertise is 
important.  
I am located at the Center for food Safety and applied nutrition and will focus on nu-
tritional aspects, describing the legal basis for the actions that we take—how my office uses 
its legal authority. I’ll finish with a description of our current activities and priorities.
fDa’s Legal authority
our legal authority is founded in three laws. The federal food, Drug, and Cosmetic 
act, as amended, is the primary law that governs what we do. everyone has great ideas 
about what fDa could do, but, in fact, our legal authority to regulate comes from the 
federal food, Drug, and Cosmetic act, the fair Packaging and Labeling act, and the 
Public Health Service act. The purpose of labeling is to inform the consumer at the point 
of purchase about the basic nature of the food, its ingredients, its nutritional attributes 
and other material or essential information, including warnings or clarifications. Iden-
tification of certain allergens is now mandatory in food labeling. The small print that 
is usually hard to read is often the mandatory part of food labeling. It has to be on the 
principal display panel or what’s defined as the information panel. other labeling—the 
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information that is typically most prominent—is usually voluntary and presented at the 
manufacturer’s discretion, i.e. claims, marketing statements, and promotions. It is im-
portant to remember that all labeling—whatever is on the product or stated on a related 
website about the product—must be truthful and not misleading. figure  lists the items 
that are considered mandatory elements for labeling in the United States. Canada’s laws 
are similar, and Canada and the United States are unusual in that nutrition information 
is mandatory in our labeling. europe is going through a process to develop mandatory 
nutrition labeling. 
figure . Mandatory label requirements for foods, including sdietary supplements.
Biotechnology
a noteworthy item that relates to biotechnology issues is the concept of material fact 
information; any information that reveals facts in light of representations already on the 
label or any consequences of the use of the product have to be included on the label. If 
biotechnology changes the product in a manner that is considered a material fact, you 
have to give consumers that material fact, i.e. not the biotech piece, but what is different 
about that product in terms of its composition or use.
nutrition Labeling
In 990, the nutrition Labeling and education act (nLea) was enacted, making nutrition 
information mandatory on most packaged foods, and the regulations specified a format. It 
was no longer left to the manufacturer’s discretion on how the information was presented. 
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It shifted emphasis toward the macronutrients that are associated with chronic disease 
risk and allowed for nutrient-content and health claims. The nLea provides consumers 
with information to help them select foods for healthier diets. It eliminated confusion 
about nutrient-content claims, ensuring that when a claim is made, consumers can rely 
on that information. It also protects consumers from unfounded claims by developing 
a process by which health claims are authorized. It also encourages product innovation 
through the marketing of nutritionally improved foods. for example, there was a major 
effort to get rid of trans-fat before its mandatory labeling went into effect. 
The public-health justification for enacting the nLea included a surgeon general’s 
Report on Nutrition and Health, a national academy of Sciences report, Diet and Health, 
and Dietary Guidelines for Americans jointly from the Department of Health and Human 
Services (DHHS) and the Department of agriculture (USDa), which made specific 
recommendations on how to improve health. Items to be listed on the “nutrition facts” 
label are shown in figure .
figure . Items to be quantified on the “nutrition facts” label.
There are cases where some nutrients need not be listed, but the details of those regula-
tions are beyond the scope of this presentation. 
The nutrition facts label was designed with education in mind. Several formats were 
consumer-tested, which led to the inclusion of the concept of “daily value,” to provide 
consumers with an easy means of judging whether a product is high or low in a nutrient, 
as part of planning their diets. The nLea contains education as part of its core, so it was 
important that the nutrition facts be useful in education.
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anPrM
an advanced notice of proposed rule-making (anPrM) lists the agency’s questions and 
requests information in order to engage in a rule-making process. Three of these have been 
published in recent years, seeking input on possible revision of the nutrition facts. one 
was on the display of calorie information on the food label. another was on serving size, 
particularly for products that can be reasonably consumed in one eating occasion; most 
of us are familiar with how we’ve gone from -ounce to 0-ounce sodas, exemplifying 
a need to reexamine serving size. and the third was major from a scientific perspec-
tive—revision of reference values and what the mandatory nutrients will be. This was 
driven particularly by the Dietary reference Intake reports from the national academy 
of Sciences, providing new scientific information for revising our reference values. The 
005 dietary guidelines will apply until the 00 process is completed.
Public-Health Context
In addition to considering scientific information, the public-health context is important. 
for example, prevalence of childhood and adolescent obesity has increased significantly 
since the late 90s. Sodium intake is another critical issue. Less than 5% of the US 
population consumes ,00 mg or less of sodium daily, most of which originates in pro-
cessed foods. another particularly relevant dimension involves those food groups whose 
consumption is encouraged. Looking at fruit consumption, we are not doing too badly 
in terms of the percentage of the population meeting the recommendations (fig. 3), 
whereas for vegetables we barely make it off the baseline, in terms of the percentage of 
the population meeting those recommendations. also for whole grains, very few people 
meet the recommendations (fig. 3).
figure 3. fractions of the US population consuming 
indicated servings of fruits, vegetable and grains, 003–00
(source national Health and nutrition examination Survey, CDC).
3Schneeman
Label Details
Serving size is at the top of the nutrition-facts label (fig. ). Do we have the right num-
bers? are we displaying calorie information appropriately? Many questions have been 
raised about calories from fat and whether this item is needed. Do we need to improve 
the presentation format? we’ve had comments about the footnote, which many don’t 
understand. Is there a better use for that space?
figure . The nutrition-facts label.
voluntary Information
from mandatory information on the nutrition facts label under the aegis of nLea, I 
want to shift to voluntary information. four general categories of claims can be used in 
nutrition labeling. Dietary-guidance and nutrition-support statements are not pre-ap-
proved by the agency. It’s the manufacturer’s responsibility to substantiate any such claims, 
and to make sure they are truthful and not misleading. a dietary-guidance statement is a 
general message that refers to categories of food, e.g. “fruits and vegetables are part of a 
healthy diet,” or “The food-guide pyramid recommends so many servings of vegetables,” 
or similar statements. we are in the process of examining dietary-guidance statements: 
should the agency be setting parameters dictating when dietary-guidance statements 
can be used on food products? nutrition-support statements include structure-function 
claims about maintaining health and function or structure of the body. for example, 
“Calcium builds strong bones” is a structure-function claim. again, in the United States, 
we do not pre-approve or review those. They are the manufacturer’s responsibility to be 
truthful and not misleading.
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Claims that need to be reviewed by the agency before they can be used are of 
two types:
• nutrient-content claims that refer to a nutrient level in a product, and 
• health claims that characterize the relationship between a food or food 
component and reduced risk of disease or a health-related condition.
Nutrient-Content Claims
figure 5 gives examples of “expressed nutrient-content claims” stating that a component 
is non-existent or low or a good source or an excellent source. They may be comparative 
claims, stating that a food has more of a nutrient than another or it has less of nutri-
ent, and particular types of percentage claims are used for dietary supplements. one of 
the challenges is making sure that we have the best tools and techniques for measuring 
nutrient content. The defined terminology, shown in figure 5, helps the consumer un-
derstand, for example, that, if something is described as an “excellent” source, it has a 
specific meaning.
figure 5. examples of expressed claims.
nutrient-content claims are not possible for many compounds, including some 
bioactives, because reference values are unavailable. we don’t know what constitutes a 
recommended amount, so it’s not feasible to state when a food is a good or excellent 
source. Most regulations that apply to nutrient-content claims are only for nutrient or 
dietary substances that have a daily value (fig. ). we don’t have that for antioxidants in 
general or for carotenoids, for example. again, that’s a challenge to science.
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There are also “implied” nutrient-content claims, which suggest that a nutrient is present 
or absent, or equivalent to the level in another product (fig. ). fDa has defined when the 
term “healthy” may be used, in terms of minimum fat, saturated fat, sodium, cholesterol 
and certain beneficial nutrients, providing context for the consumer (fig. ). 
figure . Basis for nutritional-content claims.
figure . Implied nutrient-content claims.
Health Claims
Health claims are science-based statements of disease-risk reduction from foods and dietary 
supplements without being regulated as drugs. Before nLea, the agency would have to 
approach such a declaration as a drug claim. Critically important is reduction in the risk of 
a certain type of disease; it’s not about prevention, mitigation, treating or curing a disease. 
a key element of a health claim is that the food or supplement has to contain a specific 
substance. also, the disease or health-related condition has to be defined.
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we’ve had some discussion about using biomarkers to estimate risk. Studies that 
require clinical outcomes—heart disease, cancer, etc.—are costly, therefore biomarkers 
offer a useful tool to show when risk has been reduced. we have five biomarkers that are 
validated surrogate endpoints of disease:
• LDL cholesterol or plasma cholesterol reduction for cardiovascular disease,
• blood-sugar levels or insulin resistance for diabetes,
• mild cognitive impairment for dementia.
• polyps for colon and rectal cancers, and
• bone-mineral density for osteoporosis.
an Institute of Medicine (IoM) project, funded by fDa, has the objective of devel-
oping a framework for elucidating more biomarkers to serve as surrogate endpoints of 
chronic disease. few such tools are applicable to cancer, for example, therefore it’s difficult 
to develop health claims in this area.
Three approaches are available for obtaining a health claim (fig. 9). nLea claims 
are based on significant scientific agreement. we authorize these through rulemaking, 
which means the agency stands behind the claim and makes it available through federal 
regulation. The agency developed qualified health claims as a result of a set of court cases 
that the agency lost, particularly with dietary supplements. These claims characterize the 
quality and strength of the scientific evidence because they are not based on significant 
scientific agreement; we do them only through enforcement discretion, not through 
figure . Criteria for the use of “healthy.”
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figure 9. Health claims in food labeling.
rulemaking. Thirdly, an authoritative statement from a branch of the government or the 
national academy of Sciences can be the basis of a health claim.
Significant scientific agreement implies consistent relevant evidence from well designed 
studies, whereas a qualified health claim is based more on emerging evidence, for which 
we use several types of qualifiers. Certain qualified claims are categorized as “highly 
unlikely” or “uncertain.” 
on our website, a final guidance document, titled “The evidence-Based review System 
for the Scientific evaluation of Health Claims,” details the steps the agency goes through 
to review the scientific evidence that is submitted with a petition. This would be a valuable 
aid for graduate students when designing their research, especially if they are working on 
something that eventually might relate to a health claim. figure 0 provides a schematic 
representation of the process. 
all relevant information must be submitted, not just favorable studies. we examine all 
of these, keeping in mind our guidance outlines for what kinds of information cannot 
be used for a scientific decision: review articles, meta analyses, book chapters, abstracts, 
animal and in vitro studies, non-identification of the substance or the disease, etc. (fig. 
0). we also identify fatal flaws within any of the studies, such as if there is no control, 
relevant statistics are lacking, or they have key confounders that are not controlled for. 
often we receive observational data without any intake validation, and studies that are 
conducted on malnourished populations; again we set those aside because they are not 
useful in the decision-making process. Having accumulated data that are useful to us, we 
go through an evaluation to determine whether or not they constitute credible evidence 
for the claim, because some will support the claim and some will not support it. If there 
is no credible evidence, then we deny the petition. If there is some credible evidence we 
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rank the level of scientific credibility, and then proceed with rulemaking for a significant 
scientific agreement (SSa) claim, or enforcement discretion for a qualified health claim 
(QHC). Many people think we use different evaluation processes for these two claims, 
which isn’t so. The strength of the scientific evidence determines the outcome.
regulation Development
as indicated, we implement the federal food, Drug and Cosmetic act, which is amended 
routinely. The two primary ways in which we implement the act are by adding to the 
Code of federal regulations (Cfr) and by publishing guidance documents. These go 
through a notice-and-comment process, which can take time.
a rulemaking process may be initiated several different ways. a judicial decision may 
be involved. I mentioned that, for updating nutrition facts, we started with an advanced 
notice of proposed rulemaking, asking questions. It then can become a proposed rule to 
which comment is invited, and eventually we get to a final rule. Many factors have to be 
considered, requiring a multi-disciplinary approach. The background material provides 
scientific justification. also, does the government have an interest from a public-health 
or other perspective in proceeding with the regulation? what are the petitions? what 
are the grounds for taking action? Does the fDa have the legal authority? How is the 
law interpreted to justify proceeding? There is also a first-amendment consideration. 
figure 0. The evidence-based review system.
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Labeling is deemed as speech, since we may be either compelling speech or suppressing 
speech, requiring a first amendment analysis. also, there has to be a regulatory-impact 
analysis, which is where economists contribute. we have to do a cost-benefit analysis on 
any rule under consideration, and the office of Management and Budget (oMB) would 
like to see that the benefit outweighs the cost; if that is not clear from the analysis, then 
it’s difficult to make progress in rulemaking. 
There is plenty of opportunity for scientific input. for example, on the nutrition side, 
we rely heavily on reports from the national academy of Sciences, and peer-reviewed 
scientific literature. we often engage with consultants either through advisory commit-
tees or public meetings, and experts may be consulted individually on a particular topic. 
The Federal Register describes everything, including notices, that we want comment on. a 
docket is opened, to which we solicit comments. Several dockets have been open recently; 
one on front-of-pack labeling and one on menu labeling, for example. These provide 
opportunities for the scientific community to give us comments. Most important are 
independent evaluations of scientific information that we need to consider. It’s nice to be 
offered opinion; however, opinion is never in short supply, so we look for the scientific 
evidence that is relevant. once we are finished within fDa, several other layers of review 
are required within the government before something is published. 
Current Priorities
a major area of interest right now is addressing labeling on the principal display panel, 
also referred to as front-of-pack labeling. Under this initiative, we have taken several en-
forcement actions. In early 00, we issued seventeen warning letters identifying claims 
on the front of food packages that are inconsistent with regulations and which we think 
are misleading to consumers. we have stated publicly that we are working on regulations 
regarding dietary-guidance statements to ensure that they are helpful to consumers in 
choosing diets consistent with the dietary guidelines. we are conducting consumer research 
on various front-of-pack labeling systems, to better understand how consumers use and 
comprehend those labels. and we have stated publicly that the agency intends to develop 
guidance on a government-sponsored approach to front-of-pack labeling, for which the 
research component will be critically important. and the Institute of Medicine of the 
national academy of Sciences has a study on front-of-pack labeling underway.
two other areas of high intensity are menu and vending-machine labeling. we are 
evaluating a national academy report on strategies to reduce sodium intake in the United 
States with a view to formulating a pathway forward for the agency. with respect to menu 
and vending-machine labeling, a directive tucked away in the many pages of the Patient 
Protection and affordable Care act is the requirement that chain restaurants and similar 
retail establishments with twenty or more locations disclose nutrient-content information 
for standard menu items, including specifically that calories should be listed on menus, 
menu boards and food on display. It also requires certain-sized vending-machine opera-
tors to disclose certain nutrient-content information, particularly calories, on items. The 
statute provides us with only  months to develop a regulation for these requirements 
of the statute.
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In Summary 
at fDa, science, policy and human behavior come together. Ultimately, our goal is to 
make sure that consumers have safe and nutritious food.
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My focus is on what science is needed for a health claim or a nutrient-content claim, and Barbara Schneeman has paved the way for me1 by describing these claims, which I will briefly review. I’ll discuss the require-
ments for a product to carry a health claim or a nutrient-content claim. It’s not enough 
to get the health claim, you must have a product that can carry that health claim. I’ll 
talk about fDa’s nutrient profiling—I’m calling it “nutrient profiling” although it can 
be called other things—and then segue into nutrient profiling for point-of-purchase sys-
tems. Point-of-purchase systems are little checkmarks, stars or smiley faces on packaging, 
directing consumers to healthy products. I’ll talk about what these mean and the future 
direction in that area.
Health Claims
a health claim is an expressed or implied statement in labeling about the relationship of 
a food substance to a disease or health-related condition. where many people—individu-
als and manufacturers—go wrong is, instead of looking at decreased risk of disease, they 
think in terms of treating, mitigating or curing disease, which categorizes the active agent 
as a drug. also, and very importantly for both health claims and nutrient-content claims, 
they must have pre-market approval from fDa. Makers who place health claims on their 
products without prior approval receive warning letters from fDa (e.g. fig. ).
The Science Behind the Claims and Why 
the Product that Bears a Claim Needs to be 
“Healthy”
Joanne r. Lupton
Texas A&M University
College Station, Texas
JLupton@tamu.edu
1Pages 33–.
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a warning was issued for Pollock baby fillets, on which the label stated that they help to 
prevent heart attacks (fig. ). If this were an approved health claim, the label could state 
that the risk of heart attack was decreased but not that heart attack was prevented. The 
letter from fDa stated that this would categorize the product as a drug, subject to other 
regulatory strictures. Packaging on a herbal supplement claimed “constipation relief ” or 
“restoring regularity.” You can’t have constipation and mitigate it with a health claim, you 
must decrease the risk of it occurring in the first place. Diamond of California claimed 
that their shelled walnuts’ content of omega-3 fatty acids “inhibits the tumor growth 
that is promoted by the acids found in other fats,” which defined the product as a drug; 
furthermore, it would be a new drug requiring an approved new-drug application. to 
make matters worse, Diamond also claimed that “studies have also shown that omega-3s 
may lower the risk of stroke.” although “lowering the risk” was consistent with a health 
claim, no such health claim had been applied for. You can’t make up a health claim saying 
that risk is decreased. Their claim that the walnuts contain omega-3 at .5 g per serving 
may seem innocuous; however, next to that statement were four little hearts, making an 
apparent connection between that amount of omega-3 in the product and heart disease. 
figure . Misbranded foods that led to receipt of warning letters from fDa.
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The fDa warning letter cautioned that “the heart symbols adjacent to this statement 
make this an implied health claim.”
figure  shows, in brief, guidance for industry issued in 002. This and the 009 ver-
sion2 are required reading for anyone who wants to be a principal investigator on a study 
that may in the future be used for submission of a health claim. It clarifies pitfalls to be 
avoided when preparing and applying for a health claim. The company representative 
sends a dossier to fDa describing studies the results of which support the health claim. 
when fDa starts the review, any animal and/or in-vitro studies, review articles, and meta 
analyses—with a few exceptions—are set aside and major consideration is given to human 
studies on non-diseased populations. The animal, etc., studies can be used as background 
information, but they are not considered directly for the actual health claim. Substance 
X must reduce the risk of disease Y, with substance X and disease Y both defined and 
characterized.
Let’s say that we want to make the statement that eating fish decreases the risk of heart 
disease. we would have to cite studies that had people eating fish and the endpoint would 
have to be decreased risk of heart disease or any one of the acceptable markers for heart 
disease. alternatively, let’s say that we want to claim that consuming omega-3 fatty acids 
decreases the risk of coronary heart disease. Instead of fish studies, we would use omega-
3-supplement studies. or let’s say we wanted to make a similar claim for docosahexaenoic 
acid (DHa) or eicosapentaenoic acid (ePa), then we would have to show the results of 
the presence of DHa or ePa in the diet.
2an updated version, issued in 009, is available at http://www.cfsan.fda.gov/guidance.html.
figure . enforcement discretion letters.
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Substance X and disease Y have to be measurable and—very importantly—validated 
surrogate endpoints are necessary. for a heart disease, an endpoint would be LDL cho-
lesterol, total cholesterol or blood pressure, which are accepted biomarkers. The results 
of a study will be discounted unless the data apply to an accepted biomarker 
The submitted data are characterized as either intervention trials or observational studies. 
with the former, the single most important type of intervention study is a randomized 
clinical trial; the subjects of the trial and the information obtained must be able to be 
extrapolated to the population that is the subject of the health claim. Some observational 
studies are more important and receive higher levels of consideration because they en-
tail less potential for bias. Long-term cohort studies rank higher than retrospective or 
cross-sectional studies. within a prospective cohort study, some type of measurement 
other than a food-frequency questionnaire—e.g. blood levels of a certain omega-3 fatty 
acid—would give the quality of that study a higher rating. Studies are completely elimi-
nated from consideration if they are deemed to be seriously flawed. for example, if the 
subjects already had cancer, a decreased risk of cancer would be meaningless and the 
results of the study would be unacceptable. on the other hand, some factors are on a 
continuum, such as blood pressure. You might make the case that people with moderately 
elevated blood pressure constitute a non-diseased population, since a lot of people over 
a certain age do have elevated blood pressure. The same may be said regarding obesity in 
view of the fact that two thirds of the US population are overweight or obese. It’s another 
continuum, and, again, you would have to make a case for it. If there is no appropriate 
control group or the control group is dissimilar from the intervention group, the study 
would be considered as seriously flawed and eliminated from consideration. Similarly, 
elimination would occur if the effects obtained do not result clearly from the substance 
of interest. for example, an effect obtained from eating spinach cannot be deemed to be 
due to the lutein content of the spinach.
on completion of this process, the remaining studies are rated as “high,” “moderate” or 
“low” in quality. Then the “surviving” studies—those that still count—are considered and 
the quality and quantity of the evidence are appraised along with their relevance to the 
US population. from the overall consistency of the entire body of data, fDa deduces the 
strength of the science showing that the food or nutrient or substance decreases the risk of 
the disease. The stronger the relationship, the better the science, the fewer the qualifica-
tions required on the eventual label. fDa sends an enforcement discretion letter, which 
describes how the health-claim petition was evaluated. enforcement discretion letters are 
also available on the fDa’s website and they make for useful reading (fig. ). 
Case Study: Enhanced Omega-3 Eggs
a producer of hens’ eggs petitioned fDa for a health claim that daily consumption of one 
egg containing 0 mg of omega-3 fatty acids (balanced : with omega- fatty acids) 
reduces the risk of heart disease and sudden fatal heart attack (fig. 3). They submitted 
seventy-four peer-reviewed publications, of which twenty-eight were on nonhuman 
subjects; therefore, we actually considered forty-six. Step  focused on the substance, i.e. 
the egg with the specific fatty acid composition. of eighteen intervention trials described, 
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seven were eliminated because fish-oil supplement, not the egg, was used. other omega-3 
supplements were used in five of the eighteen trials, so they were eliminated from further 
discussion. only six studies were left to provide evidence between intake of the substance 
and decreased risk of the disease. Three of those had such strong diet modifications in the 
intervention group—much more than the consumption of one egg—that they were very 
different from the control group. Those were eliminated. we were down to three clinical 
trials with the eggs, of which one showed no statistical comparisons, one provided no diet 
composition and one had no control group. In spite of the work and expense involved 
on the part of the company in making the submission, fDa concluded that none of the 
eighteen clinical-intervention trial reports in the petition was useful in evaluating the effects 
of polyunsaturated fatty acid-enriched eggs on risk of heart disease. The claim was denied 
and the last sentence in the letter of denial was: “even if there were credible evidence for 
the proposed claims, polyunsaturated fatty acid-enriched eggs would be disqualified from 
bearing a health claim because of their cholesterol content.” one would have thought that 
the producer would have anticipated this response and saved the not-insubstantial sum 
of money, time and effort involved in attempting to procure the health claim.
nutrient-Content Claims
Dietary Fiber
The health-claim process is long and rigorous, and, unless the scientific basis of the 
claim is strong, a qualified health claim—which you probably wouldn’t want on your 
product—may result. Therefore, people are turning to other types of claims, including 
nutrient-content claims. a daily value has to be quoted in order to obtain a nutrient-
content claim. a content of 0% of the daily value of a nutrient in a serving is a “good” 
figure 3. Case study: enhanced omega-3 eggs.
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source, and 0% of the daily value is an “excellent source.” for dietary fiber in a cereal 
(fig. ), the daily value is 5 g for a ,000-calorie diet; therefore, .5 g of fiber per serv-
ing would be a “good” source and 5 g would be an “excellent” source. However, fiber 
cannot be interpreted in terms of whole grain (which we attempted to do in the 005 
Dietary Guidelines to encourage people to eat more whole grains, because they generally 
contain more fiber than refined grains). Contrary to popular belief, there simply isn’t a 
daily value for a whole grain. 
Isoflavones
a somewhat similar situation prevails for soy isoflavones, for which figure 5 summarizes 
a warning letter. The product label stated that the applicable soy product was “very high” 
in isoflavones, whereas the warning letter stated that fDa authorizes claims of “high” 
and a “good source,” but does not authorize claims of “very high.” The letter went on to 
state that, in any case, there is no daily value intake for isoflavone because it isn’t a nutri-
ent, and so a nutrient-content claim is meaningless. other similar cases are described on 
the fDa website.
requirements for a Product to Carry a Claim
from fDa’s perspective, if a food product carries a health claim or nutrient-content claim 
it has to be below a certain bar for “nutrients to limit” and it has to be above a certain 
bar for at least one key “nutrient to encourage” (fig. ). also, there has to be at least a 
minimum effective amount of the beneficial ingredient in the food for it to carry the 
claim. If it’s above the disqualifying levels for “nutrients to limit,” it can’t carry a health 
figure . nutrient-content claims: dietary fiber and whole grain
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claim. If it’s a nutrient-content claim and it’s above this, it can still get a nutrient-content 
claim, but it has to disclose on the front of the package, right next to what it is saying in 
terms of a “good” or an “excellent” source. Let’s say it’s too high in saturated fat, it has 
to refer to the back panel or to the nutrition facts panel for the amount of fat, to bring 
it to people’s attention.
P-o-P nutrient Profiling Systems
Point-of-purchase nutrient-profiling systems are useful if they direct shoppers to healthier 
products. If they are easy to understand, they can be particularly beneficial for those 
figure 5. fDa response to a nutrient-content claim.
figure . requirements for foods bearing claims (fDa’s nutrient profiling).
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who do not have a lot of time for food shopping, circumventing the need to consult the 
nutrition facts panel or do calculations to make comparisons.
Discretionary Calories
By visiting the website mypyramid.gov, we can find out our calorie allotments for the day, 
i.e. how many calories can one take in without gaining or losing weight. If we take the 
number needed in terms of energy intake and subtract from that the calories required to 
obtain needed nutrients from foods, the difference is our discretionary calories. That can 
be a glass of wine, a dessert, or full-sugar soda, for example—however you wish to spend 
them because you’ve already spent your calories on the foods and the nutrients that you 
need without exceeding your energy requirement.
The issue here is, how many discretionary calories do we actually have to spend? when 
the USDa provides the number of servings that we should have for our energy level, 
gender and age, those numbers are based on the item in each food group that is lowest 
in fat, added sugar, and sodium. for example, in the dairy category, a recommendation 
of three glasses of milk a day means three glasses of non-fat milk—not % or %, and 
certainly not ice cream, and not even low-fat yogurt. Three glasses of % milk would 
mean using discretionary calories.
two thirds of adults in the United States are either overweight or obese, therefore they 
have no discretionary calories and should be eating less than their calorie allotments so 
that they lose weight. Many others are not meeting their nutrient requirements because 
they are not choosing the most nutrient-dense foods. for example, most of the dietary 
fiber we get from vegetables in the United States is from french fried potatoes, which is 
not to imply that this a good source of fiber. Similarly, our greatest sources of grain fiber 
are hot-dog and hamburger buns. again, these are not great sources of dietary fiber, but 
we eat a lot of them and they contain some fiber. These examples show how we are wast-
ing some of our calories by not picking the most nutrient-dense foods and they illustrate 
the potential utility of point-of-purchase nutrition-profiling systems.
a major criticism, however, is that there are multiple point-of-purchase nutrition-profil-
ing systems with multiple nutrition criteria, resulting in consumer confusion rather than 
helping to solve the problem. It’s generally agreed that a unified system is needed to cut 
through the clutter, and fDa has taken action with workshops and consumer-research 
projects. They are supporting an Institute of Medicine panel to evaluate different systems. 
They’ve held a press conference and sent a letter to manufacturers seeking input on what 
they are looking for and, if there is to be a unified system, what it should be. Information 
is expected to be available by the end of 00.
In Summary
The evaluation of health claims is a rigorous, science-based process. Products that carry 
health or nutrient-content claims must meet nutrient-profiling requirements. There’s a 
reason for not directing people to good substances that are in bad vehicles—we cannot 
afford to waste calories on non-nutrient-dense foods. Consequently, fDa and the Insti-
tute of Medicine are evaluating nutrient-profiling systems for point-of-purchase labeling. 
results should be available by December, 00.
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when considering how to promote health by linking agriculture, food and nutrition, it makes perfect sense to have a closer look at existing legisla-tion in the area of nutrition and health claims made on food products. This 
is particularly important because what industry is allowed to say about the impact on 
health of the foods it sells is an essential element in a number of areas, such as consumer 
awareness, consumer education, product research and development, and research-funding 
opportunities. after all, why would anyone invest considerable resources to do research, 
develop and market a particular food product that would be more nutritious or would 
help mitigate certain disease-risk factors, if the law were to prohibit any commercial 
communication on those health benefits? 
when examining existing legislation on nutrition and health claims made on foods, it 
is also useful to consider the regulatory framework in the european Union (eU). There 
are three main reasons for that. firstly, the eU is certainly one of the most regulated 
regions in the world, particularly in the food area, and it tries to “export”—or at least 
promote—its regulatory options to other regions and countries worldwide. food legis-
lation adopted in the eU tends to inspire regulators in other countries. Secondly, eU 
food laws, in general, tend to be more restrictive than in other regions. Thirdly, the eU 
legislation on nutrition and health claims was adopted recently and some of its provisions 
are still being developed, causing considerable controversy. Therefore, keeping an eye on 
the developments in the eU in terms of food claims will help promote understanding of 
what food manufacturers will be able to communicate to consumers in the eU as well as 
what new regulatory “tools” could potentially be replicated in other countries.
The EU Regulation on Nutrition and Health 
Claims: Current and Future Trends
Miguel fernandes da Silva
European Advisory Services
Brussels, Belgium
miguelsilva@eas.eu
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The eU regulation on nutrition and Health Claims [regulation (eC) no 9/00], 
hereafter “the regulation,” has certainly been one of the most controversial pieces of 
legislation of the last decade in the area of eU food law. Its significant impact—current 
and future—on the food industry, particularly on functional foods and food supplements, 
has made its gradual implementation remarkably complex and contentious. In addition, 
some of its provisions, such as nutrient profiles, have raised such significant opposition 
from industry that its ongoing implementation has constantly been the subject of ex-
tensive press coverage, with a number of tough political and technical debates, since its 
adoption in December 00.
Before the adoption of this legislation, various national legal frameworks regulated the 
use of nutrition and health claims across the eU. Some Member States had strict rules 
whereas others relied only on very general principles. In certain cases, the differences 
among national provisions were obstacles to the free movement of food products within 
the eU market. This situation also created significant distortions of competition on the 
market. This explains why the food industry itself was one of the main entities asking 
eU regulators to harmonize legislation in this area. 
Scope and objectives of the regulation
The regulation became applicable on July , 00, across all twenty-seven eU Member 
States. In principle, the same rules are now applicable to all companies selling their 
products in the eU market, including imported products.
The regulation applies to all nutrition and health claims made in all “commercial com-
munications.” These include not only claims made on product labels, but also claims made 
in advertising (television, radio, etc.), websites, promotional leaflets, on-shelf presentations, 
etc. any communication on the nutritional or health benefits of a food product made on 
any commercial entity must comply with the provisions of the regulation.
when proposing and adopting this legislation, the eU regulators intended to achieve 
three main objectives:
• to ensure a high level of protection for consumers. This would be achieved 
through measures aiming at ensuring that all claims are scientifically substanti-
ated, and also through provisions intended to avoid the over-consumption of 
certain products due to the claims they would make. 
• to facilitate consumer choice. a clear set of rules applying across the eU, with 
strict conditions and specific restrictions would allow consumers to make their 
purchases knowing that the claims made on the products they would buy are 
meaningful and scientifically justified. 
• to ensure the effective functioning of the internal market. Similarly, the same 
rules applying to all twenty-seven national markets would lead to equal condi-
tions of competition for the food industry while enabling the free movement of 
food products across the eU.
to achieve these objectives, the regulation is based on two key principles:
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• All nutrition and health claims must be approved at EU level. 
• Certain foods will be prohibited from nutrition and/or health claims.
all Claims Must be approved at eU Level
The regulation defines two general types of claims—“nutrition claims” and “health 
claims”—which are approved through different authorization procedures. nutrition 
claims are defined in the regulation as “any claim suggesting that a food has particular 
beneficial nutritional properties due to the energy, nutrients, or other substances it con-
tains, contains in reduced or increased proportions or does not contain.” Health claims 
are defined as “any claim suggesting that a relationship exists between a food category, a 
food or one of its constituents and health.”
The key principle laid down in the regulation is that all nutrition or health claims 
must be approved at the eU level through the applicable procedures and be included 
in a positive list. only the claims mentioned in the eU positive lists will be permitted 
in the eU. 
Permitted Nutrition Claims
The regulation itself includes, in its annex, a positive list of the permitted nutrition claims 
(table ). Since January 9, 00, these have been the only permitted nutrition claims 
in the eU market. all others are prohibited, including certain nutrition claims that have 
been widely used across the eU until recently, such as “high energy,” “cholesterol free,” 
“extra light,” “trans-fat free” and “high in omega- fatty acids.”
Source of fiber
High fiber
Source of protein
High protein
Source of [name of vitamin(s)] and/or [name of mineral(s)]
High [name of vitamin(s)] and/or [name of mineral(s)]
Contains [name of the nutrient or other substance]
Increased [name of the nutrient]
reduced [name of the nutrient]
Light/lite
naturally/natural (as a qualifier for other nutrition claim,
e.g. “naturally high in fibre”)
Low energy
energy reduced
energy free
Low fat
fat free
Low saturated fat
Saturated-fat free
Low sugar
Sugar free
with no added sugars
Low sodium/salt
very low sodium/salt
Sodium free or salt free
Table 1. lisT of permiTTed nuTriTion claims in The eu.
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The annex to the regulation includes specific conditions of use that must be complied 
with in order for a food product to bear a particular nutrition claim. as an example, a 
claim that a food is “fat free” may be made only if the product contains no more than 0.5 
g of fat per 00 g or 00 mL. also, claims expressed as “X% fat free” are prohibited.
This positive list of permitted nutrition claims may be amended to take into account 
scientific and technological developments. a first amendment was adopted in february 
00 [Commission regulation (eU) no /00] with the addition of five more per-
mitted nutrition claims on fatty acids: “source of omega-3 fatty acids”; “high in omega-3 
fatty acids”; “high in mono-unsaturated fat”; “high in poly-unsaturated fat”; and “high 
in unsaturated fat.”
as it stands, the annex on nutrition claims is generally considered to be very restric-
tive. for example, claims relating to cholesterol (“cholesterol free,” “low in cholesterol”) 
are not included, although they were popular with certain consumers. Their inclusion 
in the positive list had been requested by industry and a number of Member States, but 
the regulators decided in the end not to authorize them because they were regarded as 
potentially misleading. It was feared that consumers did not understand the difference 
between dietary cholesterol and blood cholesterol, and the small impact the former has on 
the latter. another example of a “popular” nutrition claim that has not been included in 
the positive list is “high energy.” The fact that this claim, and any claim having the same 
meaning, is not authorized in the eU has considerable implications on sports foods, for 
example. a large number of product concepts, such as energy bars, energy gels and sports 
beverages have been severely affected by this decision. 
Certainly, one of the most restrictive aspects of the regulation, in relation to nutrition 
claims, is the very limited number of permitted comparative nutrition claims and the 
conditions applying to them. as it currently stands, the regulation authorizes only four 
comparative nutrition claims: “energy-reduced,” “increased [name of nutrient],” “reduced 
[name of nutrient]” and “light/lite.” one of the conditions of use for these four claims is 
that there must be a difference in the content of the nutrient in question of at least 30% 
between the products being compared. This is clearly a challenge for food manufacturers 
carrying out reformulation programmes, as reducing the content of certain nutrients by 
30% is difficult to achieve and, in certain cases—such as salt reduction—it may even 
lead to consumer rejection of the new recipe. This restrictive condition, particularly for 
reduction claims, is seen as a missed opportunity for eU regulators to give an incentive 
to industry to reformulate their products. By raising the bar too high, the regulators may 
have discouraged certain companies from improving their product recipes; why would 
a company reformulate its products at great cost if the law does not allow those efforts 
to be communicated to consumers? are reductions in fat, saturated fat, salt or sugar of 
5% or 0% really irrelevant? 
Permitted Health Claims?
Contrary to the situation for nutrition claims, the regulation itself does not include 
a positive list of permitted health claims. However, it lays down specific provisions re-
quiring the establishment of such positive lists, as well as describing the corresponding 
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authorization procedures that must be followed to obtain authorization for different 
types of health claims. 
The regulation classifies health claims in three broad categories, to each of which dif-
ferent authorization procedures apply:
• nutrient-function claims, which include all claims referring to the growth, devel-
opment or the functions of the body (e.g. “calcium helps maintain strong teeth 
and bones”), as well as psychological and behavioral claims (e.g. “substance X 
helps improve concentration and memory”), and slimming and satiety claims (e.g. 
“substance Y helps you want to eat less/lose weight”). 
• reduction-of-disease-risk claims, which “state, suggest or imply that the con-
sumption of a food category, a food or one of its constituents significantly reduces 
a risk factor in the development of a human disease” (e.g. “substance Z has been 
shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the 
development of coronary heart disease”).
• Claims referring to children’s development and health. The regulation itself does 
not provide a definition for this category of health claims. However, guidance 
on the implementation of the regulation (Guidance on the Implementation of 
regulation no 9/00, 00) was adopted at a later stage, which clarified 
that this particular type of health claim would include: a) those solely referring to 
the development and health of children, and where the scientific substantiation is 
valid only for children, i.e. the scientific substantiation should result from stud-
ies conducted with children; b) those used on products intended exclusively for 
children, like follow-on formulae and cereal-based baby foods.
obtaining authorization for health claims and their subsequent inclusion in a positive 
list is possible through two different authorization processes that are currently operational 
in parallel.
Process 1—The Authorization Procedure for Nutrient-Function Claims 
that were Submitted for Approval by January 2008
The regulation established an authorization procedure for nutrient-function claims, 
whereby the Member States had to send to the european Commission, before the end 
of January 00, their national lists of proposed health claims. These lists included the 
proposed conditions of use for each claim, the proposed wordings and lists of scientific 
references substantiating the claims. The Commission compiled these national lists and 
sent them to the european food Safety authority (efSa) for a scientific evaluation, before 
establishing a Community list of permitted health claims. The regulation clarifies that 
until this list is established, claims submitted for approval through this procedure will be 
allowed to remain on the market until a final decision is adopted on them. 
The Commission was probably expecting a few hundred health claims to be tabled for 
adoption. However, the twenty-seven eU Member States submitted a total of 3,0. 
The process for collecting these claims differed from one country to another. for example, 
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one Member State submitted more than 0,000 claims, which had been proposed by its 
national food industry, whereas another Member State submitted only nine, which were 
the only ones that had officially been approved in the past by the national authorities. 
However, a considerable number of the claims submitted were essentially duplicates, as 
the same claims were often submitted by the same applicants in the different Member 
States where the claims were being used. with some time and effort, the Commission was 
able to reduce the list of proposed claims to ,3, by removing duplicates and deleting 
entries that were incomplete or inappropriate. 
efSa is now evaluating the scientific basis for these ,3 proposed health claims. Be-
cause the number of claims to be assessed remains quite high, efSa will publish the results 
of its assessment in several batches. to date, only two batches have been published, cover-
ing fewer than ,000 claims (table ). However, they indicate what should be expected 
from future evaluations, and what types of claims are likely to be approved or rejected in 
the eU. already, impact on the market is becoming clear, particularly for sectors such as 
probiotics, antioxidants and botanicals. The first efSa evaluations were mostly negative 
(% for the first batch, 9% for the second) with rejections of most claims submitted 
on probiotic bacteria/microorganisms, antioxidants, plant extracts/botanicals, and claims 
on carbohydrate glycemic index/response. The higher rate of positive evaluations in the 
first batch can be explained by the fact that these correspond essentially to claims for 
vitamins and minerals for which there has long been scientific consensus.
Table 2. efsa evaluaTions of nuTrienT-funcTion claims 
(To daTe)—arTicle 13.3.
Batch number
 1 2
Publication date october , 009 february 5, 00
number of claims 53  
processed
Substances involved vitamins & minerals antioxidants
 Dietary fibers Carbohydrates glycemic index/response
 fatty acids Probiotics/microorganisms
 Probiotic bacteria Botanicals and herbals
 other (chewing gum, Substances linked to joints health
 plant extracts, etc.) other (honey, stearic acid, guar gum, etc.)
Positive evaluations 33% %
negative evaluations % 9%
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approximately 3,50 additional nutrient-function claims await evaluation. Based on 
these efSa evaluations, the eU regulator will then need to officially approve or reject the 
proposed claims, and include the approved ones in a positive list. Due to the considerable 
number that remains to be evaluated, the authorization process is expected to take until 
0. although it is difficult to predict how many claims are likely to be approved in the 
end, one can guess that, based on the current trend of the efSa evaluations, the final list 
of permitted claims will comprise a few hundred rather than a few thousand. and some 
very popular claims currently on markets worldwide may not be included.
Process 2—The Authorization Procedures for Nutrient-Function Claims 
Submitted for Approval after January 2008, for Reduction of Disease-Risk 
Claims and for Claims referring to Children’s Development and Health.
In addition to the authorization procedure described above, the regulation provides the 
possibility of obtaining authorizations for other types of health claims on the basis of 
individual application dossiers, i.e. reduction of disease-risk claims and claims referring to 
children’s development and health. This applies also to “new” nutrient-function claims that 
were not submitted via a Member State before the end of January 00. These application 
dossiers will also be scientifically evaluated by efSa, and the claims will subsequently be 
approved or rejected by the european Commission. approximately 50 individual claim-
application dossiers have been submitted so far (some of which have been withdrawn), of 
which eleven have been officially authorized (tables 3a, b) and forty-five officially rejected. 
approximately 0 additional applications currently await evaluation. 
as is illustrated in table , around 0% of the individual claim applications assessed 
by efSa received a negative opinion. This confirms the strict evaluation standards being 
applied by efSa to evaluate the scientific evidence being put forward by applicants to 
substantiate their proposed claims. 
The outcomes so far of the two authorization processes mentioned above clearly illustrate 
that the scientific bases being tabled by applicants to justify their claims are not meeting 
the standards being applied by the efSa to evaluate their quality. as efSa is evaluating 
the evidence submitted in both processes using the same criteria, it is not surprising that 
recurring reasons are being given for negative evaluations in both processes. These are, 
essentially:
• weakness of the scientific evidence submitted, and 
• insufficient characterization of the substance for which the claim is made. 
a number of proposed claims were made for broad categories of foods (“dairy products,” 
“fruits,” “fruits and vegetables”) which typically include many products with a range of 
nutritional compositions and impacts on health. for example, efSa considers that it 
cannot approve claims relating to “dairy products” because this category includes many 
types of foods, from Camembert cheese to fat-free yoghurts. also, the studies submitted 
were focused only on certain dairy products. In efSa’s terms, the substance—“dairy 
products”—is not sufficiently characterized to allow validation of the scientific evidence 
submitted.
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Table 3a. healTh claims officially auThorized (To June 2010), based 
on individual applicaTion dossiers—arTicles 13.5 and 14.
Health claims referring to the reduction of a risk factor in the development 
of a disease [Article 14(1)(a)]
Nutrient/substance/food Claim Conditions/restrictions of use
Plant sterols/plant stanol esters
Plant sterols: sterols extracted 
from plants, free or esterified with 
food-grade fatty acids.
Plant stanol esters
Chewing gum sweetened with 
00% xylitol
Plant sterols and plant stanol 
esters have been shown to 
lower/reduce blood choles-
terol. High cholesterol is a risk 
factor in the development of 
coronary heart disease.
Plant sterols have been shown 
to lower/reduce blood choles-
terol. High cholesterol is a risk 
factor in the development of 
coronary heart disease.
Plant stanol esters have been 
shown to lower/reduce blood 
cholesterol. High cholesterol is 
a risk factor in the development 
of coronary heart disease.
Chewing gum sweetened with 
00% xylitol has been shown 
to reduce dental plaque. High 
content/level of dental plaque 
is a risk factor in the develop-
ment of caries in children.
Information to the consumer that the ben-
eficial effect is obtained with a daily intake 
of .5–. g plant sterols/stanols. reference 
to the magnitude of the effect may be made 
only for foods within the following cat-
egories: yellow fat spreads, dairy products, 
mayonnaise and salad dressings. when 
referring to the magnitude of the effect, the 
entire range “ to 0 %” and the duration 
to obtain the effect “in  to 3 weeks” must 
be communicated to the consumer.
Information to the consumer that the ben-
eficial effect is obtained with a daily intake 
of at least  g plant sterols. Information to 
the consumer that the beneficial effect is 
obtained with a daily intake of .5–. g 
plant sterols. reference to the magnitude 
of the effect may be made only for foods 
within the following categories: yellow fat 
spreads, dairy products, mayonnaise and 
salad dressings. when referring to the mag-
nitude of the effect, the entire range “ to 
0%” and the duration to obtain the effect 
“in  to 3 weeks” must be communicated 
to the consumer.
Information to the consumer that the ben-
eficial effect is obtained with a daily intake 
of .5–. g plant stanols. reference to the 
magnitude of the effect may be made only 
for foods within the following categories: 
yellow fat spreads, dairy products, mayon-
naise and salad dressings. when referring 
to the magnitude of the effect, the entire 
range “ to 0 %” and the duration to 
obtain the effect “in  to 3 weeks” must be 
communicated to the consumer.
Information to the consumer that the bene-
ficial effect is obtained with a consumption 
of –3g of chewing gum sweetened with 
00% xylitol at least three times per day 
after the meals.
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Table 3b. more healTh claims officially auThorized (To June 2010), 
based on individual applicaTion dossiers—arTicles 13.5 and 14.
Health claims referring to children’s development and health [Article 14(1)(b)]
Nutrient/substance/food Claim Conditions/restrictions of use
α-linolenic acid (aLa) & linoleic 
acid (La), essential fatty acids
Calcium and vitamin D
Calcium
vitamin D
Phosphorus
Protein
water-soluble tomato concentrate 
(wStC I and II)
essential fatty acids 
are needed for normal 
growth and develop-
ment of children.
Calcium and vita-
min D are needed for 
normal growth and 
development of bone 
in children.
Calcium is needed for 
normal growth and 
development of bone 
in children.
vitamin D is needed 
for normal growth and 
development of bone in 
children.
Phosphorus is needed 
for the normal growth 
and development of 
bone in children.
Protein is needed for 
normal growth and 
development of bone 
in children.
water-soluble tomato 
concentrate (wStC) 
I and II helps main-
tain normal platelet 
aggregation, which 
contributes to healthy 
blood flow.
Information to the consumer that the beneficial 
effect is obtained with a daily intake of  g of 
α-linolenic acid (aLa) and a daily intake of 0 
g of linoleic acid (La).
The claim can be used only for food which is 
at least a source of calcium and vitamin D as 
referred to in the claim SoUrCe of [naMe 
of vItaMIn(S)] anD/or [naMe of 
MIneraL(S)] as listed in the annex to regula-
tion 9/00.
The claim can be used only for food which is 
at least a source of calcium as referred to in the 
claim SoUrCe of [naMe of vItaMIn/S] 
anD/or [naMe of MIneraL/S] as listed in 
the annex to regulation 9/00.
The claim can be used only for food which is at 
least a source of vitamin D as referred to in the 
claim SoUrCe of [naMe of vItaMIn/S] 
anD/or [naMe of MIneraL/S] as listed in 
the annex to regulation 9/00.
The claim can be used only for food which is at 
least a source of phosphorus as referred to in the 
claim SoUrCe of [naMe of vItaMIn/S] 
anD/or [naMe of MIneraL/S] as listed in 
the annex to regulation 9/00.
The claim can be used only for food which is at 
least a source of protein as referred to in the claim 
SoUrCe of ProteIn as listed in the annex 
to regulation 9/00.
Information to the consumer that the beneficial 
effect is obtained with a daily consumption of 3 
g wStC I or 50 mg wStC II in up to 50 mL 
of either fruit juices, flavored drinks or yogurt 
drinks (unless heavily pasteurized).
Health claims based on newly developed scientific evidence [article 3(5)]
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another key lesson learned in recent years is that companies tend to be overoptimistic 
about the quality of their research and the strength of their application dossiers. Most 
applications were negatively evaluated by efSa because the scientific evidence submit-
ted did not include human-intervention studies. It was hoped by many that efSa could 
be persuaded to, in certain cases, refer to a grading of the available evidence to evaluate 
whether the data submitted supported the claims—“convincingly,” “possibly,” “probably,” 
or “insufficiently”—but efSa refuses to be persuaded and strictly applies its gold stan-
dard: human-intervention studies are a must to obtain a positive evaluation. Commission 
regulation (eC) no 353/00 clearly lays down, hierarchically, the levels of data that 
should ideally be included in an application dossier:
• Human data
 — Human-intervention studies, randomized controlled studies, other ran-
domized studies (non-controlled), controlled (non-randomized) studies, other 
intervention studies.
 — Human observational studies, cohort studies, case-control studies, cross-sec-
tional studies, other observational studies such as case reports.
 — other human studies dealing with the mechanisms by which the food could 
be responsible for the claimed effect, including the studies on bioavailability.
• non-human data
 — animal data including studies of aspects related to absorption, distribution, 
metabolism, excretion of the food, mechanistic studies, and other studies.
 — Ex vivo or in vitro data based on either human or animal biological samples 
related to mechanisms of action by which the food could be responsible for the 
claimed effect, and other non-human studies.
Table 4. efsa evaluaTions of individual claims applicaTion dossiers 
(To June 2010).
Type of claim Favorable Favorable with Issues raised Total
  limited conditions
new functional claims  –  
(article 3.5)
reduction of disease risk claims 5 – 0 5
(article )
Claims referring to children’s 
development and health   3 
(article )
total     5
 (%) (%) (9%) (00%)
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However, it is clear now that most of the studies mentioned above will be useful in an 
application dossier only if submitted as supporting evidence for well designed human-
intervention studies, without which there is very little chance of success. There is no 
grading of the available evidence.
a good illustration of the strict evaluation criteria being used by efSa is provided 
by its opinion on an application for a reduction-of-disease-risk claim on cranberry juice 
(european food Safety authority, 009a). The proposed claim was: “[the product] helps 
reduce the risk of urinary tract infection in women by inhibiting the adhesion of certain 
bacteria in the urinary tract”. efSa concluded that the evidence submitted by the applicant 
was insufficient to establish a cause-effect relationship between the consumption of the 
product in question and the claimed effect. although the application dossier contained 
a number of human studies, they were dismissed by efSa for the following reasons:
• Six human studies were judged of limited relevance because the claim targeted 
healthy women (aged  and above), whereas the studies were carried out on 
unhealthy subjects (patients suffering from neurogenic bladder) and children.
• In an additional human study the daily dose of the active substance consumed 
was approximately six times higher than the use levels proposed for the claim.
• although five other human-intervention studies were considered pertinent to the 
claimed effect, efSa criticized the two key randomized, placebo-controlled trials. 
The first one for its short duration and lack of statistical power, the second one for 
the lack of adequate randomization and high drop-out rate.
• The other three pertinent human studies were also criticized by efSa due to 
significant limitations, including the use of different cranberry formulations (ma-
trixes) from that in the application, poor study design, as well as high drop-out 
rates in some of the studies.
• It is also noteworthy that efSa did not consider meta-analyses and previous 
opinions by national food-safety authorities (on the same/similar claim) as rel-
evant evidence.
Interestingly, although efSa recognized a proven in vitro inhibitory effect on adhesion 
of E. coli to mucosal cells, it concluded nevertheless that the evidence submitted did not 
establish that the anti-adherence effects shown in vitro are predictive of the occurrence 
of a clinically relevant bacterial anti-adherence effect within the urinary tract under the 
conditions of use proposed for the claim. This claim was rejected by the european Com-
mission in november 009 (Commission regulation (eC) no /009). 
Based on the efSa evaluations so far, as well as on efSa’s guidance for the prepara-
tion of claim-application dossiers (european food Safety authority, 00, 009b), one 
can list key criteria that potential applicants should use to assess the strength of their 
application dossier (eaS, 00):
• Is the food or food constituent sufficiently characterized to the extent that it 
can be verified that the food or food constituent is the subject of the studies 
 performed and therefore responsible for the claimed effect?
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• are the studies carried out with the food or food constituent that is the subject of 
the claimed effect?
• are human studies available with appropriate outcome measures in relation to the 
claimed effect?
• are the conditions under which the food or food constituent is tested in the hu-
man studies representative for the proposed conditions of use for the claim (level 
of intake, pattern of consumption, etc.)?
• are the human studies or study group representative of the proposed target of the 
claim? Can the study results be extrapolated to the target population of the claim?
• Is a rationale available to explain how studies in animals or in vitro support the 
claimed effect in humans?
However, these criteria were “officially” disclosed only after a considerable number of 
applications had already been submitted (Processes  and  above). efSa’s evaluation 
criteria became clearer after its first detailed opinions had been published. for example, 
the level of characterization that efSa requires for microorganisms (probiotics) was clearly 
stipulated only after efSa had already evaluated (negatively) a considerable number of 
claims on probiotics.
needless to say, the extremely high rate of negative claim evaluations by efSa, and 
the expected subsequent rejection by the european Commission of the vast majority of 
the claims submitted for approval, were not greeted with joy by the food industry in the 
eU. Consequences for the food market will be considerable, particularly in the area of 
functional foods, food supplements and botanicals. Based on the efSa evaluations so far, 
it is fair to say that the mass rejections of most claims on antioxidants, probiotic bacte-
ria/microorganisms, botanicals/plant extracts, joint health and glycemic index/response 
are likely to lead to serious difficulties for those markets. It is essential that makers of 
functional foods and supplements be able to communicate the beneficial effects of their 
products on the body or health. not being able to do so means the end of such product 
concepts. It could also mean that fewer funds will be available for research in those ar-
eas, particularly if companies feel that regulators are unlikely to allow any commercial 
communications for those substances. These efSa evaluations could, therefore, be the 
beginning of the end for certain functional-food markets in the eU.  
Certain foods will be Prohibited from Claims
The first principle established by the regulation is that all claims must be approved at the 
eU level. However obtaining the authorization for a particular health claim on a specific 
substance will not be enough to ensure its use with the food formulation or product 
concept of choice. a second obstacle needs to be taken into account to determine use of 
the permitted claim on a specific product: the nutrient profile.
Nutrient Profiling
when drafting its proposal for a regulation on nutrition and health claims, the european 
Commission feared that indiscriminate use of claims by food manufacturers could lead to 
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overconsumption of “certain” food products, which could potentially contribute to the 
rising levels of obesity and diet-related diseases. It was feared also that the use of claims 
on such less nutritionally balanced products could potentially “mislead consumers when 
trying to make healthy choices in the context of a balanced diet” (regulation 9/00, 
whereas ). Therefore, as part of the objective of ensuring “a high level of protection for 
consumers,” and with the aim of avoiding the overconsumption of “certain” foods and 
consumer confusion as to what a balanced diet really is, the eU regulators introduced 
the concept of nutrient profiles in the claims regulation. nutrient profiling will be used 
as a tool to determine which foods will be “healthy enough” for claims to be made and 
which foods will be considered “unhealthy” and therefore unsuitable for claims. 
This concept has been one of the most controversial provisions of the regulation, 
leading to numerous scientific debates, political negotiations and intense lobbying by the 
food industry as well as by health and consumer non-governmental organizations. The 
main criticism raised by industry, as well as by a considerable number of nutritionists, 
against nutrient profiling is that it does not make much sense to classify individual foods 
as “healthy/good” or “unhealthy/bad.” It is acknowledged that the relevant factor in terms 
of obesity and diet-related diseases is whether the range of foods that is consumed over a 
certain period of time is sufficiently varied and balanced. This argument was also stressed 
by efSa itself, which recognized in its 00 scientific opinion on the establishment of 
nutrient profiles that “there is an inherent difficulty in seeking to apply to individual 
food products nutrient-intake recommendations that are established for the overall diet” 
(european food Safety authority, 00).
as was requested by the regulation, the Commission asked efSa for scientific advice 
on the development of nutrient profiles. However, the efSa advice remained very general, 
consisting essentially of a list of possible options on how profiles could potentially be 
developed, indicating also the respective advantages and disadvantages of each option. as 
a consequence, the profiles are being developed mostly on the basis of political negotia-
tions between the Commission and the Member-States experts, rather than on the basis 
of purely scientific arguments. This explains why the establishment of the profiles has 
been such a difficult task, and why the Commission was not able to meet the January 
009 deadline required by the regulation to establish the profiles.
The Commission tabled a first proposal in June 00, and various texts were then suc-
cessively discussed until March 009, at which time the process was put on hold when the 
political discussions reached a dramatic point: on the one hand, Member-State experts 
were seriously unhappy with the Commission’s proposals and were making too many 
requests for exemptions for specific products—considered to be of national interest!—and, 
on the other hand, various services within the Commission itself were unhappy with the 
proposals being tabled by the service in charge of the negotiations, essentially for legal 
and economic reasons. So far, the Commission has not tabled any new proposals.
although the process that will lead to the establishment of nutrient profiles in the eU 
is currently on hold, the proposals that have been discussed already give a good impres-
sion of what they will look like in the end. The Commission is focusing on three key 
nutrients: saturated fat, sodium and sugars. Different thresholds would be established 
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for these nutrients. The profiles would consist of generic thresholds for foods in general, 
expressed per 00 g or 00 mL, as well as specific thresholds for certain food categories 
that play important roles in the diet (e.g. dairy products, cereal products, meat products). 
Certain foods could be exempted from having to comply with the profiles, such as fruits 
and vegetables, food supplements, and sugar-free chewing gum. Products containing 
higher levels of saturated fat, sodium and sugars than the applicable thresholds would be 
restricted or prohibited from nutrition and/or health claims.
as was already mentioned, the development of the nutrient profiles has been essentially 
a political process with difficult negotiations on various points, including:
• what food categories should benefit from adapted thresholds?
• How should these categories be defined?
• what thresholds should apply to these categories?
• what foods should be exempted from the need for profiles?
as efSa was not asked to develop a profiling system or to propose possible nutrient 
thresholds for different food categories, this is being done by the Commission and the 
Member-State experts. Inevitably, these discussions became very political with different 
thresholds being proposed by different Member States without any apparent scientific 
justification. for example, in the discussions on the threshold that should be set for sugar 
in the category “non-alcoholic beverages,” some Member States insisted on a level of 5 
g, another proposed  g, and a few suggested 0 g, without providing any explanations 
whatsoever to justify why 5,  or 0 g would be most appropriate. 
It is clear that the food industry is not a strong supporter of nutrient profiling for 
many reasons, among which is the serious risk that nutrient profiling could hinder in-
novation—particularly in the area of product reformulations—as it will represent a clear 
disincentive for the development of healthier products within certain food categories. It 
will simply not be possible to make any claims at all (not even “reduction” claims) due to 
the strict thresholds that are being considered. However, although many legal, technical 
and scientific reasons are being put forward by industry to oppose nutrient profiling, one 
of the key reasons explaining this opposition has nothing to do with the nutrition and 
health claims. The main fear is that if a european, harmonized nutrient-profiling system, 
which would be used to identify “healthy” and “unhealthy” foods, were to be agreed by 
the Commission and the twenty-seven Member States, it would then be very difficult 
to resist calls for further restrictions and discriminations against certain food products. 
already a number of national and eU-wide campaigns are calling for restrictions, such as 
color-coded nutrition labelling (“traffic lights”), advertising restrictions and food taxation, 
that would be based on the future eU profiles.
Conclusion
although not all of the key provisions of the eU claims regulation have been imple-
mented yet, it is already possible to see its future impact on the eU market for functional 
foods, as well as on other related areas of activity such as food and nutrition research. It 
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is now clear that the full implementation of the claims regulation will lead to a drastic 
reduction in the number of nutrition and health claims being used on the eU market. 
as a result, and taking into account the recent evaluations by efSa of some of the claim-
applications dossiers, it is fair to say that a number of product concepts, some of which 
have been successful worldwide in past years, will be facing serious challenges. Certain 
segments of the functional-foods market will be forced to reconsider their product con-
cepts, particularly in the areas of antioxidants, probiotics, low glycemic-index products, 
and herbal products. The implementation of the regulation will also lead to considerably 
less flexibility for food manufacturers and marketers to communicate to consumers the 
beneficial nutritional and health properties of certain products. Such communications 
will also be increasingly more standardized and repetitive as companies will need to keep 
their messages as similar as possible to the approved claims which, in addition, are not 
necessarily consumer-friendly.
Science will be the determining factor for success. The quality of the scientific evidence 
submitted to substantiate an application for the authorization of a health claim will be the 
essential element that will determine whether the application—and the product concept 
that would use the claim in question—has any chance of being approved. However, it must 
be stressed that it is efSa, and efSa alone, that will ultimately decide whether the data 
submitted really establish a cause-effect relationship between the substance or food and 
the claimed benefit. This should be taken into account if one intends to carry out studies 
to demonstrate the beneficial properties of certain substances. It would be worthwhile 
taking a closer look at the criteria being applied by efSa to evaluate claim-application 
files, particularly with regard to the importance given to well designed human-interven-
tion studies. finally, the potential future implementation of nutrient profiles is likely to 
have a devastating effect on a number of functional foods as associated nutrition and/or 
health claims will be prohibited. This will also have very concrete implications on funding 
opportunities for research, as no company will want to invest in research if none of its 
current and future products will be the subject of claims due to their nutritional composi-
tion. and, worryingly for industry, when such a tool that will help discriminate between 
“healthy” and “unhealthy” foods will be agreed at the eU level, the temptation for national 
and european regulators to use it for other restrictive purposes will be very real.
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Carl Keen: one of the things that was stressed in the latest IoM1 biomarker report is the 
suggestion that all of the food claims today should be at about the same level of a standard 
pharmaceutical. Miguel, you touched upon this. The cost of that may be prohibitive. Is 
it reasonable to ask that of the food industry or do we have to find some way to tweak 
it? Is there a light at the end of the tunnel?
Barbara Schneeman: fDa’s goal with the biomarker report had been to identify a bet-
ter process to develop validated biomarkers. for diseases for which we don’t have valid 
biomarkers—many of the cancers for example—the only clinical studies that are possible 
to ascertain decreased risk are long term. with suitable biomarkers that are surrogate 
endpoints of disease, shorter-term studies are possible. So the recommendations were a 
little bit confusing based on what fDa had hoped to get out of that report, but we are 
gleaning, we are looking through it and hoping that the scientific community may be able 
to identify ways that they can take biomarkers that are currently in use and validate them 
as surrogate endpoints or develop new biomarkers that might be used in that capacity.
Roger Wasson (Wasson and Associates): You’ve talked about the regulations and about the 
rating systems and the labels, but I wondered if you would each go outside your own 
area and comment about advertising, because even some of the groups that you have 
regulated are able to come together and say something about “heart healthy” or omega-3 
or something else, on the web, in advertising and public relations—technically discon-
nected from the label itself—and advance a conversation on some of these issues that are 
quasi-claim making, but are not necessarily clearly regulated.
Regulatory Framework for Food Health Claims 
Q&a
Moderator: Carl L. Keen
University of California
Davis, California
1Institute of Medicine.
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Joanne Lupton: actually, I think it’s the opposite right now. I’m actually surprised how the 
federal trade Commission, the ftC, is coming after people for advertising and websites. 
If it’s on the label and it’s on the website, it counts the same, and fDa can go after those 
individuals. That’s coming under more scrutiny rather than less.
Schneeman: as Joanne mentioned, we have a guidance document on our website pointing 
out when material on the web can be considered labeling. for example, if a website UrL 
is provided on a food label then we can review anything on that website as labeling. The 
most famous instance in the United States was the cherry juice case about cancer. we can 
also look at advertising as a way of understanding the manufacturer’s intended use of the 
product. So, it’s not that we are regulating the advertising, but if it gives us information 
in a situation in which we might need to take enforcement action, we can use it to help 
inform our process. as a segue from your question, ftC was instructed by Congress to 
convene a work group from CDC, fDa and USDa to develop a report on criteria for 
marketing foods to children and, in December of 009, a workshop was held in wash-
ington, DC, with a preliminary discussion of the criteria that the work group had been 
considering. ftC will publish a Federal Register notice with the proposed criteria, with 
the goal of receiving comment before it actually sends its report to Congress, which is 
due in July 00. I know that this has been an area of interest in europe as well. Children 
are a vulnerable group. Should we be taking more steps to manage what is marketed and 
promoted to children in terms of food choice?
Miguel da Silva: and, in the case of europe, the claims regulation applies to all com-
mercial communications, including websites and advertising, as I said. for example, 
last year, I think it was the aSa, the advertising Standards authority, of the United 
Kingdom prohibited ads on television for some food companies because they were not 
complying with the claims regulation. So, that is already having an effect on advertising 
per se in the UK.
Rickey Yada (University of Guelph): we often talk about science-based policy. Should we 
be looking at policy-based science now?
Lupton: actually there is definitely a role for both and what you heard from the panel 
here is how we use scientific evidence to support the development of a policy, specifically 
around claims. But, where we probably need the research to go in the other direction, 
keep in mind that the intent with nutrition labeling is to help consumers make better 
food choices, and research can be done to help us figure out whether we are achieving that 
goal. are there ways that we should be improving our labeling? Certainly in the front-of-
pack labeling arena, there is a lot of speculation that this is going to be a tool that helps 
consumers, particularly some consumer groups that aren’t currently using nutrition facts. 
research can help us understand behavior, so, as the policy evolves, you need research to 
understand the impact the policy is having.
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da Silva: In europe, we have clearer separation between the risk assessors and the risk 
managers. That’s why, in my presentation, I explained that the european food Safety 
authority looks at the science, but it’s really the Commission and the Member States that 
authorize or decline the claim. now, they tend to follow efSa advice, so if efSa says that 
the claim is scientifically justified then the Commission and regulators will approve it. 
However, what we are seeing also is, in the case of nutrient profiles, efSa gave an opinion 
on how profiles could be established, but now it’s pure politics. no science is involved.
Amanda Martin (University of Minnesota): even if you ban claims, you’re not banning 
the food. will it actually affect consumer choice? By taking away the “probiotic” claim 
will yogurt consumption rates go down?
da Silva: Yes, that is a problem. for a functional food, if they cannot make a claim, who 
will pay more to buy it? and that’s particularly the case for antioxidants, for probiotics 
and for all food supplements. If you have a pill, but the label doesn’t tell you what it does 
for you, then why would you buy it? So, it really has a serious impact. of course, even if 
a claim is prohibited, your product can remain on the market, but, if you have developed 
it as a functional food delivering a health benefit, you will want to communicate that to 
the consumer. when claims for probiotics were being rejected, Dannon withdrew their 
dossier on activia, so as not to have a public rejection on their dossier. They have stopped 
their claims, but are keeping the products on supermarket shelves because people, having 
been “educated,” are familiar with the media messages. However, I wonder what will be the 
situation in a number of years, because to educate people you need to educate constantly 
as the consumer population evolves.  
Schneeman: You raised an interesting point and it can play out in different ways. first of all, 
yogurt can be part of a healthful diet. If you are interested in consuming dairy products, 
that is certainly one way to do it. It’s not surprising that consumers tend to think positive 
of a product like that. a company that chooses to go down that path has to weigh the risks 
to them. Because, on the one hand, they do gain a halo if it looks like their product has 
a health benefit. But then, having a negative message come out about that product could 
tarnish that halo. If consumers already believe it and let’s say it’s a placebo effect, then the 
tarnish may not impact them, but, in some cases, it can have a much more negative effect: 
why would I trust a company that has said something not supported by the science? It 
gets complicated in terms of the messaging and how consumers perceive it.
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the changing landscape for research and development in the pharma-ceutical and food industries, coupled with changing societal attitudes and requirements, creates new challenges and opportunities for industry-academe 
collaborations. The case of alimentary pharmabiotics is a representative niche area with 
opportunities for both industrial sectors. although manipulation of the gut microbiota 
in the treatment and prevention of several disorders has become a plausible strategy, a 
more intriguing prospect is the potential to “mine’’ diet-host-microbe interactions for 
functional food ingredients and for novel discovery.  
Changing Landscapes
as the pharmaceutical industry faces increasing challenges in drug discovery, new models 
for research and development (r&D) are called for (Crommelin et al., 00; Shah et al., 
00). The landscape today is dominated by declining output of new molecular entities, 
more outsourcing of r&D, partnerships and alliances, increasing emphasis on biologics 
over small molecules and a commercial imperative for agility and flexibility. at the same 
time, advances in understanding major disease processes promise to open the way for 
definition of subsets of patients at a molecular level, with genotyping replacing historic 
approaches to phenotyping diseases. This will tend to fragment the industry’s mass markets 
into genotype segments and will undermine the old blockbuster model (“one-size-fits-all 
drug”) with a new era of personalized medicine. 
Alimentary Pharmabiotics: Common 
Ground for Academia with the Food and 
Pharmaceutical Industries
fergus Shanahan
University College Cork
Cork, Ireland
f.Shanahan@ucc.ie
“…remember that words are signals, counters. They are not immortal.”
—Brian Friel (Translations)
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The degree to which this brave new world will prevail is likely to vary for different 
diseases, and will be influenced by societal attitudes toward the treatment and prevention 
of disease, in particular, depending on whether a pharmacological or non-pharmacologi-
cal approach is favored (Crommelin et al. 00). The pharma sector is likely to remain 
dominant in innovation and may engage with academia in pursuit of solutions for chronic 
inflammatory, infectious and neoplastic diseases. for other disorders, particularly where 
alternatives to drug treatment are desired, small companies, academia and publicly funded 
institutions are likely to take a leading position with declining involvement of big pharma. 
examples of the latter may include the exploration of functional-food ingredients or the 
pursuit of remedies for heterogeneous “functional” disorders and for those euphemistically 
referred to as “lifestyle” disorders (Crommelin et al. 00).
against these changing scenarios, opportunities for the food industry, especially in the 
functional-food business, must be considered in light of greater regulatory constraints, 
more stringent requirements for claims on food products, and a modern society that is risk 
averse. Thus, the distinction between a functional-food ingredient and a drug becomes 
blurred. furthermore, pressure to control prices and focus on niche markets will affect 
both the food and pharma industries. 
opportunities for industry-academe interactions in both the food and pharma sectors 
will flourish, provided an entrepreneurial approach to science is encouraged, and where 
academic institutions provide for greater flexibility and agility in adapting to change. The 
case of alimentary pharmabiotics, as an example of a common ground for the food and 
pharmaceutical industries to explore in collaboration with academia, is summarized below.
alimentary Pharmabiotics
Despite major technologic and conceptual advances in biology, new drug development 
in gastroenterology appears to be in decline (Parsons and Garner, 995; Caskey, 00). 
while large fortunes have been expended by the pharmaceutical industry in synthetic-
drug development, it is noteworthy that about half of the drugs approved by the food 
and Drug administration (fDa) in the United States in the past twenty-five years have 
been derived from natural living material in the wider environment (newman and 
Cragg, 00; Bernstein and Ludwig, 00). Therefore, it seems logical and timely that 
the inner microenvironment of the alimentary tract might be another rich repository 
from which functional-food ingredients and new drugs can be mined (Shanahan et al., 
009; Shanahan, 00). 
an alimentary “pharmabiotic” is the name that we have given to products derived 
from mining host-microbe interactions in the gut that have a proven health benefit. 
This encompassing neologism overcomes the limitations of restrictive definitions of 
probiotics, prebiotics, synbiotics and postbiotics. Thus, it embraces whole organisms, 
live or dead, components and metabolites thereof, and genetically modified organisms 
and the concept has the potential for translation to the marketplace by either the food or 
pharmaceutical industry. representative examples of the potential for mining microbe-
microbe interactions, host-microbe and diet-host-microbe interactions in the gut are 
summarized in table . 
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whether pharmabiotics mined from the natural environment of the gut will be exploited 
by the food or the pharma sector will depend in part on whether a small molecular entity 
or a bacterial fragment is involved, the nature of the desired effect, and the clinical indica-
tion. The clearest delineation will be the treatment of established disease or biomarkers of 
early disease in the case of the pharmaceutical sector, whereas the food industry is more 
likely to focus on disease prevention as measured by reduction in a biomarker of risk. 
opportunities for academic collaborations exist in both scenarios. to that end, academic 
research centres, such as the alimentary Pharmabiotic Centre (http://www.ucc.ie/research/
apc/), have espoused the virtues of hybrid science and hybrid scientists capable of working 
across the boundaries of traditional disciplines and at the food-pharma interface. These 
include scientists, clinicians, and clinician-scientists with the collective ability to bring 
scientific ideas from the laboratory through the clinic to the bedside and marketplace. 
research in academic centers can be aligned to simultaneously suit the requirements of 
both the food and pharma industrial sectors while fostering an environment conducive 
to entrepreneurship and freshness of ideas. for those who doubt it can be done—it can 
be done because it is being done!   
Table 1. opporTuniTies for “mining” The guT microbioTa 
for pharmabioTics.
Interaction Pharmabiotic Reference
Microbe-microbe
Host-microbe
Diet-host-
microbe
exploration of bacteriocins against
specific pathogens (e.g. Clostridium 
 difficile)
anti-inflammatory drugs from bacterial 
components or metabolites that modify 
mucosal inflammation (e.g. lipoteichoic 
acid, CpG Dna)
Immunomodulatory drugs from bacterial
cell-wall polysaccharides
analgesic activities (some but not all
probiotics are beneficial in irritable
bowel syndrome and visceral
hyperalgesia)
Manipulation of the microbiota may
alter bioavailability of dietary calories
Interaction between the microbiota and
dietary components may alter the
composition of host adipose tissue.
rea et al. (00)
Grangette et al. (005);
obermeier et al. (003)
rachmilewitz et al. (00)
Mazmanian et al. (005, 00)
rousseaux et al. (00)
Bakhed et al. (00)
wall et al. (009)
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I will discuss how we’ve tried to link food, health and agriculture in Canada, which has been a challenge. The networks of Centers of excellence (nCes) was a program established by the federal Government in 99 with the goal of mobiliz-
ing Canada’s research capability. The government realized that, because the country is so 
broad geographically, a mechanism was needed to link expertise and build critical mass 
in certain areas to “mobilize Canada’s research talent in the academic, private and public 
sectors and apply it to developing the economy and improving the quality of life of Cana-
dians.” funding comes from the federal granting agencies that are equivalent to the nIH 
and the nSf in the United States—the Canadian Institutes of Health research and the 
natural Sciences and engineering research Council—as well as from the Social Sciences 
and Humanities research Council, and Industry Canada, which is a federal government 
department with the mandate of adding economic benefit to Canada.
The nCes are now focused on four broad areas (fig. ). I contribute to the Advanced 
Foods and Materials Network (afMnet) under the aegis of Health, Human Development 
and Biotechnology. Because of the success of those original networks, the federal govern-
ment has launched other multidisciplinary, sector-driven programs with the underlying 
theme of doing transformative research (e.g. fig. ).
A National Network for Advanced Food and 
Materials
rickey Y. Yada
University of Guelph
Guelph, Ontario
ryada@uoguelph.ca
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afMnet
we submitted an application to the federal government for a multidisciplinary grant with 
the intent of bringing together researchers who traditionally hadn’t worked together for a 
couple of days to develop a research project that was different from what we were already 
doing. out of that process we received a million dollars to work on a project on biofilms, 
involving computer simulation, mathematical models, biochemistry, etc. This became 
one of the seeds for our network. another contributory factor was a failed application; 
we applied to the provincial government for a broadly multidisciplinary grant, which, I 
believe, was ahead of its time. The application, written by food scientists and nutritionists, 
was reviewed by a medical panel whose view of food was simply something that you eat 
three times a day to satisfy requirements. at that time, there was a call for proposals by the 
figure . networks of Centers of excellence (nCes):
Canada-wide networks linking universities, public and private sectors.
figure . other nCes.
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nCes to build a program in food and health. food was becoming increasingly important 
for the agricultural community in terms of how to add value; there was a surge of interest 
in functional foods and nutraceuticals; there was also a call for proposals involving social 
scientists. our timing was good.
also at that time, I was fortunate to sit on a royal Society panel that looked at food 
biotechnology in Canada, the only food scientist on the panel of twelve, comprising 
ethicists, lawyers and ecologists. from that experience, I gained an appreciation of the 
importance of consumer and ethical issues, and the relevance of social science.
we submitted a successful application and began work in 003. networks of Centers 
of excellence have a defined maximum lifetime of  years. we are in the process of 
finishing up our first  years and are applying for renewal. we get $5. million1 a year 
from the program, which in some countries isn’t a lot, but it helps leverage money, one 
of the intents of the network. It links academia, government, industry and not-for-
profit organizations (fig. 3). Seventy researchers are involved, at twenty-two Canadian 
universities. our big claim to fame are the people involved, what we call “HQP” (highly 
qualified personnel), which includes students—undergraduate and graduate—post-docs 
and technical staff. we support 00 to 50 people and have forty-four industry partners. 
we have about $3.5 million dollars in cash or in-kind contributions as matching funds 
with the $5. million. our federal and provincial governments are involved, as I said, 
as are some not-for-profits, and some foreign organizations are also involved. The whole 
intent is to build critical mass in specific areas.
1Dollar amounts in this chapter refer to Canadian currency.
figure 3. afMnet nCe.
we started off with three interrelated topic areas, with the tag-line of “atom to applica-
tion,” i.e. using bench research to market commercially viable products or technologies 
(fig. ). we set up a topic specifically for social scientists—on regulation, policy and 
consumer health—with the rationale that if our products/technologies fail to meet 
regulatory approval then our research would have no tangible results. we engaged social 
scientists, ethicists and policy people from the outset in order to understand the challenges 
of getting over the regulatory hurdle.
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we have two major research programs (fig. 5). “Discovery” projects have a –3 year 
lifetime, each with funding of ~$ million dollars; current areas of focus are nutrigenom-
ics, gut health, sodium reduction, biofilms, etc. The “translational” program comprises 
Strategic transition of application of research (Star), which covers the proof-of-concept 
gap. traditionally, funding agencies finance good fundamental science. on the other hand, 
industry often is looking for products or technologies to buy, whereas the developmental, 
proof-of-concept stage is unaddressed. It’s a difficult area in Canada, as in other countries, 
for which we decided to provide funds.
funding requirements are shown in figure . each project involves individuals from 
at least two disciplines—we encourage more—and two different organizations. also 
required is a financial contribution from at least one partner who will be the receptor of 
the product potentially resulting for the research. as an example, a nutrigenomics project 
involving nano-encapsulation of folic acid fits these criteria: colleagues at seven institu-
tions are collaborating, with funding from four partner companies.
figure . original research programs.
figure 5. research programs.
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figure  lists some of our current projects, from polymorphisms to nutrigenomics, 
again biofilms, identification of bioactives, to sodium. Social scientists are involved in 
most of the projects, but we also have a specific social-science project, examining consumer 
issues. Led by a colleague of mine at the University of Guelph, Spencer Henson, they 
are monitoring ,000 people in Guelph, who are demographically representative of the 
Canadian population. This consumer group is used to monitor progress and development 
in several of our projects. In the sodium project, for example, they were being used to 
determine what sort of platform consumers would be comfortable with.
Knowledge transfer
Most university researchers are not interested in intellectual property (IP). They are pas-
sionate about doing research but, when it comes to protection of IP or commercialization 
issues, many will say, “Don’t bother me with that. I need to get a paper out.” once a 
scientific discovery is announced at a conference or in a published article, it is publicly 
disclosed and companies will no longer be interested in developing it as a commercial 
entity. another issue in Canada is that different universities have different IP policies. In 
some cases, the IP belongs to the university and sometimes the IP belongs to the individual 
researcher. at Guelph we just transitioned from university-owned to investigator-owned. 
we learned this lesson from the University of waterloo, where the Blackberry originated. 
They returned IP back to their faculty, which has benefited the university in spades. also, 
IP is valued differently by tenure and promotions committees at different institutions; 
how many published papers are equal to a patent?
one of the things we have done for our network is to introduce an educational program 
called rB, Research to Business. a team of experts holds workshops—a venture capitalist, 
a scientist turned entrepreneur, an IP/patent lawyer, a financial expert, a person from 
the University-Industry Liaison office, and a business development director—organizes 
workshops to educate our researchers and our HQP on these issues. Most interest is shown 
by our students and postdocs because they are more open to opportunities to take their 
research to the next step.
figure . funding requirements
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Star Program
The Star program is basically proof-of-concept funding at up to $50,000 per year, to 
act as seed money (fig. ). Some of our Star projects are listed in figure 9. Bioactives 
and polysaccharides are going to be used as platforms, hopefully for nutrient delivery. 
other projects cover shellfish poisoning on the east coast of Canada to value-added 
processing of wheat bran. 
figure . Discovery projects—009
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we also have a targeted program in which rapid infusions of $50,000 are available 
to quickly address emerging issues. Matching industrial funds of 0% are expected. The 
first request for proposals was for the development of a “Dna barcode” system for iden-
tification and authentication purposes. for example, work by the fDa and the Canadian 
food Inspection agency has revealed that 0% of tuna sold in Japanese restaurants is 
actually tilapia. 
figure . Strategic transition and application of research (Star) Program.
figure 9. Star Projects.
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Business Model
Something that may be foreign to academics is our adoption of a business model, which 
is a combination of “blue sky”2 and strategic research, using a highly consultative process 
to determine our theme areas. early engagement of our public and policy researchers is 
critical. a request for quarterly reporting was very unpopular with researchers. However, 
we developed a relatively easy on-line system comprising ten questions, to provide a sense 
of how projects are progressing and, thus, facilitate success. and we can use it punitively, 
if we have to. we strongly encourage regular meetings with partners, with reports back 
to us. This system allows us to make early “go”/“no go” decisions. as in the business 
world, if failure is inevitable it is better to fail early because diligence is required on how 
we spend our money. Sustainability is also part of the business plan: can the network be 
maintained without the lifeline of funding from the government?
Governant Structure
I chair the research-management committee, which looks after the day to day operations 
(fig. 0) and I report to a board of directors, comprising a variety of people including 
venture capitalists. an international scientific advisory board has been wonderful in pro-
viding insight into topical areas, including identification and authentication.
figure 0. network governance.
2research that has no immediately apparent commercial applications.
Improving Communications
Communications have been a subject for discussion at this conference. You can write an 
excellent grant to finance scientific research, but unless political elements are addressed, 
successful funding may be elusive. we took it upon ourselves to engage in an active outreach 
program through communication by producing a magazine, ADVANCE, which achieves 
several things. It engages journalism students in helping us to write about the research 
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figure . International food research Collaboration—objectives.
that we do as a network, and convey it to the public. I often say that one of my greatest 
challenges as a scientist is telling a class of grade-3 students what I do as a scientist, in 
language that they understand. our intent with this magazine is similar. we send it to 
our members of parliament, our Senate members, our provincial partners, and all of our 
nGos and researchers, with the intent of educating people on our activities, including 
helping our politicians understand what we are doing as a network.
we also work with a number of groups, including dieticians, the George Brown Chef 
School in toronto, and healthcare providers. In conjunction with the George Brown 
School a –3-day workshop has been developed for family physicians and research chefs. 
The intent is for physicians to understand the components that contribute to food’s 
nutritional quality and functionality because nutrition education is missing from many 
medical curricula.
we are working also with the Canadian Medical association and have an insert in their 
magazine, Health. The mother of one of our scientists saw this magazine in her family 
doctor’s office and reported, “oh, I read about your research”; Health had replaced a 5-
year-old National Geographic magazine in the waiting room. However, this was a tough 
nut to crack. The concept of using food as a preventative measure rather than as disease-
treatment mechanism was something that the Canadian Medical association apparently 
viewed as a challenge to future employment.
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we launched the International food research Collaboration (fig. ) at the 009 
Institute of food technologists meeting. This fosters partnerships around the world, al-
lowing access to information and sharing resources; it’s a portal, providing access to the 
r&D community globally to find out who’s doing what, strategic directions, potential 
synergies and, hopefully, reducing redundancies which otherwise are common. wouldn’t 
it be nice if we all collaborated, particularly in terms of research and training? our initial 
members are in australia, new Zealand, Greece and other countries in europe, and 
Japan (fig. ). at a recent meeting in Paris, we talked to a number of potential partners 
and we are in discussions with a biocluster in Japan. we welcome other partners in this 
international endeavor.
figure . International food research Collaboration—early members.
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Strategic Directions
food and health are our primary considerations as are nanoscale science and technology, 
traceability/authenticity, and the all-important regulatory aspects and consumer attitudes. 
figure 3 illustrates how we view our organization, as a facilitator and a portal. 
figure 3. afMnet’s strategic role.
Yada
9 Promoting Health by Linking agriculture, food, and nutrition
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I am the managing director of Physic ventures, one of a number of partners in a firm whose mission is to invest in keeping people healthy. I think we are the only venture-capital firm with a mission expressly focused on preventing disease and 
preventing the degradation of the environment rather than trying to fix something that 
is already broken. By no means will I be comprehensive in terms of where all nutrition 
innovations are coming from, but I want to frame how a venture-capital investor might 
think about this.
a venture-capital company manages other people’s money. we have about $00 million 
under management, from a variety of institutional investors. Some are big pension funds. 
we have investment from two of the largest pension funds in the world, both of which 
are in California, as well as some of the world’s largest corporations. we have, as major 
investors in our fund, two of the largest food and beverage companies in the world, with 
whom we have deep collaborative relationships in terms of using their expertise to gain 
insights into the market and into science and, in turn, they use our view of emerging 
technologies and entrepreneurship as a means of understanding market opportunities.
Physic ventures
“Physic” comes from the Latin word meaning the science of healing. we got our name 
from the Chelsea Physic Garden in London, one of the most beautiful small protected 
gardens in the world which is now open to the public. It includes oncology, dermatology 
and rheumatology gardens, and is a beautiful reconnection to the roots of the science of 
food and medicine.
Where Will Business Find the Next Best Food 
and Nutrition Innovations?
william rosenzweig
Physic Ventures
San Francisco, California
cakaye@physicventures.com
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The Physic ventures’s thesis is built on the nexus of personal health and planetary health 
and the nexus of life science and lifestyle. our investment landscape is rather unusual 
for a venture-capital firm because it includes sector-specific interests like information 
technology, biotechnology and semiconductors. our linkage between personal health and 
planetary health also makes us unusual. one of our focus areas over the last couple of years 
has been the personalization of health, which brings in genomics, information technology 
and the management of very complex data relevant to the individual. another of our 
themes is sustainable agriculture, as a subset of what we think of as sustainable living. we 
are interested in how technology comes to the consumer market. on our team is a person 
from Genentech, another from Cyron and a physicist and expert in nanotechnology from 
Lawrence Livermore national Lab. So we have expertise in the life sciences and material 
science, as well as in healthcare, healthcare delivery and consumer marketing. 
our insights for where innovations come from are gained in the midst of an ecosystem 
that includes industry, academia, government and others in the venture-capital community. 
at the heart of this are entrepreneurs; venture capitalists invest in entrepreneurs who have 
the magical transformative abilities to turn ideas into businesses using a combination 
of strategy, execution, persistence, patience, tenacity, vision of course, and—I have to 
say—luck. any successful entrepreneur who doesn’t admit that luck was involved is not 
providing full disclosure. But there are ways of increasing the chances of getting lucky, 
which is one of the functions of venture capitalists. They take a portfolio approach to 
investing. we see about a thousand investment opportunities a year in the “life science 
meets lifestyle” area. a lot of it is in the food and nutrition area, in which we make 
approximately four investments a year. entrepreneurs should not be discouraged, but 
recognize that capital is constrained. Most people are very choosy about what they invest 
in, and venture-capitalist investors, in particular, have very specific ideas about what is an 
investable proposition. a number of the innovations I will discuss have not quite risen to 
the dynamic of having venture-capital-type characteristics, which tend to have ambitious 
returns on investment. venture capitalists aspire to produce 5% to 0% returns on capital 
and tend to invest in companies that can scale up quickly and dramatically.
we are in the midst of a cultural upheaval, and our world view increasingly is that food 
equals health. for some of the large food companies, it’s a new concept that they are being 
held up as accountable and responsible for health, rather than merely providing fun and 
calories, good taste and enjoyment. all of a sudden, it’s about health. furthermore, we 
are seeing convergence of the green movement, the sustainability movement, with the 
health movement with far-reaching implications. venture capitalists and entrepreneurs 
always look for environments in which disruption is afoot. where can we create a better 
mousetrap? where can we create a model that is going to disrupt the incumbent leaders? 
The food industry is being chastised, criticized and held up as accountable—similarly 
to how the tobacco companies were—for the obesity epidemic. However, they are also 
on the offense, saying that they are concerned about these issues, while adjusting their 
portfolios. They are trying to transform their processes, their ingredients and, of course, 
they are spending a lot of money trying to reposition their identities. 
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about 5 years ago at a UC-Davis conference, I talked about functional food and food 
as medicine and, since then, that theme has cooled as an area for innovation and invest-
ment. we launched four functional-food companies four years ago in a rapid incubator 
process taking technologies out of universities like Davis, Brandeis and MIt, putting them 
in very tasty, convenient, healthy natural foods, and today, two of those four companies 
are thriving and two had to be closed. one that is thriving is Corazon foods. It produces 
the world’s first healthy potato and tortilla chips—delivering phytosterols in a snack-pack 
form—which licensed intellectual property and clinical studies from Brandeis. and the 
other one that’s still in business is attune foods, which delivers probiotics through healthy 
food bars. The two that didn’t make it were in the satiety space and the sleep space.
It has become clear to us that, with the regulatory environment and with the claims 
landscaping so ambiguous, even diligent companies that are doing the clinical studies 
are finding it difficult to gain differentiation in the marketplace. also, the cultural ethos 
has shifted dramatically through voices like those of Michael Pollan and Marion nestle 
who are talking about a “back to the land” movement. The idea of “more science in my 
food” has become a lot less desirable from a commercial perspective. Therefore, we have 
not made an investment in a functional food business or platform since about 00. Part 
of that was the downturn in the economy, making it even more difficult for early-stage 
businesses to gain traction and get off the ground.
Innovation themes
on the science front, chemistry is moving to the biological realm, as did pharmaceutical 
companies 0–5 years ago. food companies are moving in this direction too. PepsiCo 
has a new chief scientific officer, a Mayo-Clinic-trained epidemiologist who had been head 
of global r&D at takeda Pharmaceuticals, Mehmood Khan, who has been talking to me 
about shifting their entire r&D apparatus from a chemical processing basis to a biologi-
cal basis requiring more understanding of metabolism, nutrigenomics, metagenomics, 
and personalization. transparency is an important theme throughout the supply chain 
and throughout the consumer market. and we are seeing movement from innovations 
being product based to being integrated-service based or systems based. we’ve seen our 
investment practice move from investing in brand platforms to investing in integrated 
systems, at the core of which is behavioral science rather than biological science. with 
respect to linking food and health, there’s a lot of interest in how to promote, incentivize, 
enforce, and sustain healthy behaviors that relate to food. food is becoming connected 
to exercise, community, etc. I also want to talk about the movement that we are seeing 
towards local and artisanal food. finally, my fifth theme will be food equity. 
Biobased Approach
In the Physic ventures portfolio, we have a company called Chromatin, which is a good 
example of a venture-backed intermediary. Scientists at Chromatin are working closely 
with UC-Davis. a recent publication in Nature Biotechnology was a collaborative effort 
involving Chromatin’s Ceo and Davis scientists. Chromatin is a venture-backed company. 
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It has raised a little over $5 million, providing an intermediary platform to rapidly com-
mercialize technologies from academia by forming fast-moving partnerships with industry 
players for proof-of-concept and pilot-scale developments. Such companies are important 
because large institutions cannot be so flexible. This is a corollary to how biotech changed 
the pharmaceutical industry. It’s now happening in agricultural biotechnology
Transparency
on the transparency side, GoodGuide provides information on the health, environmental 
and social attributes of products we consume. It was started by a scientist at UC Berkeley. 
we developed the business plan for this company in my social-venture development 
class at Berkeley. Physic led the series-B financing of this company. new enterprise as-
sociates (nea) and Draper fisher Jurvetson (DfJ) are co-investors. The iPhone has an 
application to scan the barcode of a product and bring up on the screen the GoodGuide 
health, environment and society ratings. The consumer can appraise the health attributes 
of a product being considered for purchase, as well as the environmental practices of the 
company and how they treat their workers. In 5–0 years, this kind of intermediate layer 
of information will become part of almost everyone’s purchasing behavior. GoodGuide 
started by providing information like that found in Consumer Reports. Surprisingly, 
over the last year, the company has formed partnerships with walmart, Safeway and 
Clorox—retailers and manufacturers that wish to disseminate this information for their 
own competitive purposes. walmart is committed to a significant sustainability initiative 
and is using GoodGuide to manage the complex data set involved in making purchasing 
decisions that integrate health, social and environmental concerns.
There is also a lot of interest in transparency in the supply chain. foodLogiQ provides 
traceability with a particular emphasis on local food and food safety. and Intuit is market-
ing a platform for small farmers in India to use their mobile devices to get market data 
so that, when they bring their crops to market, they can get real-time pricing informa-
tion. This can be completely transformative by bringing transparency into the market 
for small, individual farmers equipping them with the information that they need to be 
competitive. This “disintermediates” what has often been a controlled environment and 
levels the playing field.
Integrated Services
recently I went to the itunes library on the Internet and found 3,5 “health and well-
ness” applications (apps) for the iPhone. The most popular was called “Lose It,” a kind 
of calorie counter and personal diary. There are exercise logs as well. Before long, I will 
be able to choose the app that keeps track of how much I walk each day and link that to 
my food diary app and then connect that to my personal health record or my employer 
health system. all of this is coming. It will be transformative for personal behavior and 
have far-reaching impacts on the kinds of products people purchase.
another example is an emerging company that we looked at, The full Yield, which 
provides a behavioral system around fresh food. Similar to a weight watchers environment, 
it’s run in a corporate or an employee health-plan program in conjunction with a food 
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retailer, encouraging people to eat fresher, healthier fruits and vegetables via convenient, 
prepared meals comprising nutritious, minimally refined ingredients. Dannon took an 
early stake in this company, which was co-founded by Gary Hirshberg, the Ceo of 
Stonyfield farm; it’s an example of a product-based entrepreneur moving into a service 
business. another company that we thought was interesting is Local Dirt. I view “local” 
as the new “natural.” Companies are creating marketplaces for local produce using online 
platforms that help farmers connect with distributors, small markets and customers. 
other themes in the local and artisanal area are urban farming, with greenhouses located 
in cities to minimize transportation, and, in “foody” cities, the explosion of high-quality 
street food. entrepreneurship at its best, people are cooking food in their kitchens and 
selling it from trailers in the street, at fairs, etc., for example, the Perierra Crêperie in 
Portland, oregon.
The number of farmers’ markets grew from ,00 to 5,300 from 99 to 009, with a 
3% increase between 00 and 009 alone. This has important implications for the food 
industry. Information technologies are available to underpin the disaggregation and the 
de-monopolization of the food-distribution network. However, progress will be uneven, 
percolating upwards initially only in certain markets.
food equity
Most of the companies in which I have been involved—republic of tea, odwalla, 
whole foods Markets, Stonyfield farm—have catered to a segment of the population 
that I call the “worried well,” i.e. people with discretionary resources to enjoy premium 
items, including natural and organic high-quality foods regarded as premium. However, 
the theme is shifting—with more attention to underserved markets and the linkage of 
food to health, in particular to obesity and cardiovascular disease—to healthy food for a 
healthy population. Kristin richmond and Kirsten tobey, former students of mine at UC 
Berkeley’s Haas School of Business, founded a company called revolution foods, which 
is growing dramatically. They serve over 0,000 healthful meals a week to students from 
kindergarten to high school. with a lot of will and chutzpah, they started a company 
that focused on a market being overlooked. They brought ingenuity and resourcefulness 
to a very exciting company. 
a lot of work is going into figuring out how to return grocery stores to inner-city 
neighborhoods. Some funding is being aggregated from mainstream investors, foun-
dation investors and community-development investors to replace convenience stores 
that offer little fresh food. Some interesting initiatives are also coming out of large food 
companies. I happen to know about one in the Chicago area, food for Good, in which 
an intra-preneurial team in a well known food company is preparing to bring healthy 
food to an underserved population.
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William Rosenzweig is co-founder and managing director at 
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ister of progress of The republic of tea, an award-winning specialty tea company 
that is often credited with creating the premium tea category in the United States. 
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and consultant to the rockefeller foundation’s Provenex fund, an investment 
vehicle seeking “double bottom line returns” in for-profit businesses.
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Kenneth Swartzel: I’ll follow Mark McLellan’s lead with a question for all three of our 
panelists. I may receive three different answers since they come from different walks of 
life. what is the major barrier to commercialization in your world?
Rickey Yada: The challenge for us is defining the value proposition of wellness. we have a 
struggle convincing our governmental funding agencies to invest in food and health. we 
are lucky with our funding, but many of us realize that, on a political agenda, wellness is 
a long-term goal, whereas most politicians operate on a -, 3-, or -year cycle.
Will Rozenzweig: when we started our fund raising in 00, we called our fund “Con-
sumer Health wellness and Sustainable Living” and when we went out to present that 
to institutional investors—the people who control very large sums of money—we got a 
lot of pushback on this term “wellness”: what do you mean by that? Is it snake oil? Is it 
something that’s sold on late-night tv commercials? we ended up taking that word out. 
now, in the 3 or  years since, in the United States, our experience is that this word has 
been endorsed and is legitimate. So, there is hope. That Dean ornish recently got Medicare 
to cover his cardiovascular program to prevent heart disease is interesting validation.
Fergus Shanahan1: My world is an academic world, and it’s a small place. I would say that, 
in my world, the greatest barrier to commercialization is getting people to believe. My 
Food-for-Health Strategies and Programs
Q&a
Moderator: Kenneth Swartzel
North Carolina State University
Raleigh, North Carolina
1Dr. Shanahan left the discussion early to be interviewed on the conference by the media.
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favorite word is “passion” and my second-favorite word “believe.” It’s getting people who 
see their world as quite small—getting them to believe they can actually do it and getting 
them to meet people like you and listen to some of these stories. There’s such a buzz of 
achievement, fulfillment, accomplishment, and chutzpa when you pull off publishing a 
paper. But it’s so much better when you translate the paper and actually make a difference 
somewhere—even if it’s only to a small sector of the market—by getting something off 
the ground. So the greatest barrier is getting them to believe, even getting the people who 
run the universities to believe it can be done, and getting the people who coordinate the 
courses and educate our students to actually believe. That’s the biggest barrier.
Rosenzweig: I’d say two things, one is with respect to citizens. I’m going to start using 
the word “citizen” instead of “consumer,” because I think there is a problem with the 
word “consumer.” It’s antithetical to sustainability, so I’ll use “citizen” today. I’m talking 
about people who buy things and then eat them. one of the barriers is that people don’t 
really understand the true cost of producing what they buy and that many intangible 
externalities are part of those costs. we’ve been trained to think that food should be really 
cheap, which is a barrier to commercialization. we have to teach people to appreciate and 
reprioritize their spending to take care of the full system that is involved in producing 
healthy products. There was a debate this morning on the radio about methyl bromide 
vs. methyl iodide and neither one is very good for people or the planet. This relates to 
making big juicy strawberries. and somebody asked, “why don’t we just charge more 
for strawberries?” That’s an interesting solution, and a barrier. The second barrier is the 
ambiguity in the regulatory environment. It’s hard to navigate. It’s hard to get people to 
invest significant sums of money when there’s no clear pathway to being successful and to 
having their investment be protected from competitors who might not take the integrity 
part of what you are doing as seriously.
Robert Wager (Vancouver Island University): Dr. Shanahan, my wife is a clinical pharmacist 
and on a daily basis there are Clostridium difficile issues in her hospital. My question is, 
when do you think Thuricin might be a commercial product to give her another option 
to treat patients?
Shanahan: realistically, you are probably talking 0 years. But it is conceivable—there’s 
an outside chance—given that the organism that produces it is actually in the food chain, 
then that might be the most efficient way to deliver it. Beyond that, I can’t say. There 
are lots of hurdles of which the regulatory aspect is only a small one, actually. There’s the 
production side; will it be done by fermentation or will it be done by synthesis or isolation? 
Those are big hurdles. There’s an outside chance that it could end up as a food—which 
would speed it up—but I doubt it. 
James Seiber (University of California-Davis): rickey, you mentioned the George Brown 
Chef School in toronto, and you are from a food science department at Guelph and doing 
very good outreach in bridging and networking. Here at Davis, the Culinary Institute of 
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america is not very far away and we are working and growing our relationship there. what 
has worked in that interface between food science and culinary arts and what suggestions 
do you have for making that seemingly natural alliance grow and prosper?
Yada: I’ll go back to one of the words that Dr. Shanahan used: “belief.” People at George 
Brown believe that their research chefs and the students they train need to be better 
educated in nutritional science. Having willing participants—believers—on both sides 
may be the biggest hurdle that you face.
Betty Burri (Western Human Nutrition Research Center): we’ve heard a lot of good examples 
of how we’re working with K through , but that’s actually fairly late in life, nutritionally. 
Have you any comments on additional barriers or opportunities for the daycare-center 
age group or at the other extreme of life, in assisted-living homes?
Yada: one of the initiatives that we are helping to support is in the province of Quebec. 
They have undertaken a program to celebrate cultural diversity at a daycare center. It’s 
very much the Jamie oliver approach where they get young students to bring recipes 
from home and the class shares in the development of that food and at the end they 
celebrate by eating the foods from their classmates. when the reports come back from 
that group, the candidness of the students is surprising. They tell you exactly what they 
like and don’t like at that level.  
Rosenzweig: one of the opportunities that we are seeing results from increased willing-
ness to form partnerships among collaborators. The women at revolution foods were 
successful at getting whole foods to work with them early as a supply-chain partner. to 
address your question, I think there are entrepreneurial opportunities for people with 
vision and belief to address those markets and I think the road forward is to knit together 
people who share that vision. we’ve looked a lot at the market that’s being termed “aging 
in place” and certainly food is a big piece of it, but again it’s moving toward an integrated 
systems dynamic. There’s a lot of interesting technology with sensors to anticipate when 
people are going to fall and they are linking that back to, “If we can see when someone 
doesn’t take their medication they are more likely to fall and if they are not taking their 
medication they may not be eating.” My point is, there is a lot of monitoring and the 
sooner the food industry starts to think of itself as not a single point in a solution but as 
part of an overall lifestyle system, I think innovation will begin to accelerate.
Shanahan: If I might just put a plug in for the exploration of the microbiota at the 
 extremes of life—I’d probably be shot by my colleagues if I didn’t—but you are probably 
familiar with the Human Microbiome Project in the United States, which is essentially 
trying to define normal and the ranges of normal, and how diet and nutrition influence 
the composition of the microbes. If it’s really going to make an impact, I actually think 
it would be at the extremes of life. at the very early stage in life at the time when we are 
colonizing our bodies and, therefore, influencing the “education” of the immune system 
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and probably risk factors for immuno-allergic diseases, the time to intervene is very early 
on—it’s too late for us—and also at the other extreme of life, the elderly, when things start 
to break down. The Irish version of the Human Microbiome Project, called eLDerMet, 
is beginning to show that there is extreme diversity and instability in the microbiota of 
the elderly and what is particularly revealing is when the elderly go from living in the 
community to being institutionalized. You might think that’s because of living in close 
contact with others, but I think it’s almost certainly the influence of diet. Let’s remember 
that food, nutrition, diet, is the single most important factor determining the microbiota. 
But, we have to understand “normal” first.
Bonnie Dixon (University of California-Davis): My question is for will rosenzwieg. I 
was particularly interested in the part of your talk dealing with Internet and IPhone 
 applications for wellness. You said that one of the things you are watching for is a platform 
that will integrate all of these. friends who work in the area of internet applications and 
information technology say that that integration can be quite a challenge. when a lot of 
websites are competing with each other—providing similar services—it can take a long 
time for integration to occur even though that’s problematic for users. How do you see 
this developing with wellness applications?
Rosenzweig: My answer to this question is informed by a trip that I took to India not long 
ago. There you see lots of people with cell phones who don’t have computers. Their cell 
phones are computers, and it’s a remarkable example of skipping over an incumbent tech-
nology. The mobile environment is going to become rich for this sort of dynamic. when 
you think about food and behavior change, you are thinking about capturing information. 
There will be different ways to do that. You also want to give rewards or incentives for 
feedback. You want to set goals. You want to have feedback. If you pick a few key rules 
and you embed that in the platform, you create a fairly cohesive opportunity, once you 
agree on a language and a boundary for what you want to work on. we actually see this 
food, wellness, nutrition area being quite within grasp, and so, hopefully, we are going 
to make an investment very shortly in a company that will provide that platform. But it 
will be a mobile platform. It will be on an android-based phone, not on a laptop.
Amanda Martin (University of Minnesota): Dr. Yada, you mentioned that we should be 
aware of intellectual property issues. at what stage is it important to start looking at that, 
considering that one might not be aware that one’s research is heading in a direction where 
IP would eventually be important.
Yada: tom Dowler, who is at this conference, was hired as our business analyst and one 
of his charges is to educate our HQP2 on IP right from the get-go. we introduce them 
as early as possible to disclosure issues.
2Highly qualified personnel, see page .
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Rosenzweig: from a commercial perspective, if you are going to head in that direction, 
you want to get engaged in it as soon as possible. an excellent program here at UC-Davis 
is a graduate course for scientists in the business school. They do it over a semester and 
also have a “boot camp” where scientists receive training from venture investors and 
commercialization experts. IP is critical to ensure freedom to operate and exclude other 
people from doing what you want to do.
Martina Newell-McGloughlin (University of California-Davis): will, I was pleasantly 
surprised to see that you are investing in Chromatin. I was shocked to see that you think 
there is hope for a recombinant Dna technology in agribusiness given so much push 
back from europe. Clearly, you are, at least to some degree, hopeful and positive about 
this, and I’m wondering what convinced you that this was a worthwhile venture and if 
there is actually hope in europe?
Rosenzweig: I think it’s promising. obviously it’s a controversial area. a lot of our ratio-
nale for investing came from the thoughtfulness and the mindset of the scientists and 
the management team and where they were leading the company. Chromatin has been 
making good progress lately and is a great example for those thinking about being an 
entrepreneur. This company has already died five deaths and come back. There have 
been people who have abandoned it, people who have tried to take it over, investors who 
have left, and investors who have come in. But now it’s starting to thrive, so patience 
and persistence are key.
Newell-McGloughlin: well done to you for seeing that.
Rosalee Hellberg (Oregon State University): Dr. Yada, I am especially interested in your 
outreach program to physicians, educating them in food science. I’m working on a pro-
gram in which we are educating healthcare providers on the benefits and risks of sea food. 
what kinds of communication strategies and materials have you found most useful for 
communicating with physicians?
Yada: as I said, the big challenge was getting some of the hierarchy at the Canadian 
Medical association and our provincial medical association to appreciate the connection 
between food and health. we spent a number of hours talking to them, which resulted 
in that insert in the magazine to their members. Initially, we paid for a two-page insert 
and now we are on a gratis basis, so, I think they now appreciate the concept of food 
and health. as I said, the other thing that we are working on is the educational program 
for family physicians with research chefs and again, we’re not sure what the upshot will 
be because there are believers and nonbelievers within the medical and chef communi-
ties. we are hoping that, initially, we will get the believers involved and they will act as 
messengers to others.
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Rosenzweig: James Gordon, the director of the Center for Mind-Body Medicine in 
washington, DC, offers a course to physicians on food. Their materials may be a good 
resource for you.
Swartzel: I would like to end this session by having our panelists comment on a topic that 
has come up in this conference: personal choice versus regulatory intervention. would 
you care to make any comments relative to what you see as emerging, developing aspects? 
I know that’s a tough question.
Yada: Ken, that’s a real tough one but, as I often say to groups that I talk to, we need to 
empower our citizens with information so that they themselves can make healthy choices. 
There was a movement in the school-board system of toronto to remove soda machines, 
which I spoke against because it would likely drive that market underground and students 
by other means would obtain “contraband” soda. at that time, I had a chat with John 
Krebs, who headed up the food Standards agency about the Jamie oliver program, and 
he said, “wonderful goals, but not very successful. when Jamie went into those schools 
to work with the kitchen ladies he didn’t empower those kitchen ladies with knowledge. 
They were basically told what to cook and students refused to eat the meals. Money was 
passed through the fence for their buddies to supply them with ‘contraband’ food.” So, 
again, it’s all about empowering our citizens with good educational programs.
Rosenzweig: The hard part is that entrenched interests want to perpetuate themselves. These 
are large companies that have been selling products and doing very well over periods of 
time and their shareholders, their investors, expect them to keep growing. So, they end 
up in a dilemma; they are selling food products from which they make large profits but 
which are now known to be bad for people if used excessively. I’m all for empowerment. 
I also feel that money, energy and resources kept in the system to sustain incumbent 
activities slow down innovation. one of the reasons for the interesting innovation in 
this food-equity area is because there isn’t a lot of money to be made there. entrenched 
interests are not maintaining the status quo, and, as such, entrepreneurs have repriori-
tized their own values. a lot of people going to business school today aren’t saying that 
the most important thing in life is to get rich. They are saying that the most important 
thing in life is to make the world a better place. That reprioritization of values has a very 
powerful impact on the innovation system. So, regulation can be helpful when shifting 
the interests of incumbents and also in leveling the playing field, but I don’t think it’s 
helpful in constraining people in terms of what’s best for them.
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at its most basic level, food is the source of nutrition to meet daily requirements but is now taking on an ever-greater role in the quest for health  optimization. The latter focus is a luxury that is primarily the purview of an 
 affluent society and has little relevance in many areas where mere survival is the driving 
force. from the basic-nutrition perspective, there is a clear dichotomy in demonstrated 
need between different regions and socioeconomic groups, the starkest being addressing 
injudicious consumption in the developed world and under-nourishment in less developed 
countries (LDCs). Both extremes suffer from forms of malnourishment, one through 
 inadequate supply, the other, in many but not all instances, through inappropriate choices, 
the latter often influenced by economic considerations. from the food deserts of inner 
cities to the real barren wastelands of many regions, access to a healthy diet is a challenge. 
Dramatic increases in the occurrence of obesity, cardiovascular disease, diabetes, cancer 
and related ailments in developed countries are in sharp contrast to chronic under-nutri-
tion and genuine malnutrition in many LDCs. Both problems require a modified food 
supply and the tools of biotechnology, while not the sole solution, do have a significant 
part to play.
Plant Biotechnology: The Answer to your 
Nutrition Needs!
Martina newell-McGloughlin
University of California
Davis, California
mmmcgloughlin@ucdavis.edu
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agriculture as a tool
worldwide, plant-based products comprise the vast majority of human food intake, 
irrespective of location or financial status (Mathers, 00). In some cultures, either by 
design or default, plant-based nutrition comprises almost 00% of the diet. Given this, 
one can deduce that significant nutritional improvement can be achieved via modifications 
of staple crops. new and innovative techniques will be required to improve the efficiency 
of the global agriculture sector to ensure an ample supply of healthy food. to confound 
this situation, the inequity between the affluent and developing countries will continue 
to grow and only a handful of technologies are sufficiently scale-neutral to help with 
redressing this imbalance. In october 009, the United nations’ food and agriculture 
organization (fao) determined that farming in developing countries needs $3 billion 
of annual investment for production to feed the world in 050. The 00 world Bank 
Development report emphasized that, “agriculture is a vital development tool for achiev-
ing the Millennium Development Goals that call for halving by 05 the share of people 
suffering from extreme poverty and hunger” (world Bank, 00). The report notes that 
three out of every four people in developing countries live in rural areas and most of 
them depend directly or indirectly on agriculture for their livelihoods. It recognizes that 
overcoming abject poverty cannot be achieved in sub-Saharan africa without a revolution 
in agricultural productivity for resource-poor farmers, many of whom are women.
The first generation of the products commercialized from one of those technologies, 
namely biotechnology, were crops focusing largely on input agronomic traits primarily in 
response to biotic stress. The coming generations of crop plants can be grouped into four 
broad areas. The present and future focus is on continuing improvement of agronomic 
traits such as yield and abiotic stress resistance in addition to the biotic stress tolerance of 
the present generation; crop plants as biomass feedstocks for biofuels and “bio-synthet-
ics”; value-added output traits such as improved nutrition and food functionality; and 
plants as production factories for therapeutics and industrial products. Developing and 
commercializing plants with these improved traits involve overcoming a variety of tech-
nical, regulatory and perception challenges inherent in perceived and real challenges of 
complex modifications. Both the panoply of traditional plant-breeding tools and modern 
biotechnology-based techniques will be required to produce plants with the desired quality 
traits. tables a–d present examples of crops that have already been genetically modified 
with macro- and micronutrient traits that may provide nutritional benefits.
the food/Health Correlation
although the correlative link between food and health, beyond meeting basic nutrition 
requirements, has been unequivocally proven only in a number of cases, a growing body 
of evidence indicates that food components can influence physiological processes at all 
stages of life. nutrition intervention from a functionality perspective has a personal 
 dimension. Determining individual response is at least as complex a challenge as the task 
of increasing or decreasing the amount of a specific protein, fatty acid, or other com-
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Table 1a. examples of crops in research and/or developmenT 
wiTh nuTriTionally improved TraiTs inTended To provide 
healTh benefiTs for consumers and animals 1.
Trait Crop (trait detail) Reference
Protein and amino acids
  
Protein quality and level Bahiagrass (protein↑) Luciani et al., 005
 Canola roesler et al., 99;
 (amino acid composition)
 Maize (amino acid Cromwell et al., 9; 
 composition; protein↑) o’Quinn et al., 000;
  Yang et al., 00;
  Young et al., 00
 Potato (amino acid Yu and ao 99;
 composition; protein↑) Chakraborty et al., 000;
  Li et al., 00;
  atanassov et al., 00
 rice (protein↑; amino acid) Katsube et al., 999
 Soybean (amino acid balance) Dinkins et al., 00;
  rapp, 00
 Sweet potato (protein↑) Prakash et al., 000
 wheat (protein↑) Uauy et al., 00
essential amino acids Canola (lysine↑) falco et al., 995
 Lupin (methionine↑) white et al. 00
 Maize (lysine↑; methionine↑) Lai and Messing, 00;
 Potato (methionine↑) Zeh et al., 00
 Sorghum (lysine↑) Zhao et al., 003
 Soybean (lysine↑; tryptophan↑) falco et al., 995;
  Galili et al., 00
1excludes protein/starch functionality, shelf life, taste/esthetics, fiber quality and allergen/toxin-reduction traits; 
modified from ILSI (00a, b; 00).
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Table 1b. more examples of crops in research and/or developmenT 
wiTh nuTriTionally improved TraiTs inTended To provide 
healTh benefiTs for consumers and animals.
Trait Crop (trait detail) Reference
Oils and fatty acids   
 Canola (lauric acid↑; γ- Dehesh et al., 99; roesler et al.,
 linolenic acid↑; + ω-3 fatty acids; 99; Del vecchio, 99;
 :0 and 0:0 fatty acids↑; froman and Ursin, 00;
 lauric + myristic acid↑; James et al., 003;
 oleic acid↑) Ursin, 003
 Cotton (oleic acid↑; oleic Chapman et al., 00;
 acid + stearic acid↑) Liu et al., 00
 Linseed (+ ω-3 and - fatty acids) abbadi et al., 00
 Maize (oil↑) Young et al., 00
 oil palm (oleic acid↑ or stearic acid↑; Jalani et al., 99;
 oleic acid↑ + palmitic acid↓) Parveez, 003
 rice (α-linolenic acid↑) anai et al., 003
 Soybean (oleic acid↑; γ-linolenic acid↑) reddy and Thomas 99;
  Kinney and Knowlton 99;
 
  Safflower (γ-linolenic acid GLa↑) Bnet, 00
 
ponent of the plant itself (Brigelius-flohe and Joost, 00). There is also evidence that 
early food regimes can affect later life health; for example, some children who survived 
famine conditions in certain regions of africa grew into adults battling obesity and related 
problems presumably due to the selective advantage of the thrifty gene in their early 
food-stressed environment becoming a hazard during more abundant times especially if 
later diets are calorie dense. 
functional-food components are of increasing interest in the prevention and/or treat-
ment of a number of the leading causes of death including, but not limited to, cancer, 
diabetes, cardiovascular disease, and hypertension. Many food components are known 
to influence the expression of both structural genes and transcription factors in humans 
(Go et al., 005; Mazzatti et al., 00). examples of these phytochemicals are listed in 
tables a, b; the large diversity suggests that the potential impact of phytochemicals and 
functional foods on human and animal health is worth examining as targets of biotech-
nology efforts.
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Table 1c. more examples of crops in research and/or developmenT 
wiTh nuTriTionally improved TraiTs inTended To provide 
healTh benefiTs for consumers and animals.
Trait Crop (trait detail) Reference
Carbohydrates
  
fructans Chicory, (fructan↑; fructan Smeekens, 99; Sprenger et al.,
 modification) 99; Sévenier et al., 99
 Maize (fructan↑) Caimi et al., 99
 Potato (fructan↑) Hellwege et al., 99
 Sugar beet (fructan↑) Smeekens, 99
fructose, raffinose, Soybean Hartwig et al., 99
stachyose
Inulin Potato (inulin↑) Hellwege et al., 000
Starch rice (amylase↑) Chiang et al., 005; 
  Schwall, 000
Micronutrients and 
functional metabolites
  
vitamins and  Canola (vitamin e↑) Shintani and DellaPenna, 99
carotenoids
 Maize (vitamin e↑; vitamin C↑) rocheford et al., 00; Cahoon 
  et al., 003; Chen et al., 003
 Mustard (+β-carotene) Shewmaker et al., 999
 Potato (β-carotene and lutein↑) Ducreux et al., 005
 rice (+β-carotene) Ye et al., 000
 Strawberry (vitamin C↑) agius et al., 003
 tomato (folate↑; phytoene and rosati, 000; fraser et al., 00;
 β-carotene↑; lycopene↑; Mehta et al., 00; Díaz de la Garza
 provitamin a↑) et al., 00; enfissi et al., 005;
  DellaPenna, 00
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Table 1d. more examples of crops in research and/or developmenT 
wiTh nuTriTionally improved TraiTs inTended To provide 
healTh benefiTs for consumers and animals.
Traits Crop (trait detail) Reference
functional secondary apple (+stilbenes) Szanowski et al., 003
metabolites
 alfalfa (+resveratrol) Hipskind and Paiva, 000
 Kiwi (+resveratrol) Kobayashi et al., 000
 Maize (flavonoids↑) Yu et al., 000
 Potato (anthocyanin and Lukaszewicz et al., 00
 alkaloid glycoside↓; solanine↓)
 rice (flavonoids↑;  Stark-Lorenzen, 99;
 +resveratrol) Shin et al., 00
 Soybean (flavonoids↑) Yu et al., 003
 tomato (+resveratrol; rosati, 000; Muir et al., 00;
 chlorogenic acid↑; niggeweg et al., 00;
 flavonoids↑; Giovinazzo et al., 005;
 stilbene↑anthocynanins↑) Gonzali et al., 009
 
 wheat (caffeic and ferulic acids↑; UPI, 00
 +resveratrol)
Mineral availability  
 alfalfa (phytase↑) austin-Phillips et al., 999
 Lettuce (iron↑) Goto et al., 000
 rice (iron↑) Lucca et al., 00
 Maize(phytase↑, ferritin↑) Drakakaki, 005;
  allBusiness, 009
 Soybean (phytase↑) Denbow et al., 99
 wheat (phytase↑) Brinch-Pedersen et al., 000, 00
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from a health perspective, plant components of dietary interest can be divided into four 
main categories, which can be further broken down into positive and negative attributes 
for human nutrition, macronutrients [proteins, carbohydrates, lipids (oils), and fiber], 
micronutrients (vitamins, minerals, phytochemicals), anti-nutrients (substances such as 
phytate that limit bioavailability of nutrients), allergens, intolerances and toxins.
technological Challenges
There are approximately 5,000 metabolites (phytochemicals)—of the 00,000 or so 
produced by plants—with known effects in the human diet (Go et al., 005). analysis 
of these metabolites (most specifically metabolomic analysis) is a valuable tool in gaining 
better understanding of what has occurred during crop domestication (lost and silenced 
traits) and in designing new paradigms for more targeted crop improvement that is better 
tailored to current needs (Hall et al., 00). In addition, with modern techniques, we 
have the potential to seek out, analyze and introgress traits of value that were limited in 
previous breeding strategies. research to improve the nutritional quality of plants has his-
torically been limited by a lack of basic knowledge of plant metabolism and the challenge 
of resolving complex interactions of thousands of metabolic pathways. a complementarity 
of techniques, both traditional and novel, is needed to metabolically engineer plants to 
produce desired quality traits. Metabolic engineering is generally defined as the redirec-
tion of one or more reactions (enzymatic and otherwise) to improve the production of 
existing compounds, produce new compounds or mediate the degradation of undesirable 
compounds. It involves the redirection of cellular activities by the modification of the 
enzymatic, transport, and/or regulatory functions of the cell. Significant progress has been 
made in recent years in the molecular dissection of many plant pathways and in the use 
of cloned genes to engineer plant metabolism.  
although progress in dissecting metabolic pathways and our ability to manipulate gene 
expression in genetically modified (GM) plants has progressed apace, attempts to use these 
tools to engineer plant metabolism have not quite kept pace. Since the success of this 
 approach hinges on the ability to change host metabolism, its continued development 
will depend critically on a far more sophisticated knowledge of plant metabolism—
 especially the nuances of interconnected cellular networks—than currently exists. This 
complex interconnectivity is regularly demonstrated. relatively minor genomic changes 
(point mutations, single-gene insertions) are regularly observed following metabolomic 
analysis, to lead to significant changes in biochemical composition (Bino et al., 005; 
Davidovich-rikanati et al., 00; Long et al., 00). Giliberto et al. (005) used a genetic 
modification approach to study the mechanism of light influence on antioxidant content 
(anthocyanin, lycopene) in the tomato cultivar Moneymaker. However, other, what on 
the surface would appear to be more significant, genetic changes unexpectedly yield little 
phenotypical effect (Schauer and fernie, 00). 
Likewise, unexpected outcomes are often observed. for example, significant modi-
fications made to primary Calvin-cycle enzymes (fructose-,-bisphosphatase and 
phosphoribulokinase) have little effect while modifications to minor enzymes (e.g. aldase, 
which catalyzes a reversible reaction) seemingly irrelevant to pathway flux, have major 
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Table 2a. examples of planT componenTs wiTh 
suggesTed funcTionaliTy.a
Class/components Sourceb Potential health benefit
Carotenoids
α-carotene Carrots neutralizes free radicals that may 
  cause damage to cells.
β-carotene various fruits, vegetables neutralizes free radicals.
Lutein Green vegetables Contributes to maintenance of 
  healthy vision.
Lycopene tomatoes and tomato products May reduce risk of prostate cancer.
 (ketchup, sauces)
Zeaxanthin eggs, citrus, maize Contributes to maintenance of 
  healthy vision.
Dietary fiber
Insoluble fiber wheat bran May reduce risk of breast and/or 
  colon cancer.
Beta glucan oats May reduce risk of cardiovascular
  disease (CvD).
Soluble fiber Psyllium May reduce risk of CvD.
whole grains Cereal grains May reduce risk of CvD.
Collagen hydrolysate   Gelatin May help improve some symptoms
  associated with osteoarthritis.
Fatty Acids
omega-3 fatty acids - tuna; fish and marine oils May reduce risk of CvD and 
DHa/ePa  improve mental, visual functions.
Conjugated linoleic acid Cheese, meat products May improve body composition,
(CLa)  may decrease risk of certain cancers.
Gamma linolenic acid Borage, evening primrose May reduce inflammation risk of
  cancer, CvD disease and improve
  body composition.
Flavonoids  
anthocyanidins: cyanidin Berries neutralize free radicals, may reduce
  risk of cancer.
Hydroxycinnamates  wheat antioxidant-like activities, may reduce
  risk of degenerative diseases.
flavanols: catechins, tea (green, catechins), neutralize free radicals, may reduce
tannins (black, tannins) risk of cancer.
flavanones Citrus neutralize free radicals, may reduce
  risk of cancer.
flavones: quercetin fruits/vegetables neutralize free radicals, may reduce
  risk of cancer.
anot an all-inclusive list. 
bUS food and Drug administration approved health claim established for component; modified from ILSI 
(00a, b).
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Table 2b. more examples of planT componenTs wiTh 
suggesTed funcTionaliTy.
Class/components Source Potential health benefit
Glucosinolates, indoles, 
isothiocyanates  
Sulphoraphane Cruciferous vegetables neutralizes free radicals, may reduce
 (broccoli, kale), horseradish risk of cancer.
Phenolics  
Stilbenes-resveratrol, Grapes May reduce risk of degenerative
  diseases; heart disease; cancer.
  May have longevity effect.
Caffeic acid, ferulic acid fruits, vegetables, citrus antioxidant-like activities; may reduce
  risk of degenerative diseases;
  heart disease, eye disease.
epicatechin Cacao antioxidant-like activities; may reduce
  risk of degenerative diseases;
  heart disease.
Plant stanols/sterols  
Stanol/sterol ester Maize, soy, wheat, wood oils May reduce risk of coronary
  heart disease (CHD) by lowering
  blood cholesterol levels.
Prebiotics/probiotics  
fructans, inulins, fructo- Jerusalem artichokes, May improve gastrointestinal health.
oligosaccharides (foS) shallots, onion powder
Lactobacillus Yogurt, other dairy May improve gastrointestinal health.
Saponins Soybeans, soy foods, soy May lower LDL cholesterol;
 protein-containing foods contains anti-cancer enzymes.
Soybean protein Soybeans and soy-based foods 5 g/day may reduce risk of heart disease.
Phytoestrogens  
Isoflavones - daidzein, Soybeans and soy-based foods May reduce menopause symptoms,
genistein  such as hot flashes, reduce
  osteoporosis, CvD.
Lignans flax, rye, vegetables May protect against heart disease and 
  some cancers; may lower LDL cholesterol,
  cholesterol, total cholesterol, and triglycerides.
Sulfides/thiols  
Diallyl sulfide onions, garlic, olives, leeks, May lower LDL cholesterol, helps to
 scallions maintain healthy immune system.
allyl methyl trisulfide, Cruciferous vegetables May lower LDL cholesterol, helps to
dithiolthiones  maintain healthy immune system.
Tannins  
Proanthocyanidins Cranberries, cranberry products, May improve urinary tract health.
 cocoa, chocolate, black tea May reduce risk of CvD, and
  high blood pressure.
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effects (Paul et al., 995; Hajirezaei et al., 99). These observations demonstrate that 
caution must be exercised when extrapolating individual enzyme kinetics to the control of 
flux in complex metabolic pathways. with evolving “omics” tools, a better understanding 
of global effects of metabolic engineering on metabolites, enzyme activities, and fluxes is 
beginning to be developed. attempts to modify storage proteins or secondary metabolic 
pathways have also been more successful than have alterations of primary and interme-
diary metabolism (DellaPenna and Pogson, 00). while offering many opportunities, 
this plasticity in metabolism complicates potential routes to the design of new, improved 
crop varieties. regulatory oversight of engineered products has been designed to detect 
such unexpected outcomes in biotech crops and, as demonstrated by Chassy et al. (ILSI, 
00a, b, 00), existing analytical and regulatory systems are adequate to address novel 
metabolic modifications in nutritionally improved crops. 
a number of new approaches are being developed to counter some of the complex 
problems in metabolic engineering of pathways. Such approaches include use of rna 
interference to modulate endogenous gene expression or the manipulation of transcrip-
tion factors (tfs) that control networks of metabolism (Kinney, 99; Bruce et al., 
000; Butelli et al., 009, Gonzali et al., 009). for example, expression in tomato 
of two selected tfs involved in anthocyanin production in snapdragon (Antirrhinum 
majus L.) led to high levels of these flavonoids throughout the fruit tissues, which, as a 
consequence, were purple. They also stimulated genes involved in the side-chain modi-
fication of the anthocyanin pigments and genes possibly related to the final transport of 
these molecules into the vacuole, processes that are both necessary for the accumulation 
of anthocyanin (Gonzali et al., 009). Such expression experiments hold promise as an 
effective tool for the determination of transcriptional regulatory networks for important 
biochemical pathways. Gene expression can be modulated by numerous transcriptional 
and posttranscriptional processes. Correctly choreographing the many variables is the 
factor that makes metabolic engineering in plants so challenging.
In addition, there are several new technologies that can overcome the limitation of 
single-gene transfers and facilitate the concomitant transfer of multiple components of 
metabolic pathways. one example is multiple-transgene direct-Dna transfer, which 
simultaneously introduces all the components required for the expression of complex 
recombinant macromolecules into the plant genome as demonstrated by a number 
of reports, including those of nicholson et al. (005), who successfully delivered four 
transgenes that represent the components of a secretory antibody into rice, and of Carl-
son et al. (00) who constructed a minichromosome vector that remains autonomous 
from the plant’s chromosomes and stably replicates when introduced into maize cells. 
This work makes it possible to design minichromosomes that carry cassettes of genes, 
enhancing the ability to engineer plant processes such as the production of complex 
biochemicals. Christou and Kohli (009) demonstrated that gene transfer using mini-
mal cassettes is an efficient and rapid method for the production of transgenic plants 
stably expressing several different transgenes. Since no vector backbones are required, 
this prevents the integration of potentially recombinogenic sequences insuring stability 
across generations. They used combinatorial direct-Dna transformation to introduce 
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multi-complex metabolic pathways synthesizing β-carotene, vitamin C and folate. They 
achieved this by transferring five constructs controlled by various endosperm-specific 
promoters into white maize. Different enzyme combinations show distinct metabolic 
phenotypes resulting in a 9-fold increase in β-carotene, a five-fold increase vitamin C, 
and a doubling in folate production, effectively creating a multivitamin maize cultivar 
(naqvi et al., 009). This system has an added advantage from a commercial perspective 
in that these methods circumvent problems with traditional approaches that not only 
limit the amount of sequences transferred, but may disrupt native genes or lead to poor 
expression of the transgene, thus reducing both the numbers of transgenic plants that 
must be screened and the subsequent breeding and introgression steps required to select 
a suitable commercial candidate.
as demonstrated, “omics”-based strategies for gene and metabolite discovery, coupled 
with high-throughput transformation processes and automated analytical and functionality 
assays, have accelerated the identification of product candidates. Identifying rate-limiting 
steps in synthesis could provide targets for modifying pathways for novel or customized 
traits. targeted expression will be used to channel metabolic flow into new pathways, 
while gene-silencing tools will reduce or eliminate undesirable compounds or traits, or 
switch off genes to increase desirable products (Liu et al., 00; Herman et al., 003; 
Davies, 00). In addition, molecular marker-based breeding strategies have already been 
used to accelerate the process of introgressing trait genes into high-yielding germplasm 
for commercialization. tables a–d summarize the work done to date on specific applica-
tions in the categories listed above. The following sections briefly review some examples 
under those categories.
Macronutrients
Protein
The fao estimates that 50 million people worldwide suffer from under-nutrition, of 
which insufficient protein in the diet is a significant contributing factor (fao, 00). 
Protein-energy malnutrition (PeM) is the most lethal form of malnutrition and affects 
every fourth child worldwide according to the wHo (00). Most plants have a poor 
balance of essential amino acids relative to the needs of animals and humans. The cereals 
(maize, wheat, rice, etc.) tend to be low in lysine, whereas legumes (soybean, pea, etc.) 
are often deficient in the sulfur-rich amino acids, methionine and cysteine. Successful 
examples of improving amino acid balance to date include high-lysine maize (eggeling 
et al., 99; o’Quinn et al., 000) canola and soybean (falco et al., 995). free lysine is 
significantly increased in high-lysine maize by the introduction of the dapa gene (cordapa) 
from Corynebacterium glutamicum, which encodes a form of dihydrodipicolinate synthase 
(cDHDPS) that is insensitive to lysine feedback inhibition. Consumption of foods made 
from these crops potentially can help to prevent malnutrition in developing countries, 
especially among children.       
another method of modifying storage-protein composition is to introduce heterolo-
gous or homologous genes that code for proteins containing elevated levels of the desired 
amino acid, such as sulfur-containing methionine and cysteine, or lysine. an interesting 
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solution to this is to create a completely artificial protein containing the optimum number 
of the essential amino acids—methionine, threonine, lysine, isoleucine and leucine—in 
a stable, helical conformation designed to resist proteases to prevent degradation. This 
has been achieved by a number of investigators, including a sweet potato modified with 
an artificial storage protein (aSP-) gene (Prakash et al., 000). These transgenic plants 
exhibited two- and five-fold increases in the total protein contents in leaves and roots, 
respectively, over those of control plants. Significant increases in the levels of essential 
amino acids were also observed (Prakash et al., 000; ILSI, 00). a key issue is to ensure 
that total amount and composition of storage proteins is not altered to the detriment of 
the development of the crop plant when attempting to improve amino-acid ratios (rapp 
et al., 00). 
Some novel indirect approaches have also been taken to improve protein content. 
Uauy et al. (00) “rescued” an ancestral wheat allele that encodes a transcription factor 
(naM-B), which accelerates senescence and increases nutrient remobilization from leaves 
to developing grains (modern wheat varieties carry a nonfunctional allele.) reduction in 
rna levels of the multiple naM homologs by rna interference delayed senescence by 
more than 3 weeks and reduced wheat-grain protein, zinc, and iron contents by more 
than 30%. Young et al. (00) used yet another approach to indirectly increase protein 
and oil content. They used a bacterial cytokinin-synthesizing isopentenyl transferase (IPt) 
enzyme, under the control of a self-limiting senescence-inducible promoter, to block the 
loss of the lower floret resulting in the production of just one kernel composed of a fused 
endosperm with two viable embryos. The presence of two embryos in a normal-sized 
kernel leads to displacement of endosperm growth, resulting in kernels with an increased 
ratio of embryo-to-endosperm content. The end result is maize with more protein and 
oil and less carbohydrate (Young et al., 00; ILSI, 00).
Fiber and Carbohydrates
fiber is a group of substances chemically similar to carbohydrates that non-ruminant 
animals, including humans, poorly metabolize for energy or other nutritional uses. fiber 
provides bulk in the diet such that foods rich in fiber offer satiety without contributing 
significant calories. Current controversies aside, there is ample scientific evidence to show 
that prolonged intake of dietary fiber has various positive health benefits, especially the 
potential for reduced risk of colon and other types of cancer. 
recent microbiome twin studies by Jeff Gordon addressing the interrelationships 
 between diet and gut microbial community structure/function indicated that differences 
in our gut microbial ecology affect our pre-disposition to obesity or malnutrition and that 
diet rather than applied probiotics was the single most important characterization of gut 
health (turnbaugh et al., 009). These studies involved characterization of the gut micro-
biota/microbiome of twins, concordant or discordant for malnutrition, living in several 
developing countries, who were sampled just prior to, during and after treatment. 
when such colonic bacteria (especially bifidobacteria) ferment dietary fiber or other 
unabsorbed carbohydrates, the products are short-chain saturated fatty acids. These short-
chain fatty acids may enhance absorption of minerals such as iron, calcium, and zinc, 
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induce apoptosis—preventing colon cancer—and inhibit 3-hydroxy-3-methylglutaryl 
coenzyme-a reductase (HMG-Coar), thus lowering low-density lipoprotein (LDL) 
production (German, 005). Plants are effective at making both polymeric carbohydrates 
(e.g. starches and fructans), and individual sugars (e.g. sucrose and fructose). The bio-
synthesis of these compounds is sufficiently understood to allow the bioengineering of 
their properties and to engineer crops to produce polysaccharides not normally present. 
Polymeric carbohydrates such as fructans have been produced in sugar beet, and inulins 
and amylase (resistant starch) in potato (Hellwege et al. (000) without adverse affects 
on growth or phenotype. a similar approach is being used to derive soybean varieties 
that contain some oligofructan components that selectively increase the population of 
beneficial species of bacteria in the intestines of humans and certain animals and inhibit 
growth of harmful ones (Bouhnik et al., 999).   
Novel Lipids
Genomics, specifically marker-assisted plant breeding, combined with recombinant Dna 
technology provide powerful means for modifying the composition of oilseeds to improve 
their nutritional value and provide the functional properties required for various food-oil 
applications. Genetic modification of oilseed crops can provide an abundant, relatively 
inexpensive source of dietary fatty acids with wide-ranging health benefits. Production of 
such lipids in vegetable oil provides a convenient mechanism to deliver healthier products 
to consumers without the requirement for significant dietary changes. Major alterations 
in the proportions of individual fatty acids have been achieved in a range of oilseeds using 
conventional selection, induced mutation and, more recently, post-transcriptional gene 
silencing. examples of such modified oils include: low- and zero-saturated fat soybean 
and canola oils, canola oil containing medium chain fatty acids (MCfa) whose ergogenic 
potential may have application in LDCs, high stearic acid canola oil (for trans fatty acid-
free products), high oleic acid (monounsaturated) soybean oil, and canola oil containing 
the polyunsaturated fatty acids (PUfa), λ-linolenic (GLa; :3 n-) stearidonic acids 
(SDa; C: n-3), very-long-chain fatty acids (Zou et al., 99) and ω-three fatty acids 
(Yuan and Knauf, 99). These modified oils are being marketed and many countries 
have a regulatory system in place for the pre-market safety review of novel foods produced 
through conventional technology. 
edible oils rich in monounsaturated fatty acids provide improved oil stability, flavor, and 
nutrition for human and animal consumption. High-oleic soybean oil is naturally more 
resistant to degradation by heat and oxidation, and so requires little or no post-refining 
processing (hydrogenation), depending on the intended application. oleic acid (:), a 
monounsaturate, can provide more stability than the polyunsaturates, linoleic (:) and 
linolenic (:3). antisense inhibition of oleate desaturase expression in soybean resulted 
in oil that contained >0% oleic acid (3% is normal) and had a significant decrease in 
PUfa (Kinney and Knowlton, 99). Dupont has introduced soybean oil composed of 
at least 0% oleic acid, and linolenic acid of about 3%, and over 0% less saturated fatty 
acids than commodity soybean oil. Monsanto’s vistive contains less than 3% linolenic 
acid, compared to % for traditional soybeans, resulting in more stable soybean oil and 
less need for hydrogenation. 
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a key function of α-linolenic acid (aLa) is as a substrate for the synthesis of lon-
ger-chain ω-3 fatty acids found in fish, eicosapentaenoic acid (ePa; C0:5n-3) and 
docosahexaenoic acid (DHa; C:n-3), which play an important role in the regulation 
of inflammatory immune reactions and blood pressure, brain development in utero, and, 
in early postnatal life, the development of cognitive function. Stearidonic acid, ePa, and 
DHa also possess anti-cancer properties (Christensen et al., 999; Smuts et al., 003; 
reiffel and McDonald, 00). research indicates that the ratio of n-3 to n- fatty acids 
may be as important to health and nutrition as the absolute amounts present in the diet 
or in body tissues. Current western diets tend to be relatively high in n- fatty acids and 
relatively low in n-3 fatty acids. Production of a readily available source of long-chain-
PUfa, specifically ω-3 fatty acids, delivered in widely consumed prepared foods could 
deliver much needed ω-3-fatty acids to large sectors of the population with skewed n-:
n-3 ratios. In plants, the microsomal ω- desaturase-catalyzed pathway is the primary 
route of production of polyunsaturated lipids. Ursin et al. (000, 003) has introduced 
the ∆- desaturase gene from a fungus (Mortierella) succeeding in producing ω-3 in 
canola. In a clinical study, James et al. (003) observed that SDa was superior to aLa 
as a precursor by a factor of 3. in producing ePa, DHa and docosapentaenoic acid 
(DPa, C:5n-3). transgenic canola oil was obtained that contains >3% SDa, with 
an overall n-: n-3 ratio of 0.5. 
However, not all ω- fas are created equal. Gamma linolenic acid (GLa, C:3n-) is 
an ω- fatty acid with health benefits that are similar and complementary to the benefits of 
ω-3 fas including anti-inflammatory effects, improved skin health and weight-loss main-
tenance (Schirmer and Phinney, 00). a Davis, Ca, company, arcadia, has engineered 
GLa safflower oil, with up to 0% GLa, essentially quadrupling the levels obtained in 
source plants such as evening primrose and borage (Bnet, 00). Structural lipids also 
have positive health benefits; for example, in addition to their effect in lowering cholesterol, 
membrane lipid phytosterols have been found to inhibit the proliferation of cancer cells 
by inducing apoptosis and G/S cell-cycle arrest through the HMG-Coar as noted above 
(awad, 000). In addition to this and the above, specialty oils may also be developed with 
further pharmaceutical and chemical feedstock applications in mind. 
Micronutrients
Vitamins and Minerals
Micronutrient malnutrition, the so-called hidden hunger, affects more than half of the 
world’s population, especially women and preschool children in developing countries 
(Un SCn, 00). even mild levels of micronutrient malnutrition may damage cognitive 
development and lower disease resistance in children, and increase incidence of childbirth 
mortality. The costs of these deficiencies, in terms of diminished quality of life and lives 
lost, are large (Pfeiffera and McClafferty, 00). The clinical and epidemiological evidence 
is clear that select minerals (iron, calcium, selenium and iodine) and a limited number of 
vitamins (folate, vitamins e, B and a) play significant roles in maintenance of optimal 
health and are limiting in diets. 
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as with macronutrients, one way to ensure an adequate dietary intake of nutritionally 
beneficial phytochemicals is to adjust their levels in plant foods. Using various approaches 
including genomics, vitamin-e levels are being increased in several crops, including 
soybean, maize and canola, while rice varieties are being developed with the enhanced 
vitamin-a precursor, β-carotene, to address vitamin-a deficiency that leads to macular 
degeneration and impacts development. a similar method was used by Monsanto to 
produce β-carotene in canola and by fauquet in cassava. The latter is being field tested 
in nigeria. ameliorating another major deficiency in LDCs, namely of minerals such as 
iron and zinc, has also been addressed. Iron is the most commonly deficient micronutrient 
in the human diet, affecting an estimated  to  billion people. anemia, characterized by 
low hemoglobin, is the most widely recognized symptom of iron deficiency, but there are 
other serious problems such as impaired learning ability in children, increased suscep-
tibility to infection, and reduced work capacity. Drakakaki et al. (005) demonstrated 
endosperm-specific co-expression of recombinant soybean ferritin and Aspergillus phytase 
in maize which resulted in significant increases in the levels of bioavailable iron. a similar 
end was achieved with lettuce (Goto et al., 000). 
a rather interesting approach was taken by Connolly (00) to increase the levels of 
calcium in crop plants by using a modified calcium/proton antiporter [known as short 
cation exchanger  (sCaX)] to increase Ca transport into vacuoles. She also demonstrated 
that consumption of such Ca-fortified carrots results in enhanced Ca absorption. This 
demonstrates the potential of increasing plant-nutrient content through expression of a 
high-capacity transporter and illustrates the importance of demonstrating that the fortified 
nutrient is bioavailable. other targets include folate-enriched tomatoes and isoflavonoids 
(DellaPenna, 00; Yonekura-Sakakibara et al., 00).
Micronutrients
Phytochemicals
Unlike for vitamins and minerals, the primary evidence for the health-promoting roles 
of phytochemicals comes from epidemiological studies, and the exact chemical identi-
ties of many active compounds have yet to be determined. However, for select groups of 
phytochemicals, such as non-provitamin-a carotenoids, glucosinolates, and phytoestro-
gens, the active compound or compounds have been identified and rigorously studied. 
epidemiologic studies have suggested a potential benefit of the carotenoid lycopene in 
reducing the risk of prostate cancer, particularly the more lethal forms of this cancer. five 
studies support a 30% to 0% reduction in risk associated with high tomato or lycopene 
consumption in the processed form in conjunction with lipid consumption, although 
other studies with raw tomatoes were not conclusive (Giovannucci, 00). Since carot-
enoids are lipid soluble and cooking breaks down carotenoid-binding proteins, this is 
not an unexpected outcome. In a study by Mehta et al. (00) to modify polyamines to 
retard tomato ripening, they found an unanticipated enrichment in lycopene with levels 
up by - to 3.5-fold compared to conventional tomatoes (table c). This is a substantial 
enrichment, exceeding that so far achieved by conventional means. This approach may 
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work in other fruits and vegetables. flavonoids, meanwhile, are soluble in water, and 
foods containing both water soluble and fat-dissolved antioxidants are considered to offer 
the best protection against disease. anthocyanins offer protection against certain cancers, 
cardiovascular disease and age-related degenerative diseases. There is evidence that ant-
hocyanins also have anti-inflammatory activity, promote visual acuity and hinder obesity 
and diabetes. Gonzali et al. (009) and Butelli et al. (00) used snapdragon-transcription 
factors to achieve high levels of expression of oxygen-scavenging anthocyanins in tomatoes. 
In a pilot test, the lifespan of cancer-susceptible mice was significantly extended when 
their diet was supplemented with purple tomatoes compared to supplementation with 
normal red tomatoes.
other phytochemicals of interest include related polyphenolics such as resveratrol, which 
has been demonstrated to inhibit platelet aggregation and eicosanoid synthesis in addi-
tion to protecting the sirtuins, genes implicated in Dna modification and life extension; 
flavonoids, such as tomatoes expressing chalcone isomerase that show increased contents 
of the flavanols rutin and kaempferol glycoside; glucosinolates and their related products 
such as indole-3 carbinol (I3C); catechin and catechol; isoflavones, such as genistein 
and daidzein; anthocyanins; and some phytoalexins (table d). a comprehensive list of 
phytochemicals is provided in table . to reiterate: although a growing knowledge base 
indicates that elevated intakes of specific phytochemicals may reduce the risk of diseases, 
such as certain cancers, cardiovascular diseases, and chronic degenerative diseases asso-
ciated with aging, further research and epidemiological studies are still required to prove 
definitive relationships.  
Plants fighting Back
Plants produce many defense strategies to protect themselves from predators. Many, such 
as resveratrol and glucosinolates, which are primarily pathogen-protective chemicals, 
also have demonstrated beneficial effects for human and animal health. Many, however, 
have the opposite effect. for example, phytate, a plant phosphate-storage compound, is 
considered an anti-nutrient as it strongly chelates iron, calcium, zinc and other divalent 
mineral ions, making them unavailable for uptake. non-ruminant animals generally lack 
the phytase enzyme needed for digestion of phytate. Poultry and swine producers add 
processed phosphate to their feed rations to counter this. excess phosphate is excreted 
into the environment resulting in water pollution. when low-phytate soybean meal is 
utilized along with low-phytate maize for animal feeds, the phosphate excretion in swine 
and poultry manure is halved. a number of groups have added heat-and acid-stable 
phytase from Aspergillus fumigatus inter alia to make the phosphate and liberated ions 
bioavailable in several crops (Potrykus, 999). to promote the reabsorption of iron, a 
gene for a metallothionein-like protein has also been engineered. Low-phytate maize was 
commercialized in the United States in 999 (wehrspann, 99). In november 009, 
the Chinese company origin agritech announced the final approval of the world’s first 
genetically modified phytase-expressing maize (allBusiness, 009). research indicates 
that the protein in low-phytate soybean is also slightly more digestible than the protein in 
traditional soybean. In a poultry-feeding trial, better results were obtained using transgenic 
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plant material than with the commercially produced phytase supplement (Keshavarz, 
003). Poultry grew well on the engineered alfalfa diet without any inorganic phosphorus 
supplement, which shows that plants can be tailored to increase the bioavailability of 
this essential mineral. a similar effect was achieved in wheat by a Danish group, whose 
temperature-tolerant phytase resisted boiling (Brinch-Pedersen et al., 00)
other anti-nutrients that are being examined as possible targets for reduction are tryp-
sin inhibitors, lectins, and several heat-stable components found in soybean and other 
crops. Likewise, strategies are being employed to reduce or limit food allergens (albumins, 
globulins, etc.), malabsorption and food intolerances (gluten) and toxins (glycoalkaloids, 
cyanogenic glucosides, phytohemagglutinins) in crop plants and aesthetic undesirables 
such as caffeine (ogita, 003). examples include changing the levels of expression of the 
thioredoxin gene to reduce the intolerance effects of wheat and other cereals (Buchanan 
et al., 99). Using rnai to silence the major allergen in soybean (P3 a member of 
the papain superfamily of cysteine proteases) and rice (– kDa allergenic proteins). 
Blood-serum tests indicate that p3-specific Ige antibodies could not be detected after 
consumption of gene-silenced beans (Helm et al., 000; Herman et al., 003). 
Modern biotech approaches can be employed to down-regulate or even eliminate the genes 
involved in the metabolic pathways for the production, accumulation, and/or activation 
of toxins in plants. for example, the solanine content of potato has already been reduced 
substantially using an antisense approach, and efforts are underway to reduce the level 
of the other major potato glycoalkaloid, chaconine (McCue et al., 003). work has also 
been done to reduce cyanogenic glycosides in cassava through expression of the cassava 
enzyme hydroxynitrile lyase in the roots (Siritunga and Sayre, 003).
when “disarming” plants’ natural defenses in this way, one must be aware of poten-
tially increased susceptibility to pests, diseases and other stressors, therefore the recipient 
germplasm should have input traits to counter this.  
Prospects for Crop Biotechnology
Improvement of crop-nutritional quality is a technical challenge hampered by a lack of 
basic knowledge of plant metabolism and the need to resolve the complexity of intersecting 
networks of thousands of metabolic pathways. with the tools now available through the 
field of genomics, proteomics, lipomics, glycobiomics, metabolomics and bioinformatics, 
we have the potential to study and manipulate genes and pathways at the metalevel, and 
simultaneously study the expression and interaction of transgenes on tens of thousands 
of endogenous genes. with these newly evolving tools, we are beginning to dissect the 
global effects of metabolic engineering on metabolites, enzyme activities and fluxes. for 
essential macro- and micronutrients that are limiting in various regional diets, the strategies 
for improvement are clear and concerns such as pleiotropic effects and safe upper limits 
are easily addressed. However, for many putative health-promoting phytochemicals, clear 
links with health benefits are yet to be demonstrated. In addition, one must be careful 
when extrapolating attributes from an individual substance acting independently to that 
substance acting within a complex milieu. However, if such links can be established, it 
will make it possible to identify the precise compound or compounds to target and which 
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crops to modify to achieve the greatest nutritional impact and health benefit. with rapidly 
emerging technologies, the increase in our understanding of, and ability to manipulate, 
plant metabolism during the coming decades should place plant researchers in the posi-
tion of being able to modify the nutritional content of major and minor crops to improve 
many aspects of human and animal health and wellbeing. 
However, the actual commercialization of such products may have little to do with 
technical limitations and more to do with external constraints, primarily the process of 
regulatory approval. The flagship of improved nutritional varieties, namely β-carotene-
enhanced rice commonly referred to as “golden rice,” despite being under consideration 
since the late nineties and subject to a barrage of risk assessments, is unlikely to be ap-
proved until 0 at the earliest. Ingo Potrykus, the developer, says that an unreasonable 
amount of testing has been required without scientific justification. In a recent Nature 
article (Potrykus, 00) he laid the blame solely at the door of the regulatory process, 
which he considers excessive, observing that unjustified and impractical legal require-
ments are stopping genetically engineered crops from saving millions from starvation 
and malnutrition.
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Q&A
Moderator: alan B. Bennett
University of California
Davis, California
Tom Tomich (University of California-Davis): Martina, you talked about the huge regula-
tory hurdles. Carl talked earlier about the notion of risk and benefit, and so my question 
has two parts. who credibly do those risk/benefit balancing studies and how are they 
communicated to the public? 
Martina Newell-McGloughlin: The regulations in this country are at least somewhat ra-
tional. The three main agencies that cover biotechnology are the ones you might expect. 
The USDa, where most of the deregulation process is gone through, was one of the 
first to determine that, in fact, they didn’t have to introduce any new regulations—that 
those on the books were sufficient—but, that they would need to develop guidelines that 
allowed people to go through this process of determining if something had, or could 
reach, deregulation status, that is generally regarded as safe. The other agencies then are 
the ePa, looking at the environmental impact, and the fDa, where there is actually a 
voluntary consultation. You would be pretty stupid not to consult with them, so every 
company does.
Tomich: But my question wasn’t who regulates. In order to look at the risk/benefit you 
would actually have to look at the agricultural, environmental and health—
Newell-McGloughlin: all they are looking at is the risk. There is no focus—and, in fact, that 
is one of the points I made here—there is no focus at all, anywhere, on the benefits.
Tomich: So in academia? why doesn’t somebody do it?
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Newell-McGloughlin: It’s not part of the process. we do it. absolutely the benefit com-
ponent is done. nobody would be doing any of the work that I told you about because 
most of that is still sitting in the lab. It’s all aspirational. one would hope that this will 
get through the deregulation process. But in some areas—europe—it appears to be going 
backwards. There is such a focus on the precautionary principle that, in fact, it would 
probably be illegal, if you are going to interpret it to its fullest extent; it would be illegal 
to do anything for the first time. How ridiculous is that? So you are actually forced to 
depend on older, less-safe technologies. I’ll give you an example from a personal heritage 
perspective. Growing up, we used to use a particular fungicide called bluestone, copper 
sulfate, to control late blight in potato. now BaSf has developed a potato with resis-
tance to Phytophthora infestans by taking two genes from another potato, a solanaceous 
species in Mexico, and introducing them and getting complete resistance, and stable 
resistance—which is often hard with our genes—against late-blight disease. I thought 
they would be going with open arms in Ireland to get them. Instead they pulled out the 
plug, because they were told by certain groups that these were toxic. They failed under 
the precautionary principle. The alternative is using copper sulfate, which has organic 
approval because it is considered “natural.” This is a complete false dichotomy, as Carl said 
earlier, this notion of natural and non-natural. The focus should be on good and effica-
cious versus non-good, or less good. with the precautionary principle, people are stuck, 
depending on older, less-safe, less-efficacious and—for sure—less sustainable production 
systems. So, when you are in that sort of situation and there is no focus on efficacy and 
benefits, it is really difficult to get past it. 
Barbara Schneeman (US Food and Drug Administration): I just wanted to comment on 
the risk-benefit paradigm because—at least coming from the fDa perspective—to be on 
the market, foods have to be safe. They don’t have to prove a benefit to be on the market 
and on the food side of fDa you actually, in fact, separate the risk-benefit construct, 
because, to be on the market, you have to be safe. You don’t have to prove a benefit. It’s 
really in drugs that you get into a risk-benefit balance. now I think, Martina, you are 
trying to also address environmental benefits, but, at the end of the day, you still have to 
consider, “Is the food safe?”
Newell-McGloughlin: Yes. That’s what I said, it’s all risk in that respect. now, of course, 
we could run ourselves into a real problem here if we are suggesting proving efficacy. now 
you are up against drugs. You are now looking at $ billion to $ billion dollars to take 
it to market, if we are going to be looking at a pharmaceutical effect from a bioactive 
component. It’s a very finely balanced line we need to walk here, because we don’t want 
to have approval purely based on demonstrating efficacy.
Michael Jacobson (Center for Science in the Public Interest): Martina, on your last slide 
you listed a bunch of challenges. I would think a key challenge is finding something that 
consumers find useful, and I haven’t seen anything that is anywhere near the pipeline. 
Monsanto has come to me and said, “Do you have ideas of something that might be use-
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ful?” Until you get something obviously useful, like taste, consumers will say, “why should 
we eat the genetically modified wheat or canola oil or whatever?” Do you have ideas?
Newell-McGloughlin: The short-chain fructans is a particular example there, where they 
actually taste sweet. Cynthia Kenyon, looking at genes that increase longevity, found most 
of them are actually sensate. our primitive ancestors, the worms, et cetera, when sensing 
the environment, are actually responding to sugars. She has completely cut sugar from her 
diet and she looks good. The idea with the short-chain fructans is that you can, potentially, 
eliminate, high fructose corn syrup, sucrose and fructose from your diet.
Jacobson: How many years away do you think those are from market?
Newell-McGloughlin: That’s the problem. It’s sitting in Dr. Coop’s lab because he knows 
that to get it through eU approval would be an enormous hurdle; the activation energy 
is so high, especially in europe. rather interestingly, on the animal side—since I talked 
about using plants as factories—the very first approval of using a genetically engineered 
animal to produce pharmaceuticals in its milk was given in europe. There was a whole 
different view here, because, in fact, it was a pharmaceutical, an anti-thrombin agent at 
that point in time. It was a full year afterwards that the US approved it because, rather 
interestingly enough, the US was focusing on the health of the animal as well—this 
sounds counterintuitive—whereas europe was looking at the safety and efficacy of the 
anti-thrombin drug itself, atryn. But that’s just an aside. The issue is the cost, the time, 
the enormous effort to get it through.
Michael Kahn (Washington State University): I’ve come to the conclusion that many people 
oppose GMos less from the risk of the GMo itself than from the companies that are trying 
to put them out. we are in a situation now, which is ironic, where the Monsantos have 
figured that they can make enough money by pushing these things through the regula-
tory process, that they are willing to go ahead and do it, whereas, as you have indicated, 
small companies, and particularly producers of minor crop fruits and vegetables that we 
have been talking about as being nutritious here, are not going to be able to afford it. 
The whole market of those crops, in many cases, is less than what people are estimating 
for the certification. and so, instead of blocking monopolistic properties of Monsantos, 
the current regulatory situation is actually promoting them.
Newell-McGloughlin: for sure you could debate that and I absolutely agree, small com-
modities have a much harder row to hoe. The potato is a perfect example. again it was 
produced by a big company, but, in fact, I heard from one individual who blithely told 
me, “we are not allowing that BaSf product in here.” no focus on the notion that you 
are going to reduce the actual amount of chemical used to control it. The big focus was 
that it was intellectual property owned by BaSf. But the reason PIPra exists actually is 
to focus on small commodity groups, which is a huge issue, of course, in California. we 
produce about 50 commodities. So it is much, much more difficult for us to go through 
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the process of deregulation because of the cost of the biosafety hurdle. But Monsanto will 
tell you they find it a total pain too. They were talking specifically about new abiotic-
stress-resistant strains that they are bringing in, using transcription factor modifications. 
But they are back to square one with the USDa and ePa. of course, needless to say, 
they have deeper pockets than we do in academia, so it’s definitely an easier process for 
them than it is for us. and there have been very few products, in fact probably the only 
really strong product that has come out of academia is the ringspot-resistant papaya, 
from Dennis Gonsalves in Hawaii, and most of that work was done when he was at 
Cornell. There is no natural resistance against this virus, so it doesn’t matter how good 
your marker-assisted selection process is. If the genes aren’t in there you can’t breed them 
in, no matter how much you try. So he took a copy of the coat protein from the virus, 
stuck it in there and it worked through the process that got the nobel Prize, but not for 
him, called rna interference, which confers protection against ring spot. In addition, 
it helps organic farmers, who grow rings of biotech crop around their non-engineered 
varieties to reduce the viral reservoir. However, back to your point, that was one of the 
few products that has gone through the process from an academic situation. all of the 
others have come from companies. 
Alan McHughen (University of California-Riverside): Thank you Martina—enlightening 
and entertaining as usual. Just a quick comment on where are the products of benefit 
to consumers. If you ask consumers whether they would support a product, a food, a 
crop that could be developed with fewer pesticides, they would say, “Yeah, that is a good 
product. I’ll support that and I’ll even pay extra for it.” So that is a benefit to consumers. 
They might not be aware of it directly. and, secondly, several recent economic studies, 
including one from our own national research Council of the national academies, 
have resulted in publication of economic analyses of the benefits of biotechnology to US 
agriculture, and determined there is a huge economic return that is not being captured 
exclusively by companies or even by farmers, but by society at large. and that means in 
practical terms you are paying less for your food because of agricultural biotechnology. 
That’s something that consumers can relate to, but they are generally not aware of it.
McGloughlin: They’re not aware of it. It’s opaque to them.
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as sTudenT Voice aT naBc 22 participants, we were asked to discuss our views in terms of what we got out of the conference, what we felt was missing, and some needs that we can address as young scientists. our backgrounds included 
food science, nutrition, plant science, animal science, and applied economics.
overall, our view of the meeting was very positive. we were inspired by many of the 
high-quality talks and discussion sessions. we identified key strengths and aspects that 
we especially appreciated:
• Incorporating a variety of speakers with diverse perspectives and opinions.
• Showcasing specific examples and case studies with potential applications. Such 
as the BioCassava-Plus program and the mammalian milk genome project.
• addressing problems related to the diet in the United States and Canada as well 
as in developing countries.
1to increase graduate-student participation at naBC conferences, the Student Voice at NABC program 
was launched ahead of naBC 9. feedback from those involved was positive, therefore the program 
was continued for naBC 0,  and . Grants of up to $50 are offered to graduate students at 
naBC-member institutions (one per non-host institution) to assist with travel and lodging expenses. 
In some cases, travel and lodging expenses were paid by the home university for a second student. 
registration fees are waived for the Sv participants. naBC-member institutions are listed on page v. 
 Student Voice delegates are expected to attend all of the plenary sessions as well as the breakout workshops 
then to meet as a group to identify current and emerging issues relevant to the conference subject matter. 
Information on the Student Voice at naBC 3 will be available in due course at http://nabc.cals.cornell.
edu/studentvoice/.
2The Student Voice report was presented verbally at naBC  by rosalee Hellberg. This report was assembled 
by Ms. Hellberg and watchareeya Kuldamrong, with input from the other students.
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• referring to scientific studies and the use of specific details or data from these 
studies to support presentation points.
• Discourse that connected nutrition science and regulation policy.
• an overall excellent flow of the meeting. 
as young scientists, we identified several messages and needs to address in the area of 
agriculture, food, and health, including:
• The importance of consumer education and awareness.
• Because human behaviour is very difficult to change, we will need to consider 
improving the quality of foods that are already a part of the consumers’ diets in 
addition to promoting behavioural changes.
• The application of science, especially biotechnology, to address the need for 
healthy food among poverty-level populations.
• Development of solutions at the community level, such as Farm2School and the 
Old Grove Orange Program, are valid approach to incorporating healthy foods into 
children’s diets.
• Clinical trials on the health benefits of specific foods must be conducted in order 
to obtain valid health claims.
finally, we discussed suggestions that could be incorporated into future meetings:
• a greater emphasis on the potential solutions when discussing the problems as-
sociated with human health.
• an additional session focused on social science including:
 — Linking healthful advances in biotechnology to consumer acceptance.
 — How to address public perceptions of biotechnology.
 — Consumer behaviour studies focused on incorporation of healthy foods 
into the diet.
 — The effect of the media on consumer behavior.
• More information on agriculture, farming and the economics behind incorporat-
ing genetically engineered crops and biotechnological food products.
• More details on scientific studies, specific case studies, and examples rather than 
broad, all-inclusive talks.
• we would have liked more time to talk with the speakers either individually or 
in small groups. Perhaps, speakers could have either been available in designated 
areas after their talks or incorporated into the breakout-session discussions.
• a debate on the topics addressed, including ones with potential for controversy, 
would have been beneficial.
In conclusion, human health can be promoted by linking agriculture, food and nu-
trition; as Hippocrates once said, “Let food be thy medicine, thy medicine shall be thy 
food.” naBC  was an enriching experience that has inspired us to ask questions and 
to work to find solutions that improve human health through science. we greatly thank 
the organizers for giving us this opportunity to attend.
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Food and Agricultural Research:
Innovation to Transform Human Health
• The role that food plays in human health is historic and broad. “Let your food be 
your remedy,” attributed to Hippocrates 24 centuries ago, and “an apple a day 
keeps the doctor away” both encapsulate the food-health relationship.
•   A 21st-century plan to make food and agriculture a full partner in human health is 
proposed. It builds on multiple seminal contributions to key treatment advanc-
es from research in food and agriculture, and expands low-cost approaches and 
quality-of-life beneﬁ ts by mitigating diet-related diseases.
•    A 10% reduction in healthcare costs would save over $200 billion every year.
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March 6, 2009
The National Agricultural Biotechnology Council (NABC), a consortium of over thirty major research and educational institutions in the United States 
and Canada, has developed Food and Agricultural Research: Innovation to 
Transform Human Health. This document proposes a 21st-century plan to make 
food and agriculture a full partner in improved human health. The proposal builds 
on multiple seminal contributions to key treatment advances from research in 
food and agriculture, including veterinary medicine and nutrition, and expands 
low economic-cost and quality-of-life bene ts through mitigation of diet-related 
disease.
We are excited by this opportunity for food and agricultural research to expand its 
contributions to our human-health challenge. The track record and potential are 
succinctly stated and a plan of action outlined. A 10% reduction in healthcare costs 
would be equivalent to over $200 billion annually.
National Agricultural Biotechnology Council
B 15 Boyce Thompson Institute
Tower Road
Ithaca, NY 14853
607-254-4856   Fax-254-8680
http://nabc.cals.cornell.edu/   nabc@cornell.edu
Providing an open forum for exploring issues in agricultural biotechnology
           Bruce A. McPheron
           Associate Dean for Research &
           Director of the Agricultural
               Experiment Station
           College of Agricultural Sciences
           The Pennsylvania State University
           University Park, PA
         Ralph W.F. Hardy
         President
         NABC
         Boyce Thompson Institute for
             Plant Research, Inc.
         Ithaca, NY
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Food and Agricultural Research:
Innovation to Transform Human Health
Executive Summary
Delivery of healthcare is one of the most pressing social, economic, technical and political challenges of our time. Of the expenditure on healthcare in the United States—$2.2 trillion, 16% of the gross 
domestic product in 2007, and growing at more than twice the rate of in ation—diet-related chronic 
diseases, diabetes, heart disease, stroke, cancer, obesity and asthma, etc., account for about 75%. Emphasis 
has been on therapeutic and surgical treatments after disease development; prevention through food and 
diet has been under-utilized.
Research in food and agriculture has the potential to aid development of relatively low-cost, preventive 
solutions to these pressing healthcare issues. This Food and Agricultural Research: Innovation to 
Transform Human Health report provides justi cation and an action plan.
Research in food and agriculture, including nutrition and veterinary medicine, has an impressive record. 
Multiple seminal, innovative and transforming contributions have been made to the discovery, description, 
prevention and treatment of human disease including:
•    Vaccines  •    Models   •    Prion Diseases
• Antibiotics         • Production Systems  •    Small RNA Therapeutics
• Biosourced Therapeutics      • HIV    •    Biopharma Therapeutics
Developments in biology, including molecular genetics, will provide the knowledge, tools, and 
opportunities to couple food and agriculture with new approaches to improving human health and 
containing costs.. These mainly preventive approaches include:
•    Essential Nutrient       •    Toxin/Allergen Reduction •    Nutrigenomics
•    Functional Foods       •    Altering Diet   •    Food Safety 
•    Probiotics         •    Enhanced Flavor/Taste •    Education/Communication
To expeditiously bring these bene ts to human healthcare, we need a structure that integrates food and 
agricultural research as a full partner in the national health-research mission. Current national funding for 
research on food and agriculture must be expanded substantially to ensure timely delivery of preventive 
bene ts. This investment is justi able in terms of the cost savings that will result from disease prevention. 
A 10% cost reduction would save over $200 billion every year.
The new funding should be competitive and open to individuals and, in particular, to self-assembled 
groups possessing necessary skills, e.g. scientists, sociologists, economists, communicators/educators, 
marketers and regulators, from academe, government and industry. Examples of such structures exist. 
Each program will target speci c objectives to improve health.
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Introduction1,2
Preservation of human health is one of the most pressing social, economic, technical and political challenges of 
our time. $2.2 trillion—16% of the gross domestic product—
were spent on US human healthcare in 2007. These costs 
are growing at an unsustainable rate of over twice that 
of in ation in the United States and Canada. Diet-related 
chronic diseases such as diabetes, heart disease, stroke, 
cancer, obesity and asthma account for about 75% of US 
expenditure3. Food and agricultural research must become 
full partners to provide the necessary knowledgebase and 
technology to aid development of proactive solutions 
to healthcare issues that are primarily preventive and 
relatively low cost rather than reactive therapeutic and 
surgical solutions that are costly in economic and quality-
of-life terms.
Food and Agricultural Research: Innovation to 
Transform Human Health justi es greatly expanded 
investment in this area. 
Food will continue to provide nutrition, but will also 
have a prominent role in the prevention of disease. This 
role for food and agricultural research is potentially huge, 
but is poorly recognized and underfunded. The objective 
of this white paper is to expand awareness and stimulate 
action so that human health will fully bene t from the 
projected major contributions from food and agriculture. 
The explosion in life-science knowledge and technology 
are creating novel opportunities for timely delivery of these 
bene ts.
Major Seminal Contributions 
and Future Potential4
Research in food and agriculture, including nutrition and veterinary medicine, has an impressive record 
with many seminal contributions to the discovery, 
description, prevention and treatment of disease. Examples 
of transformative, innovative contributions, and future 
potentials, include:
1  The National Agricultural Biotechnology Council has already pro-
duced reports relating to food, agriculture and human health. Most rel-
evant is NABC Report 14, Integrating Agriculture, Medicine and Food 
for Future Health (2002); others are NABC Report 2, Agricultural
Biotechnology: Food Safety and Nutritional Quality for the Consumer 
(1990) and NABC Report 17, Agricultural Biotechnology: Beyond Food 
and Energy to Health and the Environment (2005).
2  The proposal is relevant to the United States and Canada. Public agri-
cultural research institutions in both countries are members of NABC.
3  Centers for Disease Control and Prevention (2004). Chronic Disease 
Overview.
4  Links to additional information are available at NABC’s webpage 
http://nabc.cals.cornell.edu/.
Vaccines
Vaccines are one of the most ef cacious and economical 
methods of preventing disease and may also be used as therapy. 
Here, agricultural research was seminal. Cowpox provided 
the  rst human vaccine as cross-protection against small 
pox, which led to its eradication. In fact, the word vaccine, 
which was  rst used to describe the use of a cowpox-related 
virus, Vaccinia, to protect against smallpox, is derived from 
the Latin word for cow (vacca). The FDA recently approved 
the  rst human vaccine against bird  u as a contingency 
against future outbreaks. Experimental vaccines produced 
by plants have been shown to lead to human immunity. 
Plant-produced vaccines have shown therapeutic potential 
for treating cancer; within mere weeks, tobacco plants 
genetically engineered with individual human-lymphoma 
antigens produced vaccines that were immunogenic.
Antibiotics
Agricultural research also provided the seminal advance 
for microbially-produced antibiotic therapy. Fleming 
discovered penicillin and showed that it was produced by a 
fungus commonly used in cheese making. However, it was 
not useful as a therapy until agricultural scientists selected 
fungal strains with higher productivity, and developed the 
fermentation system to produce clinically useful quantities 
for use in World War II. Other antibiotics are products of 
agricultural research.
Biosourced Therapeutics
Botanicals have been the source of over 25% of human 
therapeutic drugs. Aspirin for pain (and now cardiac-
disease prevention) was originally isolated from willow 
bark; taxol for treating certain cancers was derived from 
the yew tree; the blood thinner coumadin was extracted 
from moldy sweet clover; and artemisinin from wormwood 
is a new cure for malaria, replacing quinine derived from 
cinchona bark. Therapeutics derived from animal sources 
include porcine insulin used to treat diabetes.
Chicken Dog, Pig & Plant Models
Chicken, dog, pig and, more recently, plant models have 
been useful in understanding and treating human diseases. 
Gene therapy to overcome retina-related blindness in dogs 
was a model for recent initial success in similar treatment 
of human blindness. Newborn pigs were used to understand 
how rotaviruses cause diarrhea and to develop oral 
vaccines against these devastating pathogens. Research 
using the model plant arabidopsis yielded discoveries 
with potential human-health bene ts in the areas of, for 
example, in ammation and tumor suppression, macular 
degeneration, and arthritis.
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Production Systems
Chicken eggs are broadly used in human vaccine production 
partly because, while they support growth of mammalian 
pathogens, the product carries no risk of disease from the 
presence of avian pathogens. Agricultural research has led 
to the use of baculoviruses that infect insects as production 
systems for therapeutics and vaccines, e.g. HPV5 vaccine. 
These baculoviruses, grown using insect-cell lines, were 
initially developed to control insect infestations of crop 
plants.
HIV
Investigations of retroviruses in cats and chickens 
provided fundamental knowledge that jump-started 
understanding of HIV infection in the early 1980s.
Prion Diseases
Pioneering research on prion diseases like scrapie in sheep 
and mad-cow disease (bovine spongiform encephalopathy, 
BSE) in cattle provided the basis for understanding 
Creutzfeldt-Jakob disease (CJD) in humans.
Small-RNA Therapeutics & Diagnostics
Small RNAs control gene expression. Agricultural 
scientists made this seminal discovery by showing that 
they protect plants from viral infection. They are expected 
to have major impacts on cancer diagnosis and treatment, 
and treatments of cardiovascular and muscular diseases, 
diabetes, viral diseases, etc. A recent scienti c article, 
“MicroRNAs make big impression in disease after 
disease,”6 captures the potential. A 2006 Nobel Prize was 
awarded for this area of research. 
Biopharma Therapeutics & Xenotransplants
Agricultural and veterinary-medicine research produced 
the  rst transgenic plants and animals. Both transgenic 
plants and animals are being used, mainly experimentally, 
to biomanufacture therapeutics and vaccines—
“biopharma”—making it possible to rapidly scale up 
production of molecules that would otherwise be scarce or 
produced only by extraction from human tissues or blood. 
Absolute containment will be key so as to segregate pharma 
plants and animals from their food/feed counterparts. The 
Food and Drug Administration recently approved a plant-
produced vaccine for animals and a human antithrombin 
produced in goat milk for humans with genetic de ciency. 
Bioengineered pigs may be a source of organs, such as 
livers, for xenotransplantation into humans.
5   Human papilloma virus.
6   Couzin, J. (2008) Science 319 1782–1784.
Other Landmark Contributions
Agriculture and veterinary medicine7 have been pioneers 
in innovations relating to disease. Examples include the 
discovery of the  rst mammalian virus, the agent of foot and 
mouth disease. Rous sarcoma was the  rst cancer shown 
to be caused by a virus. Marek’s disease of chickens was 
the  rst cancer treated with a vaccine. HPV5 vaccine is now 
being broadly administered to women to reduce risk of 
cervical cancer. The  rst attenuated bacterium administered 
as a vaccine was for chicken cholera. Antibody-producing B-
immune cells were discovered in bursa of chickens. Insect-
transmitted diseases such as Texas fever contributed to the 
discovery that mosquitoes transmit malaria and yellow fever. 
Agricultural research developed DDT to stop transmission 
of insect-borne diseases. Male-sterile insects led to the 
eradication of the screwworm and its contamination of 
wounds, a technology that has been used throughout the world. 
The emergence of the SARS coronavirus from an animal 
host and its pandemic spread in 2003, and recent concerns 
with bird  u and swine  u, illustrate the connection between 
diseases circulating in mammalian and avian populations and 
the potential problems they create by moving to humans.
Agricultural research related to human health has been 
recognized with over  fteen Nobel prizes, many relevant 
to human health. For example in the 1960s, the structure of 
transfer RNAs was elucidated, providing one of the keys of 
the gene-to-protein sequence in living organisms; to recognize 
this historic event, the US Department of Agriculture recently 
renamed the laboratory where the work was done the Robert 
W. Holley Center for Agriculture and Health.
Essential Vitamins, Amino Acids, Fatty Acids & 
Micronutrients
Many earlier contributions of agricultural research were 
related to the discovery of essential vitamins, amino 
acids, minerals and fatty acids. For example, rickets was 
an important disease until the discovery that insuf cient 
vitamin D is causal. Elucidation of this linkage, and the 
discovery in the 1920s that inclusion of irradiated milk in 
the diet could prevent the disease, resulted from agricultural 
7   National Research Council (2005) Critical Needs for Research in Vet-
erinary Science. Washington, DC: The National Academies Press.
Most of the above examples benefit human health 
through disease treatment, while some, such as 
vaccines, are also preventive. The following ex-
amples are mainly preventive. Some, such as 
essential vitamins, amino acids, fatty acids and 
micronutrients, have a history of preventive ben-
efits, but most of the others will require further 
research to realize such potential.
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research. Today, increasing the intake of vitamin D is being 
evaluated for prevention/treatment of certain cancers and 
cardiovascular disease. The role of omega-3 fatty acids, 
derived from  sh,  ax and nut foods, is being recognized in 
neural and cardiovascular health and in child development. 
Research is in progress to modify the fatty acid composition of 
plant lipids in order to improve the healthfulness of their oils, 
e.g. making soybean oil more like canola or olive oil. Plant 
proteins often do not have a distribution of amino acids that 
is optimal for the human diet. Corn, with insuf cient lysine, 
and soybean with too few sulfur-containing amino acids, are 
being modi ed to improve dietary balance. Vitamin A and 
its precursor ȕ-carotene are necessary for normal vision. In 
some developing countries where rice is a major part of the 
diet, children become blind because of vitamin-A de ciency. 
Genetically improved generations of Golden Rice are being 
developed to contain enough ȕ-carotene to prevent millions 
of cases of blindness. The HarvestPlus Cassava Alliance, 
with Gates Foundation and other support, seeks to increase 
the ȕ-carotene and iron and zinc contents (bioforti cation) of 
this major food crop for tropical America and Africa. Foods 
containing vitamins and other bioactives at levels much 
greater than minimal nutritional requirements are Functional 
Foods, which are expected to prevent or slow chronic disease 
development as nutrient levels have protected against acute 
nutritional diseases.
Functional Foods
Vitamins and other phytochemicals are suggested to have 
functions in disease prevention beyond their value as 
nutrients. Examples are antioxidants, phenolic acids and 
polyphenols (anthocyanins, proanthocyanidins,  avonones, 
iso avones, resveratrol—associated with red wine—and 
ellagic acid). Lycopene, glucosinolates and allyl sulphides 
have been reported to have bene cial protective and/or 
therapeutic effects on a variety of diseases. Evidence for the 
effectiveness of these compounds is based mostly on cell and 
animal studies. Human clinical data are needed to establish 
ef cacy, such as has been generated for the cholesterol-
reducing effects of ȕ-glucans in oats and barley.
Probiotics
Probiotics are microbes that promote health. Genome 
sequences of gut- ora bacteria are providing understanding 
of the molecular bases of health-promoting bene ts. Dietary 
priobiotics are being marketed on the basis of promotion 
and maintenance of human health, e.g. as yoghurts with 
clinically proven gastrointestinal bene ts.
Elimination/Reduction of Food-Borne Toxins
Plants contain toxins, their natural protectants against 
mammalian and pest predation. Some such toxins are 
highly poisonous to humans, e.g. ricin in castor beans. 
Crops bioengineered for pest resistance have reduced 
levels of mold-produced a atoxins. Some toxic compounds 
may cause chronic disease if consumed over long periods. 
Canadian researchers genetically modi ed oilseed rape, 
a mainly industrial crop, so as to reduce erucic acid and 
glucosinolates and produce canola, a major new food-oil 
source with desirable fatty acid composition. Elimination 
of plant toxins should make our foods more healthful, by 
reducing the diseases they cause.
Elimination/Reduction of Allergens
Many of our major foods—soybean, wheat, peanut, milk, 
eggs, shellfish, etc.—contain potent allergens that are 
intolerable or even lethal for some humans. Susceptibility 
to these allergens is due to a combination of genetics, 
age, history and, potentially, the gut microbiota. Some 
of these foods, e.g. rice, wheat, soybean and peanut, 
are being genetically modified to eliminate/reduce their 
allergens.
Altering Diet
Altering the diet will mean inclusion of more healthful 
foods. Ideally, these foods will be similar to traditional 
counterparts, and, in some cases, will be enhanced in 
desirable  avors and tastes. Current technology enables 
modi cation of food composition, increasing desirable 
and decreasing undesirable components. Examples of 
modi ed foods already in the marketplace include milk 
that is reduced in fat content (2%, 1% and skim) and 
free of lactose for consumers who are lactose intolerant. 
Recent elimination of trans fatty acids in processed 
foods has improved their healthfulness. Wheat products 
reduced in gluten content may lower the incidence of 
celiac-disease symptoms. Organically produced food 
is another example; a small but growing number of 
consumers perceive increased healthfulness based on 
altered production methods and are willing to seek out and 
pay a premium for food that meets the organic standard. 
Although organic foods have not been proven scienti cally 
to be more healthful, the broad expansion of organic food 
sections in grocery stores suggests ready acceptance of 
foods differentiated by veri able changes in composition 
and clinical evidence of contributions to improved health. 
Some of these foods will be directed to niche markets 
of individuals based on their genetics. An encouraging 
2008 survey8 found that 67% of Americans have made 
changes to improve their diet; however, achieving broad 
improvement in the healthfulness of the national diet will 
need major initiatives in communication and education.
8  International Food Information Council (IFIC) (2008) 2008 Food & 
Health Survey: Consumer Attitudes Toward Food, Nutrition & Health. 
Washington, DC: IFIC.
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Enhancement of Flavor & Taste
The food pyramid was developed to guide consumers in 
selecting foods with cumulative bene cial effects, e.g. those 
with less sugar and fat, and more fruits and vegetables. 
Considering the increasing rates of obesity, diabetes and 
other chronic diseases, less-healthy foods are winning the 
acceptance race versus more healthy foods. A major factor 
in this unfavourable situation is the dominant role of taste—
less-healthy foods often have preferred taste. Taste and price 
have the greatest impacts on food-purchase decisions8.
Improving taste and  avor should enhance acceptance 
and consumption of healthy foods. Different individuals 
detect  avors differently, based on their genes. For 
example, about 20% of the population do not like the taste 
of broccoli, which is recognized to provide human-health 
bene ts. Human taste buds detect at least  ve tastes: sweet, 
salty, bitter, sour and umami (savory). Researchers are 
using receptors for the various tastes to develop GRAS9
compounds, as alternatives or enhancers, to reduce intake 
of sugar, fat, salt, etc. These molecular approaches should 
provide powerful redirection of food selection with the 
potential to increase the consumption of healthier foods 
with protective bene ts.
Genetic Modiﬁ cation
Many of the bene ts described above will require genetic 
modi cation of the food source. Some will require 
“traditional” breeding as has been done over the years to most 
of our plant, animal and microbial food sources. For example, 
the conversion of  rapeseed  to canola used traditional plant 
breeding at the organismal level to produce the desired 
genetic modi cation. On the other hand, molecular genetic 
techniques were used to engineer microbial production of 
highly pure—98%—chymosin for manufacture of hard 
cheeses. The bioengineered product, FDA-approved in the 
early 1990s, has largely replaced crude chymosin (rennin, 
only 2% pure) obtained from calf stomachs. Crop plants, 
such as soybean and corn, genetically engineered with 
improved agronomic traits, are being commercialized in 
most of the world except Europe. Most of the soybean grown 
worldwide is bioengineered. For many of the projected 
health bene ts, food crops and possibly animals will need to 
be modi ed using molecular genetics as well as traditional 
methods. Research investment is needed to develop the 
scienti c base to evaluate these products and, in due course, 
to assure domestic and export markets that they are safe for 
consumption. These products must be as safe as their non-
engineered parents; in addition, they will provide health 
bene ts beyond those of their parents.
Nutrigenomics
Developments in biology and genomics will provide 
the opportunity to couple agriculture, food and nutrition 
9   Generally regarded as safe.
with new approaches to improving human health 
(nutrigenomics10). A few individual human genomes 
have already been sequenced and major efforts are being 
focused on developing low-cost genomic sequencing 
for individuals. The information generated by these 
approaches will provide the bases for clinical trials that 
can link individual genotypes to outcomes, in contrast 
to the current “one size  ts all” approach. In addition 
to genomics, an expanded use of other “omics,” such 
as metabolomics, will provide more precise diagnostic 
and treatment directions. These innovations will lead 
to a greater ability to design prevention-and-treatment 
interventions that depend on implementing diet and life-
style changes, initially at the group level and, in time, may 
be individualized.
Food Safety
Food safety, essential to human health, will be 
further improved by continued innovation. Microbial 
contamination of fruit and vegetable produce and animal 
and poultry products is the major cause of food poisoning. 
Improved diagnostics and traceability will reduce 
microbial-contamination problems. Irradiation is another 
option to minimize food-borne illnesses. Production 
practices, such as routine use of antibiotics in poultry 
and animal production, are being discontinued so as to 
diminish development of antibiotic resistance in microbes 
infecting humans, and to prolong ef cacy of antibiotics. 
Animal vaccines were recently introduced to reduce 
shedding of toxic microbes during meat processing. 
Rapid-readout online tests of poultry, animal and vegetable 
products should identify unsafe foods before they enter the 
distribution chain. In addition, country-of-origin labelling 
will facilitate traceability.
Communication & Education
Disseminating the message of the necessity to eat more 
healthfully will need massive and continuous efforts in 
our educational institutions, but also aimed at adults. The 
potential bene ts are compelling: improved longevity 
and quality of life, reduced chronic-disease rates and 
containment of national healthcare expenditures. Major 
reduction in smoking over the past 50 years provides a 
good analogy. Newsletters dealing with human nutrition are 
available from university and advocacy organizations—one 
of which has about a million subscribers11—documenting
the interest in diet and health. A rating system using stars 
to identify the nutritional value of supermarket foods has 
been introduced and should facilitate consumer selection 
of healthy food.
10  The National Academies Food and Nutrition Board (2007) Nutrige-
nomics and Beyond: Informing the Future—Workshop Summary. Wash-
ington DC: The National Academies Press.
11   Nutrition Action Newsletter, published by the Center for Science in 
the Public Interest.
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Action Plan
The following action plan is proposed for expeditious delivery of the bene ts outlined above, to reduce the 
cost of healthcare and improve the quality of life.
• Research in food and agriculture, including nutrition 
and veterinary medicine, must become a full partner in 
the national mission to improve health. Our academic 
and government structures separate food and agriculture 
and human health. Colleges of agriculture and life 
sciences function separately from colleges of medicine 
and public health; the US Department of Agriculture 
is separate from the Department of Health and Human 
Services; governmental appropriations for agriculture 
are separate from those for human health. The proposed 
One Health Initiative is an encouraging step, seeking 
to unite veterinary and human medicine. Expansion is 
needed to unite food and agricultural research with health 
in both academe and government.
• Public funding for food and agricultural research, including 
nutrition and veterinary medicine, requires a log step 
increase, not redirection of existing funding, to provide 
the knowledge and technology for the disease-prevention 
opportunities outlined. The National Institute of Food 
and Agriculture  (NIFA) initiative could be a canopy. The 
new USDA Agriculture and Food Research Initiative 
(AFRI) is a positive step; however, a much larger funding 
commitment is needed.
• Funding should be competitive and open to individuals, 
to generate new knowledge, and, in particular, to self-
assembled groups from food, agriculture and health focussed 
on speci c targets and possessing the necessary breadth of 
skills, e.g. scientists, economists, sociologists, clinicians, 
marketers, regulators and communicators/educators from 
academe, government and industry. Examples exist of 
such integrated programs in food, agriculture and human 
health12. Inclusion of academe, government and industry 
seeks to capture outstanding talent independent of sector 
location and, in the case of industry, couples the technology 
to its ultimate delivery.
• The targeted programs may include functional foods, 
probiotics, reduction/elimination of food-borne toxins, 
reduction/elimination of allergens, diet alteration,  avor 
and taste enhancement, nutrigenomics, food safety, 
communication/education, and others to be identi ed.
• An initial long-term commitment (e.g. 5 years) will be 
needed to attract the innovative individuals needed to assure 
the desired outcomes in these challenging programs.
In conclusion, food and agricultural research has an 
outstanding record of contributions to human health, many 
seminal, and this action plan should expand the established 
record and, in addition, provide important low-cost prevention 
of diet-based chronic diseases.
12   Integrated food, agriculture and human health programs include the 
North Carolina Research Campus, the Linus Pauling Institute at Oregon 
State University, the functional foods component of the Agricultural 
Bioproducts Innovation Program at Agriculture and Agri-Food Canada, 
and the USDA’s Human Research Centers, one of which is at a college 
of medicine.
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